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"Until I began to learn to draw,
I was never much interested in looking at art."
- Richard P. Feynman

Zusammenfassung
Die aktuellen technologischen Fortschritte treffen auf globale Trends wie Bevölkerungswachs-
tum, steigende Lebensstandards und erhöhte Lebenserwartung, weswegen die Nachfrage
nach Biopharmazeutika höher denn je ist. Als eine der am schnellsten wachsenden Bran-
chen konzentriert sich die biotechnologische Industrie auf die Entwicklung und Herstellung
sogenannter Biologika, also neuartiger biologischer Moleküle, welche dazu beitragen, Krank-
heiten zu heilen und damit Leben zu erhalten. Einer der wichtigsten Schritte in der
Herstellung von Biologika ist das sogenannte Downstream-Processing (DSP), das darauf
abzielt, einen Wirkstoff biologischen Ursprungs aufzureinigen. Da ein Großteil der gesam-
ten Entwicklungs- und Produktionskosten auf das DSP zurückzuführen ist, steht dieser
Bereich unter besonderem Preisdruck. Zahlreiche Ereignisse aus jüngster Vergangenheit
und absehbarer Zukunft wie z.B. der Aufstieg von Biosimilars aufgrund des Patentablaufs
von Blockbuster Biopharmazeutika, der steigende Titer im Upstream-Processing (Stamm-
konstruktion, -screening und -kultivierung), die Konstruktion neuartiger, strukturell hoch
komplexer Moleküle und die Kürzung des öffentlichen Gesundheitshaushalts verlangen
bahnbrechende, kosteneffiziente Technologien. Die Entwicklung eines neuen Medikaments
erfordert aktuell eine Vorlaufzeit von bis zu zehn Jahren, und droht bis zur endgültigen
Genehmigung durch Arzneimittelbehörde (mit einer Wahrscheinlichkeit von ca. 90%) zu
scheitern. Es ist im Interesse der Patienten, der Gesundheitsbehörden und der Hersteller,
die Entwicklungszeit von Biopharmazeutika zu verkürzen.
Derzeit wird die Entwicklung von Aufreinigungsprozessen hauptsächlich auf Basis von Platt-
formprozessen und Hochdurchsatzexperimentieren (HTE) durchgeführt. Als Plattformpro-
zesse werden Prozesse bezeichnet, welche aus einer starren Abfolge von Operationseinheiten
bestehen, die zur Aufreinigung von monoklonalen Antikörpern (mAbs) mit ähnlichen che-
mischen Eigenschaften entwickelt wurden. Plattformprozesse müssen für die Aufreinigung
eines bestimmten mAb nur geringfügig angepasst werden. Sie stellen jedoch einen Kom-
promiss zwischen der Verringerung des Entwicklungsaufwands und der Einschränkung der
Freiheitsgrade in der Prozessoptimierung dar. Zur Aufreinigung neuartiger Biologika, wie
z.B. nicht standardmäßiger Antikörper, konjugierter Proteine und virusähnlicher Partikeln,
ist die starre Sequenz von Operationseinheiten in Plattformprozessen ungenügend. Im
aktuellen Arbeitsablauf der Industrie wurden Hochdurchsatztechnologien in Kombination
mit dem Konzept Design-of-Experiments (DoE) eingesetzt, um einen größeren Spielraum
durch Miniaturisierung, Parallelisierung und Automatisierung der Experimente abzudecken.
Aufgrund der empirischen Natur von HTE ist ein systematisches Screening möglicher
Lösungskandidaten und eine vergleichsweise hohe Probenmenge erforderlich. Daher sind
Ansätze basierend auf HTE häufig nicht in der frühen Phase der Medikamentenentwicklung
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einsetzbar. Der Ansatz der mechanistischen Modellierung im DSP nutzt Prozesswissen
hergeleitet aus physikalischen Grundlagen und bietet die Möglichkeit der Material- und
Zeiteinsparnis. Die üblicherweise verwendeten mechanistischen Modelle sind Differential-
gleichungen, die unter Berücksichtigung von Massenbilanzen und/oder Grundsätzen der
Thermodynamik hergeleitet werden, und beschreiben die Fluiddynamik und andere beob-
achtete Phänomene. Somit entspricht der Ansatz der mechanistischen Modellierung der
Forderung der Quality-by-Design (QbD) Initiative der US-amerikanischen Food and Drug
Administration (FDA), dass die Entwicklung und Herstellung von Medikamenten durch
wissenschaftliche Erkenntnisse unterstützt werden sollen. Als Folge findet kommerzialisierte
Simulationssoftware, welche die komplizierte Berechnung der Modelle durchführt, immer
mehr Anwendungen in der biopharmazeutischen Industrie.
Die Hauptaufgaben der mechanistischen Modellierung bilden die Bereiche Modellbildung,
Modellkalibrierung und Modellanwendung. In allen drei Bereichen verhindern bestehende
Problemstellungen einerseits den Einsatz modellbasierter Ansätze und andererseits die
Entwicklung und Umsetzung neuer Anwendungen. In Bezug auf die Modellbildung ist
die Steric-Mass-Action (SMA) Isotherme ein Beispiel für ein erfolgreiches Modell, welches
zu einem Konsens in Wissenschaft und Industrie über die Fähigkeit der mechanistischen
Modellierung zur Beschreibung von Ionenaustauschchromatographie (IEX) geführt hat. Zur
Abdeckung anderer wichtiger Proteinaufreinigungsprozesse, wie der hydrophoben Interakti-
onschromatographie (HIC) oder Polyethylenglycol (PEG) induzierter Präzipitation, fehlen
jedoch weitgehend akzeptierte Modelle, die ausreichende Genauigkeit bieten. Im Bereich der
Modellkalibrierung ist die gängige Praxis zur Bestimmung unbekannter Modellparameter
die Durchführung analytischer Kalkulationen oder numerischer Methoden wie z.B. der
Ausgleichungsrechnung. Der Nachteil dieser traditionellen Methoden besteht darin, dass
diese zeitaufwändig sind und für im experimentellen System neuauftretende Komponenten
wiederholt durchgeführt werden müssen. Kalibrierte mechanistische Modelle enthalten
eine große Menge an Information, welche jedoch bisher kaum auf andere Szenarien als die
Prozessentwicklung und Robustheitsanalyse angewendet wurden. Neue Strategien werden
benötigt, um mechanistische Modelle im vollen Umfang nutzen zu können.
Das Ziel der vorliegenden Arbeit war es, Probleme aus diesen drei Bereichen zu lö-
sen. Im Detail sollte die Menge der mechanistischen Modelle um diejenigen für HIC-
Prozesse und PEG-induzierte Präzipitation ergänzt werden; Es sollte eine Quasi-Echtzeit-
Modellkalibrierungsmethode entwickelt werden, mit deren Hilfe Modellparameter für im
experimentellen System neuauftretende Komponenten ohne zusätzlichen Aufwand bestimmt
werden können. Neue Anwendungsszenarien sollten erforscht werden, indem Informationen
zugänglich gemacht werden, die in mechanistischen Modellen verborgen vorliegen. Diese
Arbeit umfasst sechs Publikationen bzw. Manuskripte, die sich mit verschiedenen Aspek-
ten der Modellbildung, Modellkalibrierung und Modellanwendung in der mechanistischen
Modellierung befassen.
In der ersten Veröffentlichung wurde ein mechanistisches Modell für HIC unter Berück-
sichtigung des Gleichgewichts zwischen strukturierten und weniger geordneten Wasser-
molekülen auf hydrophoben Oberflächen von Proteinen und Liganden in der stationären
Phase hergeleitet. Während der Herleitung der Gleichungen wurden Annahmen getrof-
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fen und Vereinfachungen angewendet, um die Verwendbarkeit mit der Genauigkeit und
Zuverlässigkeit der Modellantwort in Einklang zu bringen. Die Fähigkeit des Modells,
Prozesse in Chromatographiesäulen zu beschreiben, wurde unter Verwendung von Prote-
inen mit unterschiedlichen Merkmalen bestätigt. Nach bestem Wissen des Autors wurden
erstmals kinetische Experimente mit linearen und stufenweisen Salzgradienten und Batch-
Chromatographie-Experimente in HIC mit weitgehend identischen Modellparametern
beschrieben und exakt vorhergesagt. Diese neue Adsorptionsisotherme ist nicht nur von
akademischem Interesse, sondern bietet auch neue Möglichkeiten für die Entwicklung von
HIC-Prozessen in der pharmazeutischen Industrie, da sie den derzeit gängigen Ansatz
basierend auf Faustregeln und HTE ersetzen kann.
Im zweiten Manuskript wurde ein mechanistisches Modell für die PEG-induzierte Pro-
teinpräzipitation vorgeschlagen, wobei die Ähnlichkeiten zwischen Proteinpräzipitation
und HIC berücksichtigt wurden. Es wurde dabei die Vorstellung angenommen, dass die
Bildung von Protein-Protein-Grenzflächen hauptsächlich durch den hydrophoben Effekt
wie in HIC, also die Reorientierung der strukturierten und weniger geordneten Wasser-
struktur auf hydrophoben Bereichen der Proteinoberflächen getrieben ist. Es wurden
Hochdurchsatz-Präzipitationsexperimente durchgeführt, um Präzipitationsdaten von Pro-
teinen unterschiedlicher Größen zu erzeugen. Nach der Kalibrierung konnte das Modell neue
Prozesse präzise vorhersagen. Der Hauptunterschied zwischen dem vorgeschlagenen Modell
und weit verbreiteten Modellen, wie der Cohn-Gleichung und den daraus hergeleiteten
Modellen, ist die Mölichkeit, den Einfluss der PEG- und Proteinkonzentration auf die
PEG-induzierte Proteinpräzipitation zu beschreiben und das Verhalten kleiner Proteine
vorherzusagen.
In der dritten Publikation wurde die einfachste Form der künstlichen Intelligenz (KI) – das
künstliche neuronale Netzwerk (KNN) – verwendet, um eine Methode zur Kalibrierung von
mechanistischen Chromatographiemodellen zu entwickeln. Die systematisch durchgeführ-
ten in silico Experimente durch Variation der Zielmodellparameter machten die in einem
unkalibrierten mechanistischen Modell verborgene Information zugänglich. Die resultie-
renden Datensätze bestehend aus simulierten Chromatogrammen und Modellparametern
wurden verwendet, um ein KNN-Modell zu konstruieren, das zur simultanen Bestimmung
der unbekannten Parameter aus dem Transport-Dispersiven Modell (TDM) und dem
stöchiometrischen Verdrägungsmodell für die Trennung einer tertiären Proteinlösung in
Kationenaustauschchromatographie (CEX) verwendet wurde. Das trainierte neuronale
Netzwerk wurde durch Kreuzvalidierung verifiziert und das kalibrierte mechanistische
Modell wurde durch drei Salzgradienten-Experimente erfolgreich validiert. Diese neuartige
Methode bietet die Möglichkeit, Modellparameter für eine im Chromatographiesystem
neuauftretende Komponente zu bestimmen, wo zeitaufwändige traditionelle Ansätze wie-
derholt durchgeführt werden müssen. Da der Rechenaufwand des KNN extrem gering
ist (mit einer Berechnungszeit von wenigen Millisekunden im untersuchten Fall), kann es
für eine automatisierte In-Prozesskalibrierung während chromatographischer Experimente
implementiert werden. Darüber hinaus hat diese Methode das Potenzial, für die mechanis-
tische Modellierung in anderen Forschungsbereichen zu Kalibrierungszwecken eingesetzt zu
werden.
x Zusammenfassung
Während sich die bisherigen Publikationen und Manuskripte auf die notwendigen Voraus-
setzungen der Modellierung (Modellbildung und Modellkalibrierung) konzentrieren, unter-
suchen die Folgenden mögliche Anwendungsszenarien der mechanistischen Modellierung.
Basierend auf mechanistischen Chromatographiemodellen wurde in der vierten Veröffent-
lichung eine gründliche Untersuchung der Stofftransport- und Adsorptionsmechanismen
von PEGylierten Proteinen in CEX durchgeführt. Diese Studie verwendete eine Kom-
bination aus dem umfassenden General Rate Modell (GRM) und der SMA Isothermen,
um Informationen über Proteindiffusion durch die Filmschicht um die Adsorberparti-
keln, Diffusion innerhalb der Partikelporen sowie Adsorptions-/Desorptionsverhalten der
PEGylierten Spezies im linearen und nichtlinearen Bereich der Isothermen zu erhalten.
Anomalien wie Peakhöhen und -breiten, die trotz eines zunehmenden hydrodynamischen
Radius der PEGylierten Spezies konstant bleiben, und die nichtlineare Korrelation zwi-
schen der Bindekapazität und der Molekülmasse der PEGylierten Proteine konnten jeweils
durch den vorgeschlagenen Diffusions-Desorptions-Kompensationseffekt und die berechnete
exponentielle Abhängigkeit des Abschirmparameters von der Molekülmasse erklärt werden.
In der fünften Veröffentlichung wurde die mechanistische Chromatographiemodellierung
mit HTE und DoE kombiniert, um einen integrierten Prozess zu entwickeln, der aus
PEG-induzierter Präzipitation, selektiver Rücklösung und CEX für die Aufreinigung eines
industriellen mAb aus geernteter Zellkulturflüssigkeit besteht. Die Prozessentwicklungsstra-
tegie kombinierte Vorteile von HTE, DoE und mechanistischer Modellierung, was zu einem
reduzierten Probenverbrauch und minimalem experimentellen Aufwand führte. In Bezug
auf die Ausbeute, Reinheit und Produktionsrate von mAb-Monomer sowie die Reduzierung
von Hauptkontaminanten, wie DNA, Wirtszellproteinen und mAb-Aggregaten, stellt der
integrierte Prozess eine geeignete Alternative zum konstenintensiven Industriestandard
der Protein A Chromatographie dar. Darüber hinaus wurde das kalibrierte und vali-
dierte mechanistische Modell auf eine periodische Gegenstromchromatographie mit drei
CEX-Säulen übertragen, um die Möglichkeiten und das Potenzial der kontinuierlichen
Multi-Säulenchromatographie zu untersuchen.
In der sechsten und letzten Veröffentlichung wurde eine neue Methode zur Fehler-Ursachen-
Analyse von Abweichungen in der Proteinchromatographie entwickelt, die auf mecha-
nistischer Chromatographiemodellierung und KNN basierte. Prozessvariationen in der
Proteinchromatographie, insbesondere die Abweichung der Bindekapazität aufgrund von
Säulenalterung, täglichem Betrieb oder Säulenmaterialaustausch, können enorme Aus-
wirkung auf die kritischen Qualitätsmerkmale des pharmazeutischen Produkts haben.
Simulationen potenzieller Prozessabweichungen auf Grundlage eines zuvor kalibrierten
mechanistischen Chromatographiemodells wurden als Daten für das Training, die Vali-
dierung und das Testen des KNN-Modells erstellt. Experimentelle Fehler, die zu einem
sehr ähnlichen Erscheinungsbild führten, hier Fehler in der ionischen Kapazität und Salz-
gradientenlänge, wurden absichtlich eingeführt, um abweichende Chromatogramme eines
Tertiärtrennproblems zu erzeugen. Das trainierte KNN konnte die Abweichungen erkennen,
ihre Ursachen identifizieren und innerhalb von Millisekunden ihre Größen ausgeben. Die
ionische Kapazität, welche einen bisher nicht während des Betriebs messbaren Parameter
darstellt, konnte mit hoher Genauigkeit bestimmt werden. Die grundlegende Idee, ein
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mechanistisches Modell und ein KNN zu kombinieren, um von ihren jeweiligen Vorteilen zu
profitieren, konnte erfolgreich umgesetzt werden. Folglich wurden nur wenige Experimente
für die Kalibrierung des mechanistischen Modells benötigt, wodurch der hohe experimentelle
Aufwand, der sonst für das Training des KNN-Modells benötigt wäre, vermindert wurde.
Insgesamt trägt diese Arbeit zu den aktuellen Trends in DSP bei, die von empirisch
getriebenen Methoden (HTE und DoE) zu Anwendungen auf Grundlage von mechanis-
tischem Verständnis und künstlicher Intelligenz führen. Die Arbeit befasst sich nicht
nur mit Fragen der Modellverfügbarkeit in wichtigen Reinigungstechniken wie HIC und
PEG-induzierter Proteinpräzipitation und ermöglicht dort eine modellbasierte Prozes-
sentwicklung, sondern schlägt auch eine KNN-basierte Kalibrierungsmethode vor, um die
Schwächen herkömmlicher Methoden zu überwinden. Darüber hinaus werden verschie-
dene Anwendungsszenarien mechanistischer Modelle gezeigt, wie z.B. das Erlangen des
grundlegenden Verständnisses für die Entwicklung von Aufreinigungsprozessen einer nicht-
typischen Molekülklasse, die Entwicklung eines integrierten Prozesses als kosteneffizientere
Alternative zum standardmäßigen Protein A Prozess und die Verwirklichung einer Me-
thode zur Fehler-Ursachen-Analyse von Abweichungen in der Proteinchromatographie für
Anwendungen in Quasi-Echtzeit. Langfristig könnte die Kombination aus mechanistischer
Modellierung und KNN ein fundamentaler Baustein eines künstlichen Prozessexperten
für DSP sein, der eine vollautomatisierte Strategie in Quasi-Echtzeit die Entwicklung,
Überwachung und Rückkopplungskontrolle von Aufreinigungsprozessen darstellt.

Abstract
The current technological advancements encounter the population growth, increasing living
standard and life expectancy around the globe, opening a rapidly expanding biopharmaceu-
tical market with high demand. As one of the fastest growing industries, the biotechnology
industry focuses on development and manufacturing of novel biological molecules – the
biologics – and strives literally to save lives. One of the key steps in the manufacturing of
biologics is the so-called downstream processing (DSP), which aims to purify an active
ingredient – here a target molecule of biological origin. DSP represents the biggest share
of the total expenditure and is faced with price pressure resulting from numerous events
in the recent past and near future. Among them, the rise of biosimilars due to patent
expiration of blockbuster biopharmaceuticals, the increasing titer in upstream processing –
USP (strain construction, strain screening and cultivation), the invention of novel, struc-
turally diverse molecules, and cuts in public healthcare budget demand disruptive, more
cost-efficient technologies. Furthermore, the development of a new drug requires a lead time
of up to a decade, and is constantly threatened by an overwhelming likelihood of failure
(approximately 90%) until its final approval. It is in interest of all parties involved, i.e. the
patients, the health authorities, and the manufacturers, to shorten the drug development
timeline.
Currently, the development of purification processes is mainly performed based on platform
processes and high-throughput experimentation (HTE). The so-called platform processes
are processes consisting of fixed order of unit operations, once developed in DSP for the
purification of standard monoclonal antibody (mAb). It provides a trade-off between the
reduction of development efforts and limitation of degrees of freedom to be optimized for a
specific molecule. To purify novel biologics, such as non-standard antibodies, conjugated
proteins, or virus-like particles, the fixed sequence of unit operations in platform processes is
not sufficient. In the current industrial work-flow, high-throughput technologies combined
with Design-of-Experiments (DoE) have been introduced to cover a larger design space by
miniaturizing, parallelizing, and automatizing the experiments to a certain extent. Due to
its empirical nature, high-throughput experimentation (HTE) is a brute-force method, i.e.
a problem-solving technique that requires a systematical screening of possible candidate
solutions, and needs a comparably high amount of sample, that is often not available in
the early stage of drug development.
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The approach of mechanistic modeling takes advantage of knowledge about the physical
fundamentals of the processes and offers advantage of both material and time saving in
DSP. Mechanistic models commonly used are, in most cases, differential equations derived
from consideration of mass balances and/or laws of thermodynamics, and describe the fluid
dynamics and other phenomena observed. Thus, mechanistic modeling is in line with the
demand of the Quality by Design (QbD) initiative suggested by the US Food and Drug
Administration (FDA), that process development and manufacturing of drugs should be
backed up by scientific understanding. As a consequence, commercialized simulation tools
are finding more and more applications in the biopharmaceutical industry.
The main tasks of mechanistic modeling can be assigned to the fields of model building,
model calibration, and/or model application. In all three fields, existing challenges impede
the use of model-based approaches on the one hand, and hinder the development and the
implementation of new applications on the other. With respect to model building, an
example for a successful model is the steric mass action (SMA) isotherm, which has led to
a general consensus about the ability of mechanistic modeling to describe ion-exchange
chromatography (IEX) processes in the academic and industrial community. To cover other
important protein purification processes, such as hydrophobic interaction chromatography
(HIC) or polyethylene glycol (PEG) induced precipitation, however, a widely accepted
model with sufficient accuracy is lacking. With respect to model calibration, the common
practice to determine unknown model parameters is to perform analytical calculation
or numerical methods such as curve fitting. Major disadvantages of these traditional
methods are that they are time-consuming and have to be carried out repeatedly for new
components in the experimental system. Calibrated mechanistic models contain a large
amount of information, but they have been barely applied to other scenarios than the
process development and robustness analysis. New strategies are needed to enable the use
of mechanistic models to their full extent.
The objective of this thesis was to solve some issues in these three fields. In detail, the
set of mechanistic models should be complemented by the ones for HIC processes and
PEG-induced precipitation; A near real-time model calibration method should be proposed,
which can be used to determine model parameters for new components in the experimental
system without additional effort; New application scenarios should be explored by making
the information accessible, which is hidden in mechanistic models.
This thesis contains six publications/manuscripts, that focus on different aspects of model
building, model calibration, and model application in mechanistic modeling. In the
first publication, a mechanistic isotherm model for HIC was derived by considering the
equilibrium between well-ordered and bulk-like ordered water molecules on the hydrophobic
surfaces of proteins and ligands in the stationary phase. During isotherm derivation,
assumptions and simplifications were made to balance the ease of use with accuracy and
reliability of model response. The model’s capability of describing column chromatography
processes was backed up using proteins of different features. To the author’s best knowledge,
kinetic linear/step-wise salt gradient and batch chromatography experiments in HIC were
described and predicted with largely identical model parameters for the very first time.
This new adsorption isotherm is not only of academic interest, but also opens up new
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possibilities for HIC process development in industry, i.e. superseding the current common
practice based on rules of thumb and HTE.
In the second manuscript, a new mechanistic model for PEG-induced protein precipitation
was proposed by taking the similarities between protein precipitation and HIC into ac-
count. The formation of protein-protein interfaces was thought to be mainly driven by the
hydrophobic effect as in HIC – the reorganization of the well-ordered and bulk-like water
structure on the hydrophobic areas of the protein surfaces. High-throughput precipitation
experiments were conducted to generate precipitation data of differently sized proteins.
After calibration, the presented model could predict uninvolved data precisely. The main
difference between the models widely used, such as the Cohn equation and derivatives, and
the proposed model is its capability to describe the influence of both PEG and protein
concentration on PEG-induced protein precipitation and to predict the behavior of small-
sized proteins.
In the third publication, the most simple form of artificial intelligence (AI) – the artificial
neural network (ANN) was employed to develop a method for calibration of mechanistic
chromatography models. Performing in silico experiments by varying the model parameters
of interest systematically made the information hidden in an uncalibrated mechanistic
model accessible. The resulting data sets consisting of simulated chromatograms and
model parameters were used to construct an ANN model, which was applied for the
simultaneous determination of the transport dispersive model (TDM) and stoichiometric
displacement model (SDM) parameters for the separation process of a tertiary protein
mixture in cation-exchange chromatography (CEX). The trained ANN model was verified
by cross validation and the calibrated mechanistic model was successfully validated by
three binde-and-elute salt gradient chromatography experiments. This novel method offers
the possibility to determine model parameters for a new component in the chromatography
system, where time-consuming traditional approaches require to be carried out repeatedly.
Because the ANN’s computational expense is extremely low, as indicated by the calculation
time of only milliseconds in the case investigated, it has the potential to be implemented for
automated real-time model calibration during chromatography experiments. Furthermore,
this method has the potential to be applied to calibration purposes in mechanistic modeling
in other research fields.
While the publications/manuscripts so far concentrate on the necessary preconditions of
modeling, i.e. model building and model calibration, the following ones explore possible
application scenarios of mechanistic modeling. Based on mechanistic chromatography
models, a full investigation on the mass transfer and adsorption mechanisms of PEGylated
proteins in CEX was carried out in the fourth publication. This study used a combination
of the most detailed general rate model (GRM) and SMA to gain information on protein
diffusion through the film layer around the adsorbent particles, diffusion inside the particle
pore, as well as adsorption/desorption behavior of the PEGylated species in the linear and
non-linear region of the isotherm. Anomalies observed, such as peak heights and widths
remaining constant in spite of an increasing hydrodynamic radius of PEGylated species
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and the non-linear correlation between the column capacity and the MW of PEGylated
proteins, could be explained by the proposed diffusion-desorption-compensation effect and
the calculated exponential dependency of the shielding parameters on the MW increase,
respectively.
In the fifth publication, mechanistic chromatography modeling was combined with HTE
and DoE to develop an integrated process consisting of PEG-induced precipitation, selective
resolubilization, and CEX chromatography for the isolation of an industrial mAb from
harvested cell culture fluid (HCCF). The process development strategy combined advantages
of HTE, DoE, and mechanistic modeling, resulting in reduced sample consumption and
minimal experimental effort. In terms of yield, purity, and production rate of mAb
monomer, as well as the reduction of main contaminants, such as DNA, host cell proteins
(HCP), and mAb aggregates, the integrated process represents a feasible alternative to
the expensive industrial standard Protein A chromatography. Furthermore, the calibrated
and validated mechanistic model was transferred to a three-column CEX periodic counter-
current chromatography (3C-PCCC) mode to explore the opportunities and potential
offered by multi-column continuous chromatography.
In the sixth and final publication, a novel method for root cause investigation of deviations
in protein chromatography was developed based on both mechanistic chromatography
modeling and ANN. Process variations in protein chromatography, especially the deviation
of capacity due to column aging, day-to-day operations, or column exchange, can have
enormous impact on the critical quality attributes (CQA) of the pharmaceutical product.
Simulations of potential process deviations based on a beforehand calibrated mechanis-
tic chromatography model were generated as learning material for training, validation,
and testing of the ANN model. Experimental errors leading to highly similar observable
deviation, here errors in ionic capacity and salt gradient length, were deliberately introdu-
ced to generate deviating chromatograms of a tertiary separation problem. The trained
ANN could recognize the deviations, identify their root causes, and respond with their
magnitudes within milliseconds. The ionic capacity – a hitherto non-observable parameter
during operation – could be determined with high accuracy. The fundamental idea to
combine a mechanistic model and an ANN to benefit from their respective advantages
could be successfully implemented. Consequently, only few experiments were required for
the calibration of the mechanistic model, avoiding the high wet-lab experimental effort
needed otherwise for the training of the ANN model.
In summary, this thesis contributes to the current trends in DSP moving from empirically
driven, state-of-the-art methods (HTE and DoE) towards applications based on mechanistic
understanding and artificial intelligence. It not only addresses the issues of model availability
in key purification techniques, such as HIC and PEG-induced protein precipitation, to enable
model-based process development, but also proposes an ANN-based calibration tool to
overcome the weaknesses of traditional methods. Furthermore, diverse application scenarios
of mechanistic models are shown, such as providing a thorough a priori understanding
of a non-typical molecule class for its purification process development, developing an
integrated process as a cost-efficient alternative to the standard Protein A process, and
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suggesting a combination of mechanistic modeling and ANN to develop a near real-time
method for root cause investigation of deviations in protein chromatography. In long term,
the combination of mechanistic modeling and ANN could be a fundamental building block
of an AI process expert in DSP, representing a fully automated, near real-time strategy for
development, monitoring, and feedback control of purification processes.
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1. Introduction
Being in the intersection of biology and technology, the biopharmaceutical industry has
changed rapidly in the last decades, providing treatment opportunities for conditions like
dementia and cancer. The so-called biologics, such as insulin, human growth hormone,
monoclonal antibodies (mAbs) and their derivatives, or virus-like particles, represent one
of the currently fastest expanding economic sectors across many different industries [1–
3]. From early 1990s to 2015, 47 mAbs have been approved by the US Food and Drug
Administration (FDA), or the European Medicines Agency (EMA) – giving an average of
two approved mAbs per year [4]. After that period, the average annual approvals of mAbs
have been increased by fivefold, as reported in 2017 [5]. At the current time, 52 and 230
mAbs have been reported to be in the phase 3 and phase 2 clinical studies, respectively.
By 2020, the global mAb market is expected to reach 125 billion USD [6].
Compared to small-molecule drugs, biologics are highly promising due to their molecular
specificity towards cells and receptors. However, due to the accompanied size and complex
structure of biopharmaceutics, they are often challenging to be produced synthetically and
require to be manufactured in and extracted from biological systems. After expression
and folding, the target molecule is accompanied by a huge amount of impurities, such as
media components, host-cell proteins, product related molecules, as well as charge variants
and glycovariants. These compounds have to be reduced and well-defined in the final drug
product to guarantee patient safety and drug efficiency, hence the so-called downstream
processing – DSP (cell disruption, clarification, and purification) is of great importance.
Since the product attributes are sensitive to slight changes in the manufacturing processes,
high standards ensured by sophisticated process design, especially in DSP, are required [7].
From many perspectives, the biopharmaceutical industry is at a turning point. There is
the so-called patent cliff of blockbuster therapeutic proteins taking place between 2012
and 2019. By definition, a blockbuster is a drug with annual sales exceeding 1 billion
USD [8]. Within a time period of 7 years, the patents of 10 blockbusters capturing an
annual market of up to 12.5 billion USD each are about to expire. A new market for
generics – the biosimilars – is expected to arise, resulting in drastical falling of the revenue
obtained through the sales of the originators [9]. The first biosimilars approved since 2006
were hormones for human growth, red blood cell production, and bone marrow stimulation,
followed by the first biosimilar monoclonal antibody in 2013 [10, 11]. Additionally, there is
a trend from large quantity blockbuster production of therapeutic drugs towards a more
personalized medicine [12]. Thus, process developments are shifted from straightforward
routines to individual customization. Recent advances in upstream processing – USP (strain
construction, strain screening and cultivation) indicate a titer increase at commercial scale
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by approximately 20% from 2014 to 2019. At the same time, however, adoption of
improvements in DSP has been predicted to be much slower [13]. Consequently, the
rising competition, the achievements in USP, as well as the demand for fast and reliable
tools result in pressure on cutting manufacturing costs and development of innovative
technologies in DSP.
As a reaction of research and development in both academia and industry, novel technologies
have been tested, developed, and introduced. Great progress can be seen in the preparative
liquid-solid column chromatography, which is the workhorse for present purification purpo-
ses because of its high resolution and the know-how accumulated in the biopharmaceutical
industry over last decades [14, 15]. The standard process development strategy for chro-
matographic unit operations is mainly based on time-consuming and labor-intensive wet
laboratory experiments. High-throughput screening in combination with the approach of
design-of-experiment (DoE) has been adopted in recent years to improve such development
setups, but still is not sufficient under the given circumstances [16]. Especially in line with
the Quality by Design (QbD) initiative suggested by the US FDA [17], mechanistic modeling
presents one of the most promising method in process development [18–25]. The artificial
neural network (ANN) modeling, which has already been applied in numerous areas and
proven itself as an extremely powerful tool, has been explored in combination with different
liquid chromatography modes and formats [26–30]. Moreover, the switch to disposable and
single-use technology has been implemented to provide a reduction in sanitization expense,
more compact, as well as flexible and multi-product facilities [31]; Alternatives to liquid
chromatography, such as precipitation has been explored [32]; Non-standard chromato-
graphy stationary phases such as membrane and fiber have been designed and tested [33];
A shift from batch to continuous processing could be observed in both chromatographic
and non-chromatographic techniques. In the following sections, theoretical foundation of
liquid-solid chromatography and precipitation with focus on protein purification as well as
a brief introduction to the most simple form of artificial intelligence – the artificial neural
network – will be presented.
1.1. Fundamentals of Liquid-solid Chromatography
In liquid-solid chromatography, a solid stationary phase and a mobile liquid phase can
be found. The stationary phase consists of a solid bed packed with porous particles,
fibers, or a monolith in a cylinder made of plastics, glass, or metal. During the transport
in the chromatographic system, the mobile phase – a heterogeneous solution containing
different species – can be separated due to differences in their retention behavior. In size
exclusion chromatography (SEC) for instance, the stationary phase has a defined pore size
distribution. In contrast to larger molecules, smaller ones are able to penetrate into smaller
pores, leaving the column later. In bioseparation, the most used chromatography class is the
adsorption chromatography, which is also the focus of this thesis. Here, the effects leading
to the retention differences between different species include fluid dynamics within the
2
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chromatographic column and their strength of adsorption on the surface of the solid phase.
Differentiated by the adsorption mechanism, the most common chromatography techniques
in the current field are affinity chromatography (AC), ion-exchange chromatography (IEX),
and hydrophobic interaction chromatography (HIC). AC has its basis on the specific binding
of target molecules to ligands on adsorber surface, such as immobilized enzymes or metal
ions. In IEX and HIC, molecules and ligands undergo electrostatic and hydrophobic
interactions, respectively.
In preparative chromatography, it is aimed to collect target molecules as highly concentrated
as possible, which cannot be achieved ideally due to the broadening of residence time
distribution of the solutes during travel along the column. The effects are summarized in
the axial dispersion and mass transfer resistance. The former has its roots in non-ideal
fluid distribution as shown in Fig. 1.1. Fluid dynamic adhesion inside the microscopic
channels of the packed bed results in a non-uniform flow velocity profile with its maximum
in the middle of the channel [34], which is schematically shown in Fig. 1.1 (a). Local
inhomogeneous voidages in the packed bed results in the mesoscopic fluid distribution
effect responsible for differences in fluid velocities and path-length of molecular traveling
(Eddy-diffusion) [34] as shown in Fig. 1.1 (b). From the macroscopic view presented in
Fig. 1.1 (c)., local non-uniformities of the voidage the column wall and the adsorbent
material lead to the so-called wall effect [34]. As column chromatography is usually
conducted at chromatographic plant consisting of pumps, valves, detectors, and tubings as
its main components, the contribution of the extra column effects cannot be neglected. All
the effects contribute to a symmetrical Gaussian distributed peak width increase – adding
up to the axial dispersion. It should be mentioned, that in large-diameter columns, the
radial fluid distribution at column inlet and column outlet is the most critical point due to
the pressure drop of the packed bed.
Figure 1.1.: Non-ideal fluid distribution responsible for the broadening of residence time
distribution according to Tsotsas [34].
Besides the axial dispersion, mass transfer resistance as shown in Fig. 1.2 contributing to
the total band broadening include convective and diffusive transport towards the particle,
film diffusion through the film layer between the interstitial and the pore volume, diffusion
into the particle pores and at the surface, as well as the adsorption/desorption on the
inner adsorbent surface. Are these mass transfer phenomena slower than the microscopic,
mesoscopic, and macroscopic fluid distribution effects mentioned above, a non-symmetrical
band broadening can be observed. Here, some molecules retain longer in the column due to
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their deeper penetration into the pore system and/or stronger interaction with adsorbent,
resulting in a late-eluting part called the peak tailing. Unlike the symmetrical peaks, which
can be described with the Gaussian distribution, the Exponential-Modified-Gauss (EMG)
function is recommended to cover the unsymmetrical ones [35–38].
Figure 1.2.: Mass transfer phenomena during protein adsorption in a porous bead.
As common in other fields of chemical engineering, the plate number 𝑁 as well as the
corresponding height of an equivalent theoretical plate 𝐻𝐸𝑇𝑃 are employed to characterize
the efficiency of packed beds. In chromatography, 𝐻𝐸𝑇𝑃 accounts for all contributions to
the total band broadening (fluid distribution non-idealities and mass transfer resistance)
and is defined as the column length 𝐿𝑐 divided by 𝑁 as shown in Eq.1.1.
𝐻𝐸𝑇𝑃 = 𝑁
𝐿𝑐
(1.1)
In practice, a non-penetrating and non-interacting molecule such as dextran is used as
tracer to approximate the 𝐻𝐸𝑇𝑃 without the contribution of the mass transfer resistance.
Following the correlation in Eq.1.2, the axial dispersion coefficient of a column 𝐷𝑎𝑥 can be
calculated with the average interstitial velocity of the flowing fluid 𝑢𝑖𝑛𝑡, which depends on
pump speed and bed porosity.
𝐷𝑎𝑥 =
𝐻𝐸𝑇𝑃 · 𝑢𝑖𝑛𝑡
2 (1.2)
The resistance caused by the boundary layer between the interstitial volume and the pore
volume is described with a film diffusion coefficient. The intra-particle diffusion is modeled
with a pore diffusion coefficient. In less complex models, a lumped film transfer coefficient
instead of both diffusion coefficients can be found. The occurrence of the surface diffusion
is often neglected in adsorption chromatography, as it is exactly then physically plausible,
if the attractive forces between the adsorbent and the adsorbate is very weak [39]. The
adsorption of adsorbate onto the surface is described by an isotherm equation.
1.1.1. Overview of Chromatography Models
Since the invention of column chromatography, there always has been desire to understand
it mathematically and great attempts to describe the chromatographic effects in different
scales [40]. Assumptions have been made in the derivation of the differential mass balan-
ces. When modeling liquid-solid chromatography, these assumptions and the resulting
simplifications have to be kept in mind:
• Homogeneous bed packing with spherical particles of constant diameter
• Homogeneous radial distributions
• Incompressible fluid with a viscosity independent of the fluid flow state
• Isothermal and isobaric process
• Constant axial dispersion coefficient
• Constant partial molar volume of components in both mobile and stationary phases
• Constant operating conditions, such as temperature, pressure, and mobile phase flow
rate
• Inert effluent
• No convection and movement inside the pore volume caused by the interstitial flow
• No size-exclusion effects
These assumptions simplify i.a. the mass balances for liquid chromatography to be
one-dimensional as depicted in Fig. 1.3.
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Figure 1.3.: The mass fluxes at the inlet and outlet of a column slice.
Considering the mass fluxes of the component 𝑖 at the inlet and outlet of a column slice
with the thickness 𝛥𝑥, the flux entering the slice is
𝑁𝑖|𝑥 = 𝜖𝑆(𝑢𝑖𝑛𝑡𝑐𝑖 −𝐷𝑎𝑥𝜕𝑐𝑖
𝜕𝑥
)|𝑥,𝑡, (1.3)
the flux leaving the slice
𝑁𝑖|𝑥+𝛥𝑥 = 𝜖𝑆(𝑢𝑖𝑛𝑡𝑐𝑖 −𝐷𝑎𝑥𝜕𝑐𝑖
𝜕𝑥
)|𝑥+𝛥𝑥,𝑡, (1.4)
and the accumulation rate in the slice
𝑁𝑖|𝑥+𝛥𝑥 −𝑁𝑖|𝑥 = 𝑆𝛥𝑥(𝜖𝜕𝑐𝑖
𝜕𝑡
+ (1− 𝜖)𝜕𝑐𝑠,𝑖
𝜕𝑡
)|?¯?. (1.5)
Here, 𝑆 equals 𝜋𝑑2𝑐/4 is the circular cross-sectional area of the column with a diameter of
𝑑𝑐, 𝜖 the column porosity, 𝐷𝑎𝑥 the axial dispersion coefficient, 𝑐𝑖 the concentration of a
component in the mobile phase at a certain time 𝑡 and position 𝑥 at the inlet, 𝑥+𝛥𝑥 at
the outlet, or the average value in the slice ?¯?, and 𝑐𝑠,𝑖 the concentration of a component in
the stationary phase (pore volume and on the inner pore surface). In Eqs. 1.3 and 1.4, the
axial dispersion is defined in analogy to Fick’s first law of diffusion. Insert the Eqs. 1.3
and 1.4 into Eq. 1.5, the mass balance equation results:
𝜖𝑆(𝑢𝑖𝑛𝑡𝑐𝑖 −𝐷𝑎𝑥𝜕𝑐𝑖
𝜕𝑥
)|𝑥,𝑡 − 𝜖𝑆(𝑢𝑖𝑛𝑡𝑐𝑖 −𝐷𝑎𝑥𝜕𝑐𝑖
𝜕𝑥
)|𝑥+𝛥𝑥,𝑡 = 𝑆𝛥𝑥(𝜖𝜕𝑐𝑖
𝜕𝑡
+ (1− 𝜖)𝜕𝑐𝑠,𝑖
𝜕𝑡
)|?¯?
(1.6)
After rewriting and assuming an infinitesimally small slice, i.e. approaching 𝛥𝑥 towards 0,
Eq. 1.7 follows.
𝐷𝑎𝑥
𝜕2𝑐𝑖
𝜕2𝑥
= 𝑢𝑖𝑛𝑡
𝜕𝑐𝑖
𝜕𝑥
+ 𝜕𝑐𝑖
𝜕𝑡
+ 1− 𝜖
𝜖
𝜕𝑐𝑠,𝑖
𝜕𝑡
⇔ 𝜕𝑐𝑖
𝜕𝑡
= 𝐷𝑎𝑥
𝜕2𝑐𝑖
𝜕2𝑥
− 𝑢𝑖𝑛𝑡𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖
𝜖
𝜕𝑐𝑠,𝑖
𝜕𝑡
(1.7)
The left-hand side is the accumulation in the mobile phase. The first term on the right-hand
side accounts for the diffusion, the second the convection, and the third the accumulation
in the stationary phase.
Based on the differential mass balance of the solute in an infinitesimally small slice of a
column, various models describing chromatographic processes have been developed. The
classification of different model approaches presented here follows Guiochon and Schmidt-
Traub et al. [40, 41]. According to the endeavor to reflect the reality, the models differ
in their complexity. The general rate model (GRM) covers convective transport, axial
dispersion, mass transfer resistance, and adsorption equilibrium/kinetic. In comparison
to the GRM, the lumped rate models (LRM) neglect either axial dispersion, adsorption
equilibrium/kinetic, or mass transfer resistance. The most simple ideal equilibrium model
takes only convective transport and adsorption in equilibrium into consideration.
1.1.2. Ideal Equilibrium Model
The ideal equilibrium model, also known as the ideal or basic model, was first describe by
Wicke [42] and later derived in the current form by De Vault [43]. The generous assumption
of local equilibrium between mobile and stationary phase neglects all effects caused by
axial dispersion, mass transfer resistance and adsorption kinetic. In mathematical terms,
the axial dispersion coefficient is set to zero and the coefficients which account for mass
transfer resistance to infinity. The concentration in the mobile phase is identical to that in
the pore volume. Hence the general mass balance equation is reduced to:
𝜕𝑐𝑖
𝜕𝑡
= −𝑢𝑖𝑛𝑡𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖
𝜖
(︂
𝜖𝑝
𝜕𝑐𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
)︂
. (1.8)
The diffusion term disappears and the accumulation term in the stationary phase is
divided into pore volume and adsorbent surface with the particle porosity 𝜖𝑝 and 𝑞𝑖 the
concentration of absorbed component 𝑖. The rearranged form can commonly be found in
literature:
𝜕𝑐𝑖
𝜕𝑡
= −𝑢𝑚𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖𝑡
𝜖𝑡
𝜕𝑞𝑖
𝜕𝑡
. (1.9)
Here, the column porosity is replaced by the total porosity
𝜖𝑡 = 𝜖+ 𝜖𝑝(1− 𝜖)
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and the interstitial velocity is replaced by the effective velocity
𝑢𝑚 =
𝜖
𝜖𝑡
𝑢𝑖𝑛𝑡.
The ideal model delivers the foundation for a variety of pioneering work on thermodynamic
behavior of a chromatographic column in linear [44, 45] and nonlinear region [46–48]. To
date, this model is still meaningful, as it can be used (after some rearrangements) to
deliver rough estimates for propagation velocity of a component inside the column, the
observable retention time of a Dirac pulse, or the position of the shocks – the sharp part of
a peak/breakthrough curve.
1.1.3. Equilibrium Dispersive Model
The equilibrium dispersive model as described by Eq. 1.10 is an extension of the ideal
equilibrium model. Additionally, peak broadening effects caused by axial dispersion and
mass transfer resistances are lumped into the apparent dispersion coefficient 𝐷𝑎𝑝𝑝, which
was first introduced by van Deemter and coworkers [45]. Thermodynamic equilibrium
between the interstitial phase, pore volume, and adsorbent surface is assumed. Formally,
all coefficients regarding mass transfer resistance are set to infinity and the film resistance
between the interstitial phase and pore volume is neglected.
𝜕𝑐𝑖
𝜕𝑡
= 𝐷𝑎𝑝𝑝,𝑖
𝜕2𝑐
𝜕2𝑥
− 𝑢𝑖𝑛𝑡𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖
𝜖
(︂
𝜖𝑝
𝜕𝑐𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
)︂
(1.10)
After introducing total porosity 𝜖𝑡 and the effective velocity 𝑢𝑚 as stated above, the
commonly used form is as described as in Eq. 1.11.
𝜕𝑐𝑖
𝜕𝑡
= 𝜀
𝜀𝑡
𝐷𝑎𝑝𝑝,𝑖
𝜕2𝑐𝑖
𝜕2𝑥
− 𝑢𝑚𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖𝑡
𝜖𝑡
𝜕𝑞𝑖
𝜕𝑡
⇔ 𝜕𝑐𝑖
𝜕𝑡
= ?˜?𝑎𝑝𝑝,𝑖
𝜕2𝑐𝑖
𝜕2𝑥
− 𝑢𝑚𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖𝑡
𝜖𝑡
𝜕𝑞𝑖
𝜕𝑡
(1.11)
In nonlinear isotherms, ?˜?𝑎𝑝𝑝,𝑖 includes concentration effects and therefore varies with
concentration changes. This model possesses the capability of describing asymmetrical
elution profiles. The observed tailing can be explained by the fact, that the late eluting
part is affected longer by the broadening effect.
1.1.4. Lumped Rate Models
In the lumped rate models, a second parameter describing rate limitation has been
introduced besides the axial dispersion coefficient. A commonly used lumped rate model is
the transport dispersive model, that summarizes the internal and external mass transfer
resistance in the effective film transfer coefficient 𝑘𝑒𝑓𝑓,𝑖. The effective film transfer is
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formally thought to be independent of the axial dispersion, but dependent on the effects
caused by mass transfer resistance, such as film diffusion, pore diffusion, surface diffusion,
and concentration of the solutes. The general mass balance equation
𝜕𝑐𝑖
𝜕𝑡
= 𝐷𝑎𝑥,𝑖
𝜕2𝑐𝑖
𝜕2𝑥
− 𝑢𝑖𝑛𝑡𝜕𝑐𝑖
𝜕𝑥
− 1− 𝜖
𝜖
(︂
𝜖𝑝
𝜕𝑐𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
)︂
(1.12)
has been extended by the mass balance in the stationary phase
𝑘𝑒𝑓𝑓,𝑖4𝜋𝑟2𝑝(𝑐𝑖 − 𝑐𝑝,𝑖) =
4
3𝜋𝑟
3
𝑝
(︂
𝜖𝑝
𝜕𝑐𝑝,𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
)︂
⇔ 𝑘𝑒𝑓𝑓,𝑖 3
𝑟𝑝
(𝑐𝑖 − 𝑐𝑝,𝑖) = 𝜖𝑝𝜕𝑐𝑝,𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
. (1.13)
The film resistance within the liquid boundary layer surrounding the spherical particles
with radius 𝑟𝑝 between the interstitial phase and pore volume is stated on the left-hand
side, whereas the accumulation in the pore volume and the adsorbent surface is declared
on the right-hand side. The solution of the transport dispersive models is always an
asymmetrical elution profile. The degree of asymmetry increases with increasing axial
dispersion coefficient 𝐷𝑎𝑥 and decreasing effective mass transfer coefficient 𝑘𝑒𝑓𝑓 .
1.1.5. General Rate Models
The general rate models are the most complex models in chromatography. Besides axial
dispersion and film diffusion, the impacts of other mass transfer phenomena are considered.
The widely used model proposed by Gu et al. [49, 50] complements the general mass
balance as shown in Eq. 1.12 by the description of diffusion inside the particle pores, which
is therefore also known as the pore diffusion model. Analogue to the transport dispersive
model, the external mass transfer – the mass transfer through the film surrounding the
particles for 𝑟 = 𝑟𝑝 – is described as in Eq. 1.13. The internal mass transfer is the mass
transfer inside the particle pores for 𝑟 ∈ [0, 𝑟𝑝]. It is modeled with Fick’s diffusion:
𝜖𝑝
𝜕𝑐𝑝,𝑖
𝜕𝑡
+ (1− 𝜖𝑝)𝜕𝑞𝑖
𝜕𝑡
= 𝜖𝑝
1
𝑟2
𝜕
𝜕𝑟
(𝑟2𝐷𝑝,𝑖
𝜕𝑐𝑝,𝑖
𝜕𝑟
). (1.14)
Neglecting the surface diffusion is justified, if a pronounced micropore system is not given
and the adsorbent affinity not high. In most cases of adsorption chromatography, the pore
diffusion coefficient exceeds the surface diffusion coefficient by orders of magnitude [51–53].
To solve the partial differential equations, initial and boundary conditions are required.
At the column inlet the boundary conditions derived by Danckwerts [54] is frequently
employed. Here, at the column outlet a zero gradient for the mobile phase concentration is
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assumed:
𝜕𝑐
𝜕𝑥
(𝐿𝑐,𝑡) = 0 (1.15)
𝜕𝑐
𝜕𝑥
(0,𝑡) = 𝑢𝑖𝑛𝑡
𝐷𝑎𝑥
(𝑐(0,𝑡)− 𝑐𝑖𝑛(𝑡)) (1.16)
1.1.6. Adsorption Isotherms
Besides the models covering the fluid dynamics in the chromatographic column in the
interstitial phase and pore volume, an adsorption isotherm has to be added for the
description of the adsorption processes on the inner adsorbent surface. The derivation of
the commonly used adsorption isotherms is based on the law of mass action. The rate of
adsorption is thought to be proportional to the product of activities of the participating
components. A comprehensive review on the current thermodynamic framework of protein
chromatography adsorption isotherms has been delivered by Mollerup [55]. An equilibrium
between all components is assumed under isothermal and isobaric condition, leading to
𝛥𝐺 =
∑︁
𝑖
𝜈𝑖𝜇𝑖 = 0. (1.17)
Here, 𝛥𝐺 is the the Gibbs free energy change, 𝜈𝑖 the stoichiometric coefficients, and 𝜇𝑖 the
chemical potentials defined as:
𝜇𝑖 ≡ 𝜇0𝑖 +𝑅𝑇 ln 𝑎𝑖 = 𝜇0𝑖 +𝑅𝑇 ln ?˜?𝑖𝛾𝑖. (1.18)
𝜇0𝑖 are the standard chemical potentials, 𝑅 the ideal gas constant, 𝑇 the thermodynamic
temperature, 𝑎𝑖 the activities, 𝛾𝑖 the activity coefficients, and ?˜?𝑖 the mole fractions. The
Gibbs free energy is defined as
𝛥𝐺 = 𝛥𝐺0 +𝑅𝑇 ln𝐾, (1.19)
with the standard Gibbs free energy 𝐺0 and the thermodynamic equilibrium constant 𝐾.
In ion-exchange chromatography, a protein 𝑃 and 𝜈 ligands 𝐿 occupied by counter-ions 𝑆
are thought to be in equilibrium with 𝜈 replaced counter-ions and a protein-ligand complex
𝑃𝐿𝜈 :
𝑃 + 𝜈𝐿𝑆 ⇔ 𝜈𝑆 + 𝑃𝐿𝜈 . (1.20)
Based on the this assumption and the consideration of Gibbs free energy change, the
stoichiometric displacement model (SDM) has been introduced as in Eq. 1.21 [56].
𝐾𝑒𝑞 =
𝑞𝑖𝑐
𝜈𝑖
𝑠𝑎𝑙𝑡
𝑞𝜈𝑖𝑠𝑎𝑙𝑡𝑐𝑝,𝑖
(1.21)
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Here, 𝐾𝑒𝑞 is the equilibrium constant, 𝑐𝑠𝑎𝑙𝑡 the concentration of counter-ion in the mobile
phase, 𝑞𝑠𝑎𝑙𝑡 the concentration of counter-ion bound to the ligands, 𝑐𝑝,𝑖 the protein concen-
tration in the pore volume. 𝑞𝑠𝑎𝑙𝑡 can be replaced by applying the electroneutrality on the
adsorbent surface with a total ligand density of 𝛬
𝑞𝑠𝑎𝑙𝑡 = 𝛬−
𝑛∑︁
𝑗=1
𝜈𝑗𝑞𝑗 , (1.22)
resulting in the commonly used form in the literature as in Eq.1.23.
𝐾𝑒𝑞 =
𝑞𝑖𝑐
𝜈𝑖
𝑠𝑎𝑙𝑡(︁
𝛬−∑︀𝑛𝑗=1 𝜈𝑗𝑞𝑗)︁𝜈𝑖 𝑐𝑝,𝑖 . (1.23)
Brooks and Cramer [57] extended the SDM isotherm by the steric hindrance factor 𝜎𝑖,
which represents the number of binding sites on the adsorbent surface sterically hindered
by the protein 𝑖 upon binding. Inserting the extended electroneutrality on the adsorbent
surface
𝑞𝑠𝑎𝑙𝑡 = 𝛬−
𝑛∑︁
𝑗=1
(𝜈𝑗 + 𝜎𝑗) 𝑞𝑗 (1.24)
into Eq. 1.21, the widely accepted steric mass action (SMA) isotherm follows:
𝐾𝑒𝑞 =
𝑞𝑖𝑐
𝜈𝑖
𝑠𝑎𝑙𝑡(︁
𝛬−∑︀𝑛𝑗=1 (𝜈𝑗 + 𝜎𝑗) 𝑞𝑗)︁𝜈𝑖 𝑐𝑝,𝑖 . (1.25)
Practically, the SMA isotherm accounts for the reduction of ionic capacity due to protein
binding, hence it delivers almost identical results as the SDM isotherm in linear region,
but is more precise in nonlinear region of adsorption.
In hydrophobic interaction chromatography (HIC), a protein 𝑃 and 𝑛 ligands 𝐿 are thought
to be in equilibrium with a protein-ligand complex 𝑃𝐿𝑛:
𝑃 + 𝑛𝐿⇔ 𝑃𝐿𝑛. (1.26)
Based on the this assumption and the consideration of Gibbs free energy change, Mollerup
introduced an isotherm model for protein adsorption in HIC analogously to the SMA
isotherm as shown in Eq. 1.27 [58].
𝐾𝑒𝑞 =
𝑞𝑖
𝑐𝑝,𝑖𝛾𝑝,𝑖𝑐𝑛𝐿
(1.27)
Here, 𝑐𝐿 is the concentration of free ligands and 𝛾𝑝,𝑖 the activity coefficient of the protein
𝑖. It is assumed that the chemical potential of the immobilized hydrophobic ligands and
the ligand bound protein are less depends on the ionic strength, hence the neglect of the
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activity coefficients of 𝑞𝑖 and 𝑐𝐿. The total concentration of ligands is defined as
𝛬 = 𝑐𝐿 + (𝑛𝑖 + 𝑠𝑖)𝑞𝑖. (1.28)
As the steric hindrance factor in IEX, 𝑠𝑖 accounts for the number of ligands sterically
hindered upon protein binding. 𝛾𝑖 is calculated according to van der Waals equation of
state [58]:
ln 𝛾𝑝,𝑖 = 𝑘𝑝,𝑖𝑐𝑝,𝑖 + 𝑘𝑠𝑐𝑠𝑎𝑙𝑡. (1.29)
Here, 𝑘𝑝 and 𝑘𝑠 are protein and salt specific constants. Consequently, the final HIC
isotherm results
𝐾𝑒𝑞 =
𝑞𝑖
𝑐𝑝,𝑖 (𝑘𝑝,𝑖𝑐𝑝,𝑖 + 𝑘𝑠𝑐𝑠𝑎𝑙𝑡) (𝛬− (𝑛𝑖 + 𝑠𝑖)𝑞𝑖)𝑛 . (1.30)
Details on the derivation of the models can be found in the aforementioned references.
1.2. Principles of Precipitation
For protein purification, precipitation is seen as an alternative technique to preparative
chromatography. The solubility of proteins in water, diluted aqueous solutions, and
concentrated salt solution was extensively studied in the last century. The protein solubility
is a thermodynamic quantity defined as a certain protein concentration in saturated
solution that is in equilibrium with a solid phase under a given set of conditions. Protein
solubility depends thereby on both intrinsic factors, which are primarily defined by the
amino acids on the protein surface, and extrinsic factors including pH, ionic strength,
temperature, and solvent additives [59]. In the beginning, proteins relatively insoluble in
water were investigated at their isoelectric points, forcing them to precipitate. The protein
solubility was found to be specific with respect to protein characteristics and the extrinsic
experimental conditions. The solubility was thought to be generally independent of the
amount of the precipitate, resulting in the suggestion of a simple heterogeneous equilibrium
between the solution and the precipitate, until the observation was made, that the solubility
of serum globulin is proportional to the amount of precipitate [60]. Furthermore, it was
found that some proteins relatively insoluble in water are very soluble in diluted acid,
base, or salt solutions. Later on, the observation of protein precipitation induced by
adding neutral salts was made [60]. At critical amount of salt added to solution containing
differently soluble proteins, the less soluble ones are precipitated, whereas the others remain
in solution. It has been observed that not only the salt concentration, but also the salt
type is of great importance for the protein solubility. Based on these effects, methods
for protein separation using salt-induced precipitation (i.a. by shielding electrostatic
interactions of proteins) have been developed. Chick and Martin [61] investigated the effect
of protein concentration upon solubility at a constant salt concentration with the model
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system consisting of egg albumin and ammonium sulfate. Based on the observation, that
an increasing protein concentration led to a greater amount of precipitated protein, they
concluded that protein solubility would be a function of the protein concentration itself.
An explanation was delivered later by Sørensen and Høyrup [62], who developed a "method
of proportionality" and demonstrated that due to the hydration of the egg albumin, the
apparent ammonium sulfate concentration was increased proportionally to the increased
egg albumin concentration. Later, the effect of the salt concentration upon solubility was
studied by Sørensen and Høyrup [63]. The relation between the salt concentration and the
protein solubility has been postulated by a logarithm equation:
log 𝑠 = ?˜??˜?+ 𝛽. (1.31)
Here, the correlation is purely empirical with 𝑠 as the solubility of the protein, ?˜? the
molecular concentration of the salt, as well as ?˜? and 𝛽 the constants dependent on protein
and salt.
This equation has been later applied to precipitation induced by polyethylene glycol (PEG),
with ?˜? as the molecular concentration of PEG, which has shown promising results for the
separation of complex mAb solutions [64]. Although precipitation is well investigated and
shows various applicable scenarios in protein purification, the fundamental mechanisms
are not completely understood [65–67]. Two theories have been proposed to describe the
mechanisms of PEG-induced precipitation of proteins.
Figure 1.4.: Theories explaining the mechanisms of protein precipitation using PEG.
The theory of excluded volume as depicted in Fig. 1.4 (a) assumes that PEG traps the
solvent in its coiled structure and occupies solvent regions, leading to a steric exclusion
of the proteins. The result is the increase of protein concentration in the non-occupied
regions until the protein solubility is exceeded and precipitation occurs [68]. The theory of
attractive depletion as depicted in Fig. 1.4 (b) extends the former theory by postulating
a formation of concentration gradient due to the overlapping of two depletion zones of
proteins. This gradient results in an osmotic pressure and finally in precipitation of proteins.
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1.3. Artificial Neural Networks
At first inspired by the biological neural networks in an animal brain, the artificial
neural networks (ANNs) are computing systems which can receive information from the
surrounding, store it, process it, and generate output information. They learn without
any a priori knowledge and evolve their own "understanding" based on learning material.
Mathematically, an ANN is a collection of interconnected artificial neurons which can
perform simple operations, e.g. multiplication and addition. Since the ANNs’ first
introduction by McCulloch and Pitts in 1943 [69], they have shown successes in various
application scenarios and finally thrives due to improved computing power in the beginning
of the 21𝑡ℎ century in different fields of artificial intelligence. For example, the Blue Brain
project aims to understand the fundamental principles of mammalian brain structure and
function based on a digital reconstruction [70]; AlphaGO defeated the humankind in the
classic board game of Go [71], which is highly abstract due to its huge number of possible
game outcomes of approximately 10170; In self-driving cars, ANNs are trained to mimic
a human driver’s acceleration, braking, and steering as responses to visual inputs from
sensor detections [72].
1.3.1. Architecture
An ANN consists of a number of processing units — the so-called artificial neurons or nodes
— in different arrangements. Besides the completely free and self-optimizing architectures,
the nodes are usually prearranged in layers as shown in Fig. 1.5.
Figure 1.5.: An ANN model of simple architecture.
The input layer is the interface between the input data and the subsequent layers in the
ANN. The nodes in the input layer receive information from surrounding and forward it to
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nodes in the hidden layer. The nodes in the hidden layers and output layer are responsible
for the calculation of the weighted sum of received signals and the biases, as well as its
processing with transfer functions. Eventually, the output signal is sent to all receiving
nodes in the next layer.
The operation in the 𝑖𝑡ℎ node in the 𝑗𝑡ℎ layer can be described mathematically as
𝜔𝑖,𝑗 = 𝜑𝑖,𝑗
(︃
𝑚∑︁
𝑘=1
𝜉𝑘𝜔𝑘,𝑗−1 + 𝜁𝑖,𝑗
)︃
. (1.32)
A node responses with the output signal 𝜔𝑖,𝑗 on 𝑚 received input signals 𝜔𝑘,𝑗−1 by
multiplying them with their specific weights 𝜉𝑘 under consideration of the bias 𝜁𝑖,𝑗 . 𝜑𝑖,𝑗 is
a linear, nonlinear, or step transfer function.
The linear transfer function as shown in Eq. 1.33 transforms the input signals linearly by
adding a bias term to their weighted sum and is mostly used for function fitting problems.
𝑦(?˜?) = 𝑎 · ?˜?+ 𝑏 (1.33)
Here, ?˜? is the input signal, and 𝑎 and 𝑏 the constants in the activation function. The most
used nonlinear transfer function is the sigmoid transfer function as shown in Eq. 1.34 which
accepts input signals from negative to positive infinity, and generates outputs between 0
and 1. The derivative of sigmoid neurons can be calculated easily, making it attractive for
calculating the weight updates during backpropagation.
𝑦(?˜?) = 𝑎1 + exp(−?˜?) + 𝑏 (1.34)
The step transfer function as in Eq. 1.35 offers a binary output and is therefore useful in
the output layer of an ANN to conduct binary classification of the inputs.
𝑦(?˜?) =
{︃
1 ?˜? ≥ 𝑎
0 ?˜? < 𝑎
(1.35)
Here, 𝑦 and ?˜? are the generated output and received input of the transfer function,
respectively, while 𝑎 and 𝑏 are any real numbers.
While the size of the input and output layers are defined by the dimension of the processed
data, the number of hidden layers, their size, and the overall connectivity are case specific.
Special attention should be paid to the complexity of the ANN architecture, since there
is always a trade-off between the ANN’s capability of solving complex problems and its
generalization performance [73, 74].
1.3.2. Supervised Learning
The paradigm of supervised learning are the important tasks mastered by the artificial
intelligence: Classification and regression. The former is also known as pattern recognition,
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the latter as function approximation. In supervised learning, input data from a labeled
training data set are mapped to the corresponding target data by applying learning
algorithms to modify the network [75, 76]. Based on the processed learning material,
the neural networks should be able to evolve their own sets of relevant characteristics.
Commonly, the weights and biases of the artificial neurons are adjusted. More advanced
meta learning algorithms, however, are capable of updating the entire network, including
the learning algorithms, the activation functions, or even the network architecture [77].
The learning success of an ANN is measured by the cost function, which is – like in other
mathematical optimization problems – a function that requires to be minimized. It is often
defined as the discrepancy between the target data and the network’s output, e.g. the
softmax cross-entropy, Kullback-Leibler divergence, or the most common mean-squared
error (MSE) as defined in Eq. 1.36.
𝐶 = 12?^?
?^?∑︁
𝑖=1
(︁
𝑦𝑖 − 𝑦′𝑖
)︁2
(1.36)
𝐶 represents the cost, ?^? the total number of training data sets, 𝑦 the desired output, and 𝑦′
the ANN response. To update the weights and biases after every iteration, the gradient of
the cost function is commonly calculated by employing the method of backpropagation [78].
In backpropagation, changing the weights and biases based on the calculation of the partial
derivatives of the cost function with respect to weights and biases is the core task. Usually,
the algorithm of backpropagation is computed in the propagation phase and the weight
update phase. In the propagation phase, the input is forwarded through the ANN to
generate the initial outputs of each node in each layer according to Eq. 1.32. According to
the cost calculated based on the cost function chosen, the error ?⃗?𝐽 in the output layer 𝐽 is
defined as
?⃗?𝐽 = ∇𝑦′𝐶 ⊙ 𝜑′(?⃗?𝐽), (1.37)
with 𝜑′ as the changing rate of the activation function 𝜑 at the weighted sum of the received
signal and the bias ?⃗?𝐽 in the output layer, which can be defined as
?⃗?𝑗 =
(︁
𝜉𝑗?⃗?𝑗−1 + 𝜁𝑗
)︁
(1.38)
for any hidden and output layer. The error ?⃗?𝑗 in terms of the error in the next layer is
defined as
?⃗?𝑗 =
(︁
(𝜉𝑗+1)𝑇 ?⃗?𝑗+1
)︁
⊙ 𝜑′(?⃗?𝑗), (1.39)
where 𝜑′ represents the changing rate of the activation function 𝜑 at the weighted sum
of the received signal and the bias ?⃗?𝑗 , ?⃗?𝑗+1 the error and 𝜉𝑗+1 the weight matrix in the
next layer. In practice, Eqs. 1.37 and 1.39 can be used to calculate the errors for any layer
in the ANN. After computing of the error of output layer, the error of the hidden layer
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prior to output player can be calculated. In this manner, errors are propagated backwards
through the entire ANN.
In the weight update phase, the gradients of the cost function with respect to weights and
biases are calculated based on the already computed errors 𝛿𝑖,𝑗 as
𝜕𝐶
𝜕𝜉𝑖,𝑗
= 𝜔𝑖,𝑗−1𝛿𝑖,𝑗 (1.40)
and
𝜕𝐶
𝜕𝜁𝑖,𝑗
= 𝛿𝑖,𝑗 , (1.41)
respectively. For starting of the next iteration, a ratio of the gradient is subtracted from
the corresponding initial weight and biases.
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1.4. Research Proposal
Biologics represent a growing share of the current pharmaceutical market. The diverse
biomolecules e.g., monoclonal antibodies (mAbs), conjugated proteins, or virus-like parti-
cles, challenge the bioseparation processes because of their different molecular properties.
This has resulted in the advancement of DSP technologies such as, chromatography and
alternative unit operations, continuous processing, disposables, process analytical tools,
and process development strategies. Fixed orders of unit operations – the so-called platform
processes – have been introduced in industry to reduce process development effort for
mAbs. With rise of other biopharmaceuticals, the standard platform processes are no longer
applicable and need to be cumstomized. Hence, high-throughput experimentation (HTE)
has been developed and adapted in academia and industry to screen a large region of
the process design space, accepting the drawbacks of its requirement for high amount of
sample often unavailable in the early development stages. Later, design-of-experiments
(DoE) has been coupled with HTE to balance the accuracy and reliability of the results
and the experimental effort needed.
Besides the advantages of saving time and material, the approach of mechanistic modeling
copes the demand of the Quality by Design (QbD) initiative suggested by the US Food
and Drug Administration (FDA), that the process development and manufacturing should
be backed up by thorough scientific understanding. In recent years, great development
attempts have been placed upon transfer model-based approaches from academia into
industrial laboratory work-flows. Successes have been shown in the usual unit operations,
especially in model-based process development and scale-up in ion-exchange chromatography
for mAb purification. However, the model-based approach is not straightforward. There
are still problems unsolved requiring attention of academic research and development,
which can be assigned to different fields of mechanistic modeling in an elementary way:
Model building, model calibration, and model application.
The ultimate objective of the present research proposal arises in these fields, to solve urgent
issues that prevent the use of model-based approaches on the one hand, and to suggest new
applications on the other. In doing so special attention was paid to artificial intelligence
based on artificial neural networks (ANNs) which was one of the fastest growing research
topics in the last decades and showed successes in diverse utilization scenarios in various
fields of technology. In chromatography processes, however, the large amount of data
required for the training of the ANNs are often not given and the usage of ANNs has been
limited to modeling of retention times. Combining mechanistic modeling and ANNs could
open up new possibilities.
Hydrophobic interaction chromatography (HIC) is frequently used in DSP for intermediate
and polishing purposes, to remove mAb aggregates and other non-polar contaminants,
and to separate antibody-drug conjugate species. In industry, HIC process development
relies entirely on rules of thumb or HTE, since an accurate description of the complex
salt-dependent protein-ligand interaction is not given. In the selective protein precipitation
using PEG – an extraordinary alternative to preparative chromatography because of its
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cost efficiency and ease of handling – a similar problem is shared. The development of
precipitation processes for biomolecules relies heavily on wet laboratory experiments and
empirical correlations. Hence, the first part of this thesis is devoted to build mechanistic
HIC and protein precipitation models, which cannot only be used to describe and develop
processes, but also as theoretical frameworks for further model extensions.
In modeling of chromatography, some of the model parameters cannot be measured directly
and are determined by employing time-consuming methods such as gradient experiments
coupled with frontal analysis, combined Yamamoto approach, or curve fitting. These
traditional calibration approaches have certain particularities in common i.e., requirement
for repeated calibration upon new compounds’ entering the system of observation and for
profound model understanding. To circumvent these disadvantages, the second part sets
the goal to develop a novel model calibration method based on artificial neural networks
which represent the most simple form of artificial intelligence.
Mechanistic chromatography modeling is a powerful tool in every aspect, nonetheless its
application scenarios reported in the literature are surprisingly limited to model-based
process development and robustness analysis. Thus, in the final part of this thesis studies
on model application are carried out to investigate the mass transfer and adsorption
mechanisms of protein conjugates, to explore an integration of precipitation and continuous
chromatography, and eventually to develop a tool for real-time root cause investigation in
deviating chromatography processes.
20 Introduction
1.5. Outline
Chapter 2 proposes an adsorption isotherm for the description of salt-dependent protein-
ligand interaction in HIC. Chapter 3 introduces a mechanistic model for protein precipitation
using PEG by considering variations in both protein and PEG concentration. Chapter 4
presents the development of a novel calibration method to overcome the disadvantages of
the traditional calibration methods. Chapter 5 addresses the issue of abnormal behavior
of PEGylated proteins in IEX by conducting a full investigation based on mechanistic
chromatography models. In chapter 6, the combination of various process development
strategies and the integration of precipitation and IEX chromatography as the alternative
to expensive Protein A chromatography are discussed. Eventually, chapter 7 explores a
new application of chromatography modeling upon process deviation.
Chapter 2: Water on hydrophobic surfaces: Mechanistic modeling of
hydrophobic interaction chromatography
G. Wang, T. Hahn, J. Hubbuch
Journal of Chromatography A (1465), 2016, 71-78
This article presents the derivation of a mechanistic model for hydrophobic interaction
chromatography (HIC). By taking the new insights into the water structure on hyd-
rophobic surfaces into account, assumptions and simplifications were made to cope
the requirement for practical applicability in model-based HIC process development.
The identifiability and reliability of model parameters were demonstrated by column
experiments, application of the inverse method, and calculation of the confidence
intervals for parameter estimates. High-throughput batch chromatography experi-
ments and column experiments beyond calibration space underline the suitability of
the isotherm model.
Chapter 3: Water on hydrophobic surfaces: Mechanistic modeling of
protein precipitation using polyethylene glycol
S. Großhans*, G. Wang*, J. Hubbuch (*contributed equally)
Manuscript submitted to Journal of Chromatography A
In this manuscript, the mechanistic similarities between precipitation and HIC
reported in the literature were used to develop a model to describe protein preci-
pitation using PEG quantitatively. After calibration, it was capable of predicting
the precipitation behavior of proteins with very different features. By providing an
opportunity to model the entire precipitation curve in dependence of protein and
PEG concentration, it supplements the widely accepted Cohn equation.
Chapter 4: Estimation of adsorption isotherm and mass transfer pa-
rameters in protein chromatography using artificial neural networks
G. Wang, T. Briskot, T. Hahn, P. Baumann, J. Hubbuch
Journal of Chromatography A (1487), 2017, 211-217
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This paper presents a calibration method for protein chromatography models based
on a combination of mechanistic modeling and ANN. In contrast to traditional
calibration methods, it was capable of identifying the model parameters immediately
when trained and presented with chromatograms. This method circumvents the
requirement for repeated model calibration of traditional methods avoiding the
associated high computational expense.
Chapter 5: Model-based investigation on the mass transfer and ad-
sorption mechanisms of mono-PEGylated lysozyme in ion-exchange
chromatography
J. Morgenstern*, G. Wang*, P. Baumann, J. Hubbuch (*contributed equally)
Biotechnology Journal (12), 2017, 1700255
This article delivers a thorough investigation on PEGylated lysozyme species in
IEX carried out using mechanistic chromatography modeling. The physical meaning
of the determined model parameters was utilized to improve the understanding
of unusual behavior of PEGylated proteins in preparative chromatography. The
knowledge gained is not only of academic interest, but also could help in industrial
purification process design and scale-up.
Chapter 6: An integrated precipitation and ion-exchange chromato-
graphy process for antibody manufacturing: Process development stra-
tegy and continuous chromatography exploration
S. Großhans*, G. Wang*, C. Fischer, J. Hubbuch (*contributed equally)
Journal of Chromatography A (1533), 2018, 66-76
This paper studies the utilization of a development toolbox consisting of high-
throughput experimentation (HTE), design of experiments (DoE), and mechanstic
modeling for the design and optimization of mAb purification unit operations.
The resulting process match the performance of an industrial standard Protein A
chromatography step providing an inexpensive alternative. Eventually, the capability
of a continuous multicolumn chromatography process was explored based on a
calibrated single column chromatography model.
Chapter 7: Root cause investigation of deviations in protein chroma-
tography based on mechanistic models and artificial neural networks
G. Wang, T. Briskot, T. Hahn, P. Baumann, J. Hubbuch
Journal of Chromatography A (1515), 2017, 146-153
This study explores the applicability of mechanistic chromatography models beyond
the common scenarios of process development and robustness analysis. With the
presented tool consisting of mechanstic models and artificial neural networks, a
root cause investigation of deviation during day-to-day operation could be realized
without stopping the manufacturing process. As an example, root cause investigation
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was carried out on deviation in the ionic capacity of ion-exchange chromatography
column, which so far had to be measured by acid-base titration. This shows one
of many hitherto unexplored possibilities to apply and to benefit from mechanistic
chromatography models.
2. Water on Hydrophobic
Surfaces: Mechanistic Modeling
of Hydrophobic Interaction
Chromatography
Gang Wang1, Tobias Hahn2, Jürgen Hubbuch1,*
1 Karlsruhe Institute of Technology (KIT), Institute of Process Engineering in Life
Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe, Germany
2 GoSilico GmbH, Karlsruhe, Germany
* Corresponding author. E-mail address: juergen.hubbuch@kit.edu
Abstract
Mechanistic models are successfully used for protein purification process development
as shown for ion-exchange column chromatography (IEX). Modeling and simulation
of hydrophobic interaction chromatography (HIC) in the column mode has been
seldom reported. As a combination of these two techniques is often encountered in
biopharmaceutical purification steps, accurate modeling of protein adsorption in HIC
is a core issue for applying holistic model-based process development, especially in
the light of the Quality by Design (QbD) approach.
In this work, a new mechanistic isotherm model for HIC is derived by consideration
of an equilibrium between well-ordered water molecules and bulk-like ordered water
molecules on the hydrophobic surfaces of protein and ligand.
The model’s capability of describing column chromatography experiments is de-
monstrated with glucose oxidase, bovine serum albumin (BSA), and lysozyme on
CaptoTM Phenyl (high sub) as model system. After model calibration from chroma-
tograms of bind-and-elute experiments, results were validated with batch isotherms
and prediction of further gradient elution chromatograms.
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2.1. Introduction
Biologics, especially therapeutic proteins, count among the fastest-growing market
segments in the current pharmaceutical industry. To cope with the growing number
of drug candidates, downstream process (DSP) development faces the challenge of
set-up processes for new molecules with limited sample volume within a short time
frame. For purification of therapeutic proteins, especially monoclonal antibodies
(mAbs), preparative chromatography is the core technology to deliver a highly pure
product [79].
Hydrophobic interaction chromatography (HIC) is a frequently used method for
intermediate and polishing purposes in DSP [80–82]. HIC is well-known for its
remarkable capability to remove aggregates and other non-polar contaminants [82–
84]. To date, HIC process development commonly relies on rules of thumb [85] or
high-throughput experimentation [86]. Alternative methodologies based on the three-
dimensional structure of the protein and its surface hydrophobicity were examined
by Mahn and Asenjo [87].
To meet the demands of the Quality by Design approach (QbD) [17–19], a high
degree of process understanding is required that can be demonstrated by model
building and simulations. At the same time, the sample volume needed for model
calibration is expected to be much less than the amount needed for screening with
the Design-of-Experiments (DoE) approach. To create a chromatography model, the
fluid dynamical principle of mobile phase mass transfer through the chromatography
column as well as the thermodynamical principles of protein-ligand interaction [88]
must be described. The mass transfer within a chromatography column is well-
studied. Several variants of equilibrium and transport-dispersive models are widely
accepted [41]. Model-based process development was demonstrated several times
for ion-exchange chromatography (IEX) [21, 89] with the steric mass action (SMA)
isotherm [90]. The SMA isotherm describes the salt-protein relationship based on the
electrostatic equilibrium theory and displacement effect, such that the salt-dependent
protein-ligand interaction is directly incorporated. In the case of HIC, this derivation
cannot be applied. The challenge of HIC modeling lies in accurately describing the
more complex salt-dependent protein-ligand interaction.
The very first theoretical framework for modeling salt effects in hydrophobic in-
teraction chromatography was derived by Melander and Horvath [91], facilitating
experimental design and result interpretation. Staby and Mollerup investigated
the thermodynamical nature of HIC and presented a mechanistic isotherm [58, 92].
The salt dependence of protein adsorption was described with an exponential term
containing protein activity as well as salt activity coefficients. Perkins et al. applied
the preferential interaction model to examine the salt dependence of the HIC capacity
factors [93]. Chen et al. also used the preferential interaction model to determine
the water molecules released upon salt-related protein binding [94]. Haimer et al.
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applied an extended Langmuir kinetic derived by Lundstrom to model the spreading
phenomenon resulting from injection of a pure protein sample [95, 96]. In addition,
Jungbauer et al. introduced a modified salt-dependent Langmuir isotherm for linear
and nonlinear conditions [97]. Water molecules were first included as participants
in the adsorption process by Deitcher et al. [98]. Their isotherm described the
salt-dependent release of water molecules from the contact area of protein and ligand.
Chen and Sun proposed to consider a dehydrated state of the protein, caused by the
hydration effect of salt ions [99]. Mirani and Rahimpour extended this two-state
isotherm with the consideration of activities instead of concentrations [100].
The formation of a hydrophobic protein-ligand interface is thought to be driven
by the hydrophobic effect, involving a reorganization of the water structure on
the hydrophobic surfaces of protein and ligand [101]. Frank and Evans assumed
a well-ordered ice-like formation of water around hydrophobic groups [102]. Later,
a clathrate-like structure of water on hydrophobic surfaces was proposed [103]. In
2014, Shiraga et al. carried out terahertz spectroscopy to study the water structure
on hydrophobic surfaces of biomolecules and found water molecules around the
hydrophobic groups to be more ordered [104].
The present manuscript was enabled by the aforementioned contributions. The new
insights into the water structure on hydrophobic surfaces were taken into account and
a new mechanistic isotherm was derived for HIC. Keeping the requirements of model-
based HIC process development in mind, several assumptions and simplifications were
made to facilitate practical applicability. Glucose oxidase, bovine serum albumin
(BSA), and lysozyme were chosen as model proteins. This set of proteins covers very
different hydrophobic properties and a wide range of sizes, being 160 kDa, 66 kDa,
and 14.6 kDa. Gradient elution as well as high-throughput batch experimentation
was carried out to prove the predictability of the new isotherm beyond the calibration
space.
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2.2. Theory
2.2.1. Derivation of a HIC Isotherm Considering the Water Structure
The adsorption mechanism in HIC has been proposed to be an equilibrium between a
protein molecule 𝑃 with stoichiometric number 𝑛 of ligands 𝐿 and the protein-ligand
complex 𝑃𝐿𝑛 [58, 93]:
𝑃 + 𝑛𝐿←→ 𝑃𝐿𝑛 (2.1)
This proposition does not explicitly describe the salt dependence in the case of
HIC. Later, Deitcher et al. proposed water to be included as a product 𝑊 with
stoichiometric number 𝜉 by assuming a release of water molecules at the protein-ligand
contact area [98]:
𝑃 + 𝑛𝐿←→ 𝑃𝐿𝑛 + 𝑛𝜉𝑊 (2.2)
A water displacement process originally proposed by Geng et al. [105] was used
as theoretical foundation. The salt was included as a participant by considering
the thermodynamic activity of water in electrolyte solutions. They applied a linear
empirical model, which describes the natural logarithm of water activity to be equal
to the product of salt concentration and a constant factor [98].
Meanwhile,thermodynamical studies have shown that hydrogen bonds between water
molecules on hydrophobic surfaces are disrupted to create a cavity. As a counterre-
action, water molecules form well-ordered structures, such that a thermodynamically
favored state is achieved [106–108]. Upon adsorption, these well-ordered water
molecules are thought to be reorienting in a bulk-like structure. This so-called
hydrophobic hydration phenomenon is added to the general consideration of the ad-
sorption mechanism according to Eqs. (2.1) and (2.2) to formulate the new adsorption
isotherm.
The hydrophobic surfaces of protein 𝑃 and ligand 𝐿 are thought to be stabilized
by well-ordered water molecules. The protein-ligand complex 𝑃𝐿𝑛 is assumed to be
bound with 𝑛 binding sites, which are stabilized by 𝛽 bulk-like water molecules 𝑊𝐵
each:
𝑃 + 𝑛𝐿←→ 𝑃𝐿𝑛 + 𝑛𝛽𝑊𝐵 (2.3)
Under consideration of Gibbs free energy and following the approach presented by
Mollerup [58], the equilibrium contant 𝐾 is derived:
𝐾 ∼= 𝑎𝑛𝛽𝑊𝐵
𝑞
𝑐𝑝𝑐𝑛𝐿
(2.4)
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Here, 𝑞 and 𝑐𝑝 are the concentrations of bound protein and protein in solution,
respectively. 𝑐𝐿 depicts the concentration of ligands available for binding and 𝑎𝑊𝐵
the activity of the bulk-like water molecules. In the next step, parameterizations for
𝑎𝑊𝐵 , 𝑐𝐿 and 𝛽 have to be found.
According to stoichiometric considerations, the number of water molecules involved
is linearly correlated to the protein concentration in the stationary phase 𝑞. Thus, a
linear correlation is proposed to substitute 𝑎𝑊𝐵 :
𝑎𝑛𝛽𝑊𝐵
∼= 𝜈𝑞𝑛𝛽 (2.5)
Here, the stoichiometric constant 𝜈 is assumed to be independent of the salt concen-
tration.
In Eq. (2.6), the free ligand concentration 𝑐𝐿 is defined as a function of total capacity
𝛬, hydrophobic binding sites 𝑛, and steric hindrance factor 𝑠 similarly to the SMA
model and formulation by Mollerup for HIC [58, 90].
𝑐𝑛𝐿 = (𝛬− (𝑛+ 𝑠) 𝑞)𝑛 (2.6)
Inserting Eqs. (2.5) and (2.6) into Eq. (2.4) and collecting all constants on the
left-hand side, we obtain the following isotherm equation:
𝐾 = 𝜈𝑞
1+𝑛𝛽
𝑐𝑝 (𝛬− (𝑛+ 𝑠)𝑞)𝑛 (2.7)
·𝛬𝑛
𝜈⇐⇒: 𝑘𝑒𝑞 = 𝑞
1+𝑛𝛽
𝑐𝑝
(︁
1− 𝑞
𝑞𝑚𝑎𝑥
)︁𝑛 (2.8)
with the saturation capacity 𝑞𝑚𝑎𝑥 = 𝛬/(𝑛+ 𝑠).
In the final step, the salt dependency of the bulk-like ordered water molecules 𝛽 is
modeled. To this, 𝛽 and the hydration number of the salt ions ℎ are assumed to
be reciprocal. As the salt ions attract water molecules to form a hydration shell,
the ionic hydration number ℎ is described with high reliability by an exponential
relation as [109]:
ℎ = ℎ0 exp(−𝑘𝑐𝑠𝑎𝑙𝑡) (2.9)
with ℎ0 being the ionic hydration number at infinite dilution and 𝑘 the constant
that describes the change of hydration number with increasing ionic concentration
𝑐𝑠. Thus, the salt-dependence of the model parameter 𝛽 can be described by the
exponential term:
𝛽 = 𝛽0 exp(𝛽1𝑐𝑠𝑎𝑙𝑡) (2.10)
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This completes the derivation of the equilibrium formulation of the isotherm model.
Assuming the interaction to be close to the thermodynamic equilibrium but time-
dependent, the kinetic formulation of adsorption isotherm results in:
𝑘𝑘𝑖𝑛
𝑑𝑞
𝑑𝑡
= 𝑘𝑒𝑞
(︂
1− 𝑞
𝑞𝑚𝑎𝑥
)︂𝑛
𝑐𝑝 − 𝑞1+𝑛𝛽 (2.11)
In accordance with Hahn et al., the equilibrium coefficient 𝑘𝑒𝑞 = 𝑘𝑎𝑑𝑠/𝑘𝑑𝑒𝑠 and kinetic
coefficient 𝑘𝑘𝑖𝑛 = 1/𝑘𝑑𝑒𝑠 are used instead of adsorption and desorption coefficients
𝑘𝑎𝑑𝑠 and 𝑘𝑑𝑒𝑠 [110]. The benefit of this formulation is that a change in 𝑘𝑒𝑞 strongly
affects the retention time, while the peak height is mainly affected by a change in
𝑘𝑘𝑖𝑛.
2.2.2. Transport-dispersive Model
To model the macroscopic mass transport inside the chromatography column with
length 𝐿 and adsorber beads with radius 𝑟𝑝, the widely accepted general rate model
(GRM) is employed [41]:
𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑡
= −𝑢(𝑡)𝜕𝑐(𝑥,𝑡)
𝜕𝑥
+𝐷𝑎𝑥
𝜕2𝑐(𝑥,𝑡)
𝜕𝑥2
−1− 𝜖𝑏
𝜖𝑏
𝑘𝑓𝑖𝑙𝑚,𝑖
3
𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑡)) (2.12)
𝜕𝑐𝑖(0,𝑡)
𝜕𝑥
= 𝑢(𝑡)
𝐷𝑎𝑥
(𝑐𝑖(0,𝑡)− 𝑐𝑖𝑛,𝑖(𝑡)) (2.13)
𝜕𝑐𝑖(𝐿,𝑡)
𝜕𝑥
= 0 (2.14)
𝜕𝑐𝑝,𝑖(𝑥,𝑡)
𝜕𝑡
=
⎧⎪⎨⎪⎩
1
𝑟2
𝜕
𝜕𝑟
(𝑟2𝐷𝑝,𝑖 𝜕𝑐𝑝,𝑖𝜕𝑟 )− 1−𝜖𝑝𝜖𝑝
𝜕𝑞𝑖
𝜕𝑡
for 𝑟 ∈ (0, 𝑟𝑝),
𝑘𝑓𝑖𝑙𝑚,𝑖
𝜖𝑝𝐷𝑝,𝑖
(𝑐𝑖 − 𝑐𝑝,𝑖) for 𝑟 = 𝑟𝑝,
0 for 𝑟 = 0.
(2.15)
Eq. (2.12) describes the mass transfer between the interstitial volume of the mobile
phase 𝑐𝑖(𝑥,𝑡) and the pore volume 𝑐𝑝,𝑖(𝑥,𝑡). It depends on the peak-broadening effects
in the interstitial volume that are lumped in the axial dispersive coefficient 𝐷𝑎𝑥,
the film transfer coefficient 𝑘𝑓𝑖𝑙𝑚,𝑖, and the voidage of the bed 𝜖𝑏. Eqs. (2.13) and
(2.14) are the Danckwerts boundary conditions. Eq. (2.15) models the exchange
between the pore volume concentration 𝑐𝑝,𝑖(𝑥,𝑡) and stationary phase 𝑞𝑖 depending
on the particle voidage 𝜖𝑝 and the component-specific pore diffusion coefficient 𝐷𝑝.
Combined with the kinetic formulation of the adsorption isotherm Eq. (2.11), a
chromatography process can be modeled and simulated.
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2.2.3. Numerical Solution
The discretization in space on a grid with equidistant nodes is performed using
the finite element method. The discretization in time is carried out with the
fractional step 𝜃-scheme [111]. The non-linear equation system is treated with Picard
iteration [112]. For parameter estimation, adaptive simulated annealing [113] and
the Levenberg-Marquardt algorithm [114] are employed. For initial simulations, the
former heuristic algorithm is chosen. It searches a larger space with random jumps
to prevent local minima. Following common approaches, the results are refined by
applying the latter deterministic algorithm.
2.3. Materials and Methods
2.3.1. Instruments
Gradient elution experiments were carried out using an ÄKTA purifier 10 fast protein
liquid chromatography system equipped with pump unit P-903, UV cell (10 mm path
length), conductivity cell, and autosampler A-900 (all GE Healthcare, Little Chalfont,
Buckinghamshire, UK). The control software UNICORN 5.31 (GE Healthcare, Little
Chalfont, Buckinghamshire, UK) was used. High-throughput batch chromatography
experiments were conducted on a Freedom EVO 200 robotic platform equipped with
a liquid handler, a robotic moving arm for transportation of plates, six fixed pipette
tips, an orbital shaker, a vacuum separation module, and a photometer infinite M200
pro (all Tecan, Männedorf, Switzerland). The instrument was controlled by Freedom
EVOware 2.5 software (Tecan, Männedorf, Switzerland).
2.3.2. Software
The kinetic adsorption isotherm was calibrated and simulated using the chroma-
tography simulation software ChromX (GoSilico, Karlsruhe, Germany). ChromX
provides numerical tools for discretization, solving of partial differential equation
systems, as well as optimization and statistical analysis [115]. The equilibrium ad-
sorption isotherm was calibrated and simulated with Matlab® R2015a (MathWorks,
USA). fsolve was used to solve the nonlinear equation, and simulated annealing was
used to estimate equilibrium isotherm parameters.
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2.3.3. Adsorber, Proteins, and Chemicals
As a HIC adsorber medium, CaptoTM Phenyl (high sub) supplied by GE Healthcare
(Carlsbad, CA, USA) was used. For high-throughput batch chromatography ex-
periments, adsorber medium was dispensed using MediaScout® ResiQuot provided
by ATOLL (Weingarten, Germany), such that 20.8𝜇L medium was packed in each
well of MultiScreen HTS-DV supplied by Merck Millipore (Billerica, MA, USA).
For linear-gradient elution experiments, a pre-packed 1mL MediaScout® miniChrom
column with dimension 50mm × 5 mm provided by ATOLL (Weingarten, Germany)
was used. Between the runs, the adsorber media were stored in 20% ethanol. Before
experimentation, the storage solution was removed by prolonged equilibration with
water, low-salt and high-salt buffer.
Three proteins of different sizes (160 kDa, 66 kDa and 14.6 kDa) and different isoe-
lectric points (acidic and alkaline) were used as model proteins to investigate the
isotherm predictability. Glucose oxidase (Aspergillus niger, no.G7141) and BSA
(bovine serum, no.A4612) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Lysozyme (hen egg, no.HR7-110) was purchased from Hampton Research (Aliso
Viejo, CA, USA).
To perform experiments near the isoelectric point of glucose oxidase and BSA, a
40mM 1-methylpiperazine buffer (Sigma-Aldrich, St. Louis, MO, USA) was used
at pH 4.5 with additional 0 and 4M NaCl. For lysozyme, a 40mM CAPSO buffer
(Sigma-Aldrich, St. Louis, MO, USA) was used at pH 10 with additional 0 and 4M
NaCl. All solutions were prepared with ultra pure water (UPW) (arium pro UV,
Sartorius, Göttingen, Germany). All buffers and storage solutions were filtrated
with a membrane cutoff of 0.22𝜇m and degassed by sonification. All proteins were
prepared equal to the loading conditions and were filtrated with a membrane cutoff
of 0.22𝜇m prior to usage.
2.3.4. Extra Column Effects
The ÄKTA system and chromatography column were characterized via tracer injection
at 60 cm/h. For determination of the system and total voidage of the column, 25𝜇L
1%(v/v) acetone (Merck, Darmstadt, Germany) was used as a pore-penetrating, non-
interacting tracer. Filtrated 10 g/L dextran 2000 kDa (Sigma-Aldrich, St. Louis, MO,
USA) solution was used as non-pore-penetrating, non-interacting tracer to determine
the bed voidage of the column. The UV signal at 300 nm and the conductivity signal
were recorded to determine these parameters and correct all measurements regarding
dead volumes.
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2.3.5. Bind-and-elute Experiments
Protein solutions of varying concentrations dissolved in corresponding binding buffer
were loaded via a 500𝜇L or 1000𝜇L loop connected to the autosampler. Different
gradients and steps were mixed from high-salt and low-salt buffer. A subset of the
chromatograms was used to perform the inverse method for parameter estimation.
The remaining runs were used to validate the calibrated model. The operating
conditions were chosen manually from the ranges given in Table 2.1. All experiments
were conducted at a linear flow of 60 cm/h to ensure a residence time of five minutes.
2.3.6. Parameter Determination
The bed voidage 𝜖𝑏 and particle voidage 𝜖𝑝 were calculated from the aforementioned
tracer injections following the methodology presented by Hahn et al. [116]. The
axial dispersion coefficient 𝐷𝑎𝑥 was calculated from the dextran peak broadening
evaluated by UNICORN 5.31. The film transfer coefficient 𝑘𝑓𝑖𝑙𝑚,𝑠 and the pore
diffusion coefficient 𝐷𝑝,𝑠 of salt were estimated based on the recorded conductivity
signal. In the case of proteins, the film transfer coefficients 𝑘𝑓𝑖𝑙𝑚,𝑖 and the pore
diffusion coefficients 𝐷𝑝,𝑖 were estimated, where the upper bound was set to 𝑟𝑝/3
Isotherm parameters of the kinetic formulation in Eq. (2.11) were also determined
using the inverse method in combination with simulated annealing and the Levenberg-
Marquardt algorithm. Since the adsorber medium and salt type did not change, 𝛽0
and 𝛽1 were estimated once for glucose oxidase and then directly adopted for BSA
and lysozyme.
2.3.7. Model Validation
The model quality was assessed by comparison of simulation and experimental
data. The 95% confidence intervals of estimated parameters were calculated from
the parameter covariance matrices, such that not only the accuracy, but also the
reliability of the calibrated model could be evaluated. As 𝛽0 and 𝛽1 were kept constant
Table 2.1.: Ranges of operating conditions for column experiments used for model calibration
and validation.
Lower bound Upper bound
Gradient start concentration [mM] 440 4020
Gradient end concentration [mM] 0 600
Gradient length [CV] 0 20
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when modeling all three protein species, this reduction of the degrees of freedom
underlines the legitimacy of the model assumptions. Furthermore, the calibrated
isotherm parameters of 𝛽0, 𝛽1 and 𝑛 were used to describe batch adsorption behavior
as additional validity check.
2.3.8. High-throughput Batch Chromatography Experiments
High-throughput batch chromatography experiments were performed at 25 oC on
the robotic platform as follows. The preparation of aliquots from CaptoTM Phenyl
(high sub) suspension was conducted by using the vacuum manifold device ResiQuot.
After removal of storage solution from the filter plate by applying a vacuum of
300mbar, the adsorber resin was washed five times with 250𝜇L UPW per well.
The equilibration was carried out three times with 250𝜇L buffer of corresponding
composition. Protein of varying concentrations dissolved in binding buffer was loaded
into each well of the filter plate. Thereafter, a wash step, elution, and regeneration
were performed. For all steps, the incubation was carried out on a shaking incubator
at 300 rpm for 1 h. Vacuum at 300mbar was applied to collect the supernatant in a
UV 96-well MTP. Salt concentrations from 1M to 0M NaCl were applied in 1/9M
steps.
Isotherm fitting determined only the packing-dependent parameters 𝑘𝑒𝑞 and 𝑞𝑚𝑎𝑥. All
other isotherm parameters, 𝛽0, 𝛽1 and 𝑛, were adopted directly from the parameter
set obtained from chromatogram fitting.
2.4. Results
2.4.1. System Characterization
The system dead volume of 330𝜇𝐿 of the FPLC was determined by tracer injection
without a chromatography column attached. This volume was subtracted from all
other data obtained from the FPLC. Based on the results of the tracer injections with
connected chromatography column, bed and particle voidage, and axial dispersion
were calculated. The results are given in Tab 2.2.
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Table 2.2.: Voidages and axial dispersion are calculated from retention volume and peak
broadening of tracer injections.
CaptoTM
Phenyl (high sub)
Bed voidage 𝜖𝑏 0.422
Particle voidage 𝜖𝑝 0.986
Total voidage 𝜖𝑡 0.992
Axial dispersion [𝑐𝑚2/𝑠] 𝐷𝑎𝑥 5.6·10−4
2.4.2. Parameter Estimation
The determined parameters and confidence intervals for all mass transfer and isotherm
parameters are given in Tab. 2.3. First, adaptive simulated annealing was used for
parameter estimation. Thereafter, a Levenberg-Marquardt algorithm was employed
to find the final optimum.
The film transfer and pore diffusion coefficients for salt, 𝑘𝑓𝑖𝑙𝑚,𝑠 and 𝐷𝑝,𝑠, were
estimated from the experimentally obtained conductivity data. Each protein-specific
parameter set was then estimated from three bind-and-elute experiments.
Fig. 2.1 shows the simulated and experimental chromatograms used for model
calibration for glucose oxidase (Figs. 2.1 a – 2.1 c), BSA (Figs. 2.1 d – 2.1 f) and
lysozyme (Figs. 2.1 g – 2.1 i). Measurements have not been post-processed, and
the simulated sum signal takes into account a linear baseline drift with a slope of
3.5mAU/M caused by salt gradients. To assess the predictive power of the calibrated
models, two additional experiments have been conducted per protein as test set.
Figs. 2.2 a – 2.2 f show the comparison of model prediction and experimental data.
To compare the performance of the presented model with previously proposed
salt-dependent isotherms, the three experiments with glucose oxidase were used to
calibrate the models by Mollerup [58] and Deitcher et al. [98]. The quality of model fit
was evaluated with the normalized root-mean-square error (NRMSE). The obtained
NRMSE of the proposed new isotherm was 0.032, compared to 0.039 for Deitcher et
al., and 0.058 for Mollerup. An exemplary simulation result for all three isotherms is
shown in Figs. 2.3 a – 2.3 c.
2.4.3. Equilibrium Adsorption Isotherm
The result of the batch chromatography experiments for glucose oxidase, BSA,
lysozyme, and ten different salt concentrations between 1M and 0M in 1/9M steps,
is shown in Fig. 2.4. The (𝑐,𝑞,𝑐𝑠)-triplets were fitted with the equilibrium isotherm
formulation shown in Eq. (2.8). As the general binding behavior is identical, the
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isotherm parameters 𝛽0, 𝛽1, and 𝑛 from Tab. 2.3 were kept constant for each protein
species. Only 𝑘𝑒𝑞 and 𝑞𝑚𝑎𝑥 were adjusted to account for the difference in skeleton-
based and bed-volume-based capacity. The lines in Fig. 2.4 show the fitted adsorption
isotherms. The resulting 𝑘𝑒𝑞,𝑏𝑎𝑡𝑐ℎ value is 0.129 and 𝑞𝑚𝑎𝑥,𝑏𝑎𝑡𝑐ℎ equals 4.604·10−4M for
glucose oxidase, 8.557·10−2 and 1.609·10−3M for BSA, 0.502 and 1.705·10−2M for
lysozyme.
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Figure 2.1.: Plots of UV signals over process run time for bind-and-elute experiments. Blue
dashed lines display the UV signal measured at column outlet. Black dashed lines show the
adjusted salt gradients. Solid lines represent the simulated chromatograms. Plots (a) – (c)
show glucose oxidase within a salt concentration between 4.02M and 0.02M, plots (d) – (f)
BSA within a salt concentration between 3.7M and 0.47M, plots (g) – (i) lysozyme within
a salt concentration between 3.63M and 0.051M. The normalized root-mean-square errors
(NRMSE) are 0.032 for glucose oxidase, 0.045 for BSA, and 0.061 for lysozyme.
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Figure 2.2.: Comparison of simulated UV signal and measurements. (a) and (d) represent
glucose oxidase within a salt concentration between 4.02M and 0.02M, (b) and (e) represent
BSA within a salt concentration between 3.23M and 0M, (c) and (f) the ones for lysozyme
within a salt concentration between 4.02M and 0.05M. The NRMSE of prediction are 0.150
for glucose oxidase, 0.080 for BSA, 0.089 for lysozyme.
Figure 2.3.: Comparison of three salt-dependent isotherm models. Blue dashed lines display
the UV signal measured at column outlet. Black dashed lines show the adjusted salt gradients.
Solid lines represent the simulated chromatograms. Plot (a) shows the simulation result of
glucose oxidase within a salt concentration between 1.02M and 0.02M using the isotherm
model proposed by Mollerup [58], (b) the simulation result using the one proposed by Deitcher
et al. [98], and (c) the result using the presented isotherm model. Fig. 2.3 (c) is identical with
Fig. 2.1 (c) and shown here for comparability.
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Figure 2.4.: Equilibrium adsorption data points from high-throughput experimentation
and resulting equilibrium isotherms. Plot (a) shows glucose oxidase, plot (b) BSA, plot (c)
lysozyme. The uppermost isotherms represent the adsorption behavior for 1M NaCl. The salt
concentration decreases in 1/9M steps from top to bottom. The NRMSE are 0.266 for glucose
oxidase, 0.093 for BSA, and 0.010 for lysozyme.
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2.5. Discussion
As the results of the model calibration for glucose oxidase, BSA, and lysozyme show
in Fig. 2.1, the overall model fit is very good. The glucose oxidase runs were used
for comparing the model’s performance with other salt-dependent isotherms. With a
comparably small NRMSE the proposed new isotherm performed best, followed by
Deitcher et al. [98], and Mollerup [58]. Despite of very different protein characteristics,
peak area, shape and height of the elution peaks are described accurately. For BSA,
the calibration was performed primarily by varying bind-and-elute salt concentration.
For lysozyme, the gradient length was primarily varied. In the case of glucose
oxidase, both bind-and-elute salt concentration and gradient length were varied
strongly. Regardless of the differences in experimental design, a good identifiability
of isotherm parameters is indicated by the remarkably small confidence intervals
given in Tab. 2.3.
Once the model parameters given in Tab. 2.2 and 2.2, Eqs. 2.10 - 2.15 are determined,
the mechanistic approach can be used to predict the protein adsorption/desorption
behavior for any given salt concentration and gradient length. The model was
validated by comparison between simulations and experimental test sets, that were
not involved in parameter estimation. In accordance with the small confidence
intervals, the chromatograms of the test sets could be predicted as depicted in
Fig. 2.2 for all three protein species. In a second validation, batch chromatography
data of each protein species was used to fit an equilibirum isotherm while keeping
most parameters constant. Here, only parameters 𝑘𝑒𝑞,𝑏𝑎𝑡𝑐ℎ and 𝑞𝑚𝑎𝑥,𝑏𝑎𝑡𝑐ℎ are expected
to differ from the column ones, because of differences in packing as well as static
and dynamic binding capacity. The two estimated isotherm parameters lead to
Table 2.3.: Parameters of the mass transfer model and kinetic isotherm formulation estimated
from three bind-and-elute experiments each. 𝛽0 and 𝛽1 were determined based on glucose
oxidase and adopted directly for BSA and lysozyme. Film transfer and pore diffusion coefficients
of salt were estimated from the conductivity signals.
Parameter Salt Glucose oxidase BSA Lysozyme
𝑘𝑓𝑖𝑙𝑚 [𝑐𝑚/𝑠] ·10−5 1.435 5.378± 3.458·10−1 9.9± 6.410·10−1 6.878± 3.684
𝐷𝑝 [𝑐𝑚2/𝑠] ·10−8 4.005 2.799± 1.797·10−1 3± 7.512·10−2 3.675± 7.095·10−1
𝑘𝑒𝑞 [−] - 34.138± 12.940 264.457± 451.483 3.555± 4.174
𝑘𝑘𝑖𝑛 [𝑠] ·10−2 - 15.700± 8.500 4.389± 8.576 1.721± 12.5
𝛽0 [−] ·10−2 - 3.574± 3.461·10−1 3.574± 1.810 3.574± 2.354
𝛽1 [𝑀−1] - 1.001± 0.043 1.001± 0.215 1.001± 9.106·10−3
𝑛 [−] - 9.576± 1.839 10.845± 1.440 8.863± 6.958
𝑞𝑚𝑎𝑥 [𝑀 ] ·10−2 - 1.280± 2.926·10−1 1.493± 8.350·10−2 48.100± 39.700
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a very good agreement with the measurements. As to be expected, the 𝑞𝑚𝑎𝑥,𝑏𝑎𝑡𝑐ℎ
values of 4.604·10−4M, 1.609·10−3M and 1.705·10−2M are slightly larger than the
corresponding column parameter values taken with respect to the whole column
volume 𝑞𝑚𝑎𝑥,𝑐𝑜𝑙𝑢𝑚𝑛 1.024 · 10−4M, 1.194 · 10−4M and 3.848 · 10−3M. The maximum
binding capacity of the whole column is given as 𝑞𝑚𝑎𝑥,𝑐𝑜𝑙𝑢𝑚𝑛 = 𝑞𝑚𝑎𝑥·(1−𝜖𝑡). Compared
with the batch isotherm data for BSA and lysozyme obtained at neutral pH [98, 99],
the results confirm the observation that an increase in HIC binding capacity can
be achieved by processing near the protein’s pI [86]. The related reduced solubility
leads to scattered excessive deviations at higher concentrations of salt and protein.
The parameters 𝛽0 and 𝛽1, describing bulk-like water molecules involved in the
adsorption/desorption process, are independent of the protein species. This indicates
that the effect of the water structure on the protein surface in investigated cases is
not relevant compared to the contribution of water molecules on the adsorber surface.
Once they are determined for a particular experimental set-up consisting of a certain
adsorber medium, buffer system and salt type, a direct adoption to other proteins can
be legitimate. The analogy to the widely employed SMA isotherm for IEX explains
this aspect. In SMA the characteristic charge depicts the number of ligands involved
in the electrostatic interaction. Here, the “strength” of every single ligand is assumed
to be constant and not dependent on the binding site. Similarly, 𝛽0 can be assumed
to be dominated by the ligand characteristics and independent from the protein
structure. When modeling multi-component systems with 𝑚 protein-species involved,
the benefit is obvious. Since only 4 isotherm parameters are protein specific, the
number of protein-specific parameters is reduced by 2𝑚 compared to Mollerup [58]
and Deitcher et al. [98].
The magnitude of maximum binding capacity 𝑞𝑚𝑎𝑥 shows good correlation with the
size of the corresponding protein. Due to the relatively high equilibrium coefficient 𝑘𝑒𝑞
of BSA, the hydrophobic binding affinity seems to be very strong. This observation
fits to findings reported in the literature [117]. Since this isotherm model does not
take the irreversible binding of BSA described by Haimer 𝑒𝑡 𝑎𝑙. into account [95], the
prediction shows slightly more deviation here.
Although assumptions and simplifications were made during the isotherm derivation
to balance ease of use with accuracy and reliability, validity and predictability are
backed up by experimental data performed under very different operating conditions.
To the best of our knowledge, this is the first work to describe and predict kinetic
bind-and-elute and batch chromatography experiments in HIC with largely identical
parameter sets.
2.6. Conclusion
In this work, the insights into the water structure on a hydrophobic surface are
used to develop a mechanistic model for the adsorption behavior of proteins in HIC.
40 Model Building in Hydrophobic Interaction Chromatography
The present approach proposes an equilibrium between well-ordered and bulk-like
ordered water molecules on the hydrophobic surface. This equilibrium is described
for a constant buffer composition, in particular without change of ionic concentration
over time. The challenge of incorporating salt effects in HIC modeling is solved by
considering the hydration number of ions as a function of the salt concentration. This
affects the equilibrium of water structures reciprocally. The parameter identifiability
and reliability are demonstrated by bind-and-elute experiments in column format,
application of the inverse method and calculation of the confidence intervals for the
estimated parameters. High-throughput batch chromatography experimentation in
combination with a largely identical isotherm parameter set underlines the suitability
of the isotherm model.
For further studies, it is possible to incorporate other changes in buffer composition
to describe protein-ligand adsorption behavior in HIC more generally. Mechanistic
extensions of the presented new thermodynamic framework are conceivable, for
example to model pH dependence, irreversible binding, protein-spreading, and multi-
layer adsorption.
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Abstract
For the purification of biopharmaceutical proteins, liquid chromatography is still
the golden standard. Especially with rising product titers, drawbacks like slow
volumetric throughput and high resin costs lead to the requirement of alternative
technologies. Selective preparative protein precipitation is one promising alternative
technique. Although the capability was proved, there is no precipitation process for
large scale monoclonal antibody (mAb) production yet. One reason might be, that
the mechanism behind protein phase behavior is not completely understood and the
precipitation process development is still empirical.
Mechanistic modeling can provide faster, material saving process development and
a better process understanding at the same time. In preparative chromatography,
mechanistic modeling was successfully shown for a variety of applications. Latest, a
new isotherm for hydrophobic interaction chromatography (HIC) under consideration
of water molecules as participants was proposed, enabling an accurate description of
HIC.
In this work, based on similarities between protein precipitation and HIC, a new preci-
pitation model was derived. In the proposed model, the formation of protein-protein
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interfaces is thought to be driven by hydrophobic effects, involving a reorganization
of the well-ordered water structure on the hydrophobic surfaces of the protein-protein
complex. To demonstrate model capability, high-throughput precipitation experi-
ments with the model proteins lysozyme, myoglobin, bovine serum albumin (BSA),
and one mAb were conducted at various pH values. Polyethylene glycol (PEG)
6000 was used as precipitant. The precipitant concentration as well as the initial
protein concentrations were varied systematically. The calibrated models were finally
validated with experimental data.
3.1. Introduction
Biologics represent a growing share of the pharmaceutical market, reached global sales
of USD 228 billion in 2016 [118]. Among them, monoclonal antibodies (mAb) are the
most important family of products [119]. The fact, that many mAbs have a relatively
low potency requiring high doses, makes mAbs one of the most expensive drugs [120].
Since 2015 the patent of first generations mAbs began to expire, resulting in a number
of biosimilars approved in the US and Europe [121]. Together with increasing pressure
on healthcare budgets, cost savings are desired [10]. Therefore improvements in
downstream processes such as alternative methods or novel development strategies
are necessary [122].
Selective protein precipitation is known as a cost efficient alternative purification
step for a long time [123]. Phase separation is carried out by adding precipitation
agents, like inorganic salts, organic solvents, or nonionic polymers to the protein
solution [124–127]. For some biopharmaceutical products precipitation is already
well established. For example, ethanol or polyethylene glycol (PEG) precipitation
is the basis of the extraction of immunoglobulin G from human plasma [128]; Viral
vaccines and virus-like particles (VLP) are purified or concentrated through PEG or
salt precipitation [129, 130]. Although there are a lot of studies on precipitation of
recombinant mAbs as well, it has not been applied for large scale mAb production
yet [131–133].
For downstream process (DSP) development mechanistic understanding is needed
to meet the demands of the Quality by Design (QbD) approach suggested by the
US Food and Drug Administration (FDA) [18]. For precipitation the understanding
of protein phase behavior is mandatory [134]. Although protein phase behavior is
experimental well investigated, the mechanism behind precipitation has not been
completely understood. This leads to a high degree of freedom in process development
and makes it challenging.
Models and simulations can reduce the number of experiments and lead to a more
thorough process understanding [135]. Cohn et al. derived an equation to describe
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protein precipitation [65]. This equation is a useful empirical expression, but less
a mechanistic description [136]. Its parameters were specified for salt precipitation
and its application to precipitation using polymers was shown [68, 137]. Sim et
al. generalized the model on the basis of hydrodynamic radii [66]. Quantitative
structure activity relationship (QSAR) was used to estimate the parameters of the
Cohn equation [67]. Anyhow, all these models have struggle with dealing small
molecular weight proteins and are not capable to cover variations in the initial protein
concentration.
PEG induced precipitation can be described by the theory of excluded volume [138–
140]. According to this theory, adding a certain amount of PEG to a protein solutions
results in phase transition of the proteins, although there is no direct interaction
between polymer and protein. The polymers are reported to trap the solvent and
therefore, sterically excludes proteins from solvent regions occupied by the polymers.
In other words, the polymers and proteins compete for the solvent which they are
solved in. Electrostatic interaction is known to have mainly repulsive influence on
protein-protein interaction, so that attractive forces can be reduced to hydrophobic
effects [141]. On molecular level, water molecules next to hydrophobic surfaces are
thought to have a well-ordered structure, different to the bulk-like ordered water in
free solution [142–144]. During precipitation a rearrangement of the protein occurs
and the hydrophobic area is reduced. Simultaneously, the water structure has to be
reorganized. A new equilibrium between well-ordered and bulk-like water is given,
resulting in an increased entropy [97, 101]. The above described hydrophobic effect
is thought to occur between two proteins in precipitation, as well as between protein
and ligand in hydrophobic interaction chromatography (HIC). Similarities between
HIC and precipitation were already shown. Melander and Horváth investigated
the salt effect on the hydrophobic effect in precipitation and HIC [145]; Nfor and
coworkers studied interrelation between the number of released water molecules in
protein precipitation and HIC [146]; and Baumgartner and coworkers investigated the
retention behavior during HIC and its correlation to protein-protein interaction [147].
The mechanistic effects of HIC are well investigated [58, 148, 149].
In this study a mechanistic protein precipitation isotherm model was derived, in-
spired by recent results in HIC modeling [150]. Based on existing precipitation
theories, water was introduced as an additional component for the model building.
With the help of high-throughput experimental technique precipitation, data for
lysozyme, myoglobin, bovine serum albumin (BSA), and a mAb were generated.
After randomization, half of the date were used to calibrate the model, the other
was used as validation set (Fig. 3.1). The model predictability for a wide range of
properties such as size, hydrophobicity, and the isoelectric point (pI) was shown.
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Figure 3.1.: Mechanistic protein precipitation modeling. By varying the amount of buffer,
protein and precipitant stock solutions the precipitant and protein concentration were varied in
high-throughput experiments. After phase separation the protein concentration was detected
using UV 280 measurement. Half of the data were used as calibration set. With this data the
parameters of the model were estimated. The so generated model was validated with the other
half of the experimental data.
3.2. Theory
In 1925 Cohn and coworkers introduced a later widely excepted semi-logarithmic
equation for modeling protein precipitation:
𝑙𝑜𝑔(𝑠) = ?˜??˜?+ 𝛽. (3.1)
The useful empirical equation describes the protein solubility 𝑠 in 𝑚𝑔/𝑚𝐿 in the
presence of ?˜? PEG in %𝑤/𝑤. Here, the phase behavior of a constant protein
concentration depends on the precipitation efficiency ?˜? and the protein solubility
in the absence of PEG 𝛽. This equation represents a summary of a macroscopic
observation on the precipitation behavior.
In the present work, the focus is placed on a mechanistic level, especially on the
behavior of water molecules during protein precipitation. In the model assumption,
the precipitation mechanism of 𝑛 protein molecules 𝑃 by a PEG molecule 𝑃𝐸𝐺
forming the precipitate 𝑃𝑛𝑃𝐸𝐺 is considered. The hydrophobic surfaces of proteins
are thought to be stabilized by well-ordered water molecules. The precipitate 𝑃𝑛𝑃𝐸𝐺
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is assumed to be stabilized by 𝛽 bulk-like ordered water molecules 𝑊𝐵:
𝑛𝑃 + 𝑃𝐸𝐺←→ 𝑃𝑛𝑃𝐸𝐺 + 𝑛𝛽𝑊𝐵. (3.2)
Precipitation using PEG is known to be a fast process [151]. Thus, following
equilibrium was considered:
𝛥𝜇 = 𝜇𝑃𝑛𝑃𝐸𝐺 + 𝑛𝛽𝜇𝑊𝐵 − 𝑛𝜇𝑃 − 𝜇𝑛𝑃𝐸𝐺. (3.3)
The chemical potentials are deduced to apply this constraint. It was assumed, that
the protein surface charges can be considered negligible in the present hydrophobically
driven mechanism.
Considering the equilibrium 𝛥𝜇 = 0 at constant temperature and pressure, it is
𝑅𝑇 ln 𝑥𝑃𝑛𝑃𝐸𝐺 + 𝑛𝛽𝑅𝑇 ln 𝑥𝑊𝐵𝛾𝑊𝐵 − 𝑛𝑅𝑇 ln 𝑥𝑃𝛾𝑃 −𝑅𝑇 ln 𝑥𝑃𝐸𝐺𝛾𝑃𝐸𝐺 (3.4)
= −𝜇0𝑃𝑛𝑃𝐸𝐺 − 𝑛𝛽𝜇𝑊𝐵 + 𝑛𝜇𝑃 + 𝜇𝑃𝐸𝐺 (3.5)
= −𝛥𝐺0 = 𝑅𝑇 ln𝐾. (3.6)
To simplify the model equation, it is assumed the activity coefficient of protein, PEG,
and precipitate to be constants. The equilibrium constant 𝐾 is derived
𝐾 =
𝑥𝑃𝑛𝑃𝐸𝐺𝑥
𝑛𝛽
𝑊𝐵
𝑥𝑛𝑃𝑥𝑃𝐸𝐺
⇒ 𝐾 = 𝑞𝑃𝑛𝑃𝐸𝐺𝑎
𝑛𝛽
𝑊𝐵
𝑐𝑛𝑃 𝑐𝑃𝐸𝐺
(3.7)
with 𝑞𝑃𝑛𝑃𝐸𝐺 and 𝑐𝑃 are the precipitated protein and protein in solution, respectively.
𝑐𝑃𝐸𝐺 depicts the concentration of PEG in solution and 𝑎𝑊𝐵 the activity of the
bulk-like ordered water molecules. In the following step, parameterizations for 𝑎𝑊𝐵
and 𝛽 have to be found. According to stoichiometric considerations, the number of
water molecules involved is linearly correlated to the precipitated protein 𝑞𝑃𝑛𝑃𝐸𝐺 .
Thus, a linear correlation is proposed to substitute 𝑎𝑊𝐵 :
𝑎𝑛𝛽𝑊𝐵
∼= 𝜈𝑞𝑛𝛽. (3.8)
The stoichiometric constant 𝜈 is assumed to be independent of the PEG concentration.
Inserting Eq. 3.8 into Eq. 3.7, and collecting all constants on the left-hand site, the
following isotherm equation is obtained:
𝐾 = 𝜈𝑞
1+𝑛𝛽
𝑐𝑛𝑝𝑐𝑃𝐸𝐺
(3.9)
· 1
𝜈⇐⇒: 𝑘𝑒𝑞 = 𝑞
1+𝑛𝛽
𝑐𝑛𝑝𝑐𝑃𝐸𝐺
. (3.10)
Finally, the PEG and protein dependency of the bulk-like ordered water molecules 𝛽
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is modeled. Since hydration of PEG, protein, and salt ions have high similarities e.g.,
attracting water molecules to form a hydration shell, the model originally describing
the hydration number of the salt ions ℎ is employed [152]:
ℎ = ℎ0 exp(−𝑘𝑐𝑠) (3.11)
ℎ0 is the ionic hydration number at infinite dilution and 𝑘 the constant that accounts
the dependency of hydration number on ionic concentration 𝑐𝑠. 𝛽 and ℎ are assumed
to be reciprocal, so that the model parameter 𝛽 can be approximated by the
exponential term:
𝛽 = 𝛽0 exp(𝛽1𝑐𝑃𝐸𝐺 + 𝛽2𝑐𝑝) (3.12)
𝛽0 is the hydration number at infinite dilution of PEG and protein, whereas 𝛽1 and
𝛽2 the constants that account for the dependency of hydration number on PEG and
protein concentration, respectively. This completes the derivation of the equilibrium
formulation of the precipitation isotherm model.
3.3. Materials and Methods
3.3.1. Disposables
All precipitation experiments were carried out in 350𝜇L polypropylene flat bottom
96-well micro plates (Greiner Bio-One, Kremsmünster, Austria). For spectroscopic
measurements samples were diluted into Greiner UV-Star® micro plates (Greiner
Bio-One, Kremsmünster, Austria).
3.3.2. Chemicals and Stock Solutions
As buffer substances, sodium hydrogen carbonate and tris (hydroxymethyl)-aminomethane
(all Merck KGaA, Darmstadt, Germany) were used. Tris hydrochloride was obtained
from PanReac AppliChem (Darmstadt, Germany). Sodium carbonate was obtained
from Sigma Aldrich (St. Louis, MO, USA). The PEG with an average molecular
mass of 6000 was obtained from Merck KGaA (Darmstadt, Germany). All buffers
were prepared with a concentration of 50𝑚𝑀 . For this, the appropriate amounts of
associated buffer components were weighted and dissolved in 𝑑𝑑𝐻2𝑂. The desired
pH was reached by varying the amount of acid and basic component for each buffer.
For the 40% (w/w)PEG 6000 and 50% (w/w)PEG 6000 stock solution, the buffer
components were first dissolved in 𝑑𝑑𝐻2𝑂 followed by adding the appropriate amount
of PEG 6000.
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3.3.3. Preparation of Protein Stock Solutions
Lysozyme from chicken egg white was purchased from Hampton Reseach (Aliso Viejo,
CA, USA). Myoglobin and BSA were purchased from Sigma Aldrich (St. Louis, MO,
USA). The mAb was provided as purified mAb from LEK d.d. (Ljubljana, Slovenia).
Lyzoszym, myoglobin and BSA were provided as lyophilized powder and therefore
first solved in the appropriate buffer. Afterward all proteins including the mAb were
filtered using 0.2𝜇m syringe filters (Satorius, Göttingen, Germany). Following the
filtration, proteins were rebuffered and desalted into the associated buffer using PD
10 desalting columns (GE Healthcare, Little Chalfont, UK).
3.3.4. Generation of Precipitation Curves
All precipitation experiments were carried out on a Tecan Freedom Evo 200 System
liquid handling station (Tecan, Männedorf, Switzerland). The liquid handling
station was equipped with an 8-tips liquid handling arm, a robotic manipulator
arm, a Te-Shake orbital shaker, an Infinite® 200 UV-Vis spectrophotometer (all
Männedorf, Switzerland), and a Rotanta 46RSC centrifuge (Hettlich GmbH & Co.
KG, Tuttlingen, Germany). The system was controlled by Evoware 2.5 (Tecan,
Männedorf, Switzerland). Excel 2016 (Microsoft, Redmond, WA, USA) was used as
data import format and for data storage. All calculations were done using Matlab®
R2016a (The Mathworks, Natick, MA, USA). All experiments were carried out at
20∘𝐶, controlled by air conditioning. Systems with a total volume of 250𝜇L containing
varying protein and PEG concentration were prepared. The PEG concentration was
varied in 12 equidistant steps. The protein concentration was varied from 1.5𝑚𝑔/𝑚𝐿
to 12.0𝑚𝑔/𝑚𝐿 in 12 steps. The position for each system on the 96-well micro plate
was randomized. After adding the protein stock solution, the system was incubated
for 15𝑚𝑖𝑛 on the orbital shaker at 1000 𝑟𝑝𝑚, and afterwards 15𝑚𝑖𝑛 without shaking.
To analyze the amount of precipitated protein, the microplate was centrifuged for
30𝑚𝑖𝑛 at 4000 𝑟𝑝𝑚. Then, the supernatant was sampled and diluted at a ratio of 1:6
for lysozyme, 1:3 for BSA, and 1:4 for myoglobin and the mAb. Subsequently, UV-Vis
absorption at 280𝑛𝑚 was measured. The protein concentration was calculated with
based on a linear calibration curve. All experiments were conducted in triplicates.
3.3.5. Numerical Procedures
The equilibrium precipitation isotherm model Eqs. 3.10 and 3.12 proposed in the
previous section contain unknown parameters, which cannot be measured experi-
mentally. Model calibration and simulation were carried out in Matlab® R2016a
(The Mathworks, Natick, MA, USA). To solve the nonlinear equation, fsolve was
used. The heuristic algorithm simulated annealing simulannealbnd was employed
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to deliver the initial parameter estimates. Afterwards, the deterministic algorithm
Levenberg-Marquardt nlinfit was used to find the final parameter estimates for 𝑘𝑒𝑞,
𝑛, 𝛽0, 𝛽1, and 𝛽2.
The data generated in high-throughput experimentation were labeled randomly with
either 0 or 1 using randi. According to the labels, the data were split into equally
sized calibration data and validation data sets of 48 samples each. The former ones
were used to proof the description capability and accuracy of the suggested model;
The latter were compared to the model prediction to back up the model’s accuracy
and predictability.
3.4. Results and Discussion
3.4.1. Model Calibration
All precipitation data from high-throughput experimentation were randomized and
divided into two equally sized data sets of 48 samples each. First, simulated annealing
was used for parameter estimation with the calibration data sets. Thereafter, a
Levenberg-Marquardt algorithm was employed to find the final optimum. The
equilibrium coefficient 𝑘𝑒𝑞, the number of proteins affected by one PEG molecule
𝑛, the hydration number at infinite dilution 𝛽0, and the constants accounting for
the dependency of hydration number on PEG 𝛽1 and protein concentration 𝛽2 for
lysozyme, myoglobin, BSA, and mAb at pH7.5 and pH8.5 are given in Tab. 3.1.
Here, the natural logarithm of the 𝑘𝑒𝑞 is presented for a better overview.
Fig. 3.2 shows the model simulation as solid curves and the experimental data used
for model calibration as circles for lysozyme (Fig. 3.2 a), myoglobin (Fig. 3.2 b), BSA
(Fig. 3.2 c), mAb at pH7.5 (Fig. 3.2 d) and pH8.5 (Fig. 3.2 e). In all cases, the
results cover 8 protein concentrations to 12𝑚𝑔/𝑚𝐿 from 1.5𝑚𝑔/𝑚𝐿 with steps of
Table 3.1.: Parameters of the precipitation model estimated from the calibration high-
throughput experimental data. The natural logarithm of the equilibrium coefficient 𝑘𝑒𝑞 is
presented for a better overview.
parameter lysozyme myoglobin BSA mAb7.5 mAb8.5
ln 𝑘𝑒𝑞 [−] 31.61 16.13 12.48 18.46 19.83
𝑛 [−] 5.32 3.73 3.18 3.28 3.53
𝛽0 [−] 3.33·10−3 3.79·10−4 4.64·10−4 1.12·10−3 1.03·10−2
𝛽1 [𝐿/𝑚𝑜𝑙] 1.16·105 1.24·105 1.92·105 4.53·105 4.38·105
𝛽2 [𝐿/𝑚𝑜𝑙] 1.40·103 1.46·103 6.82·102 7.56·103 1.62·103
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1.5𝑚𝑔/𝑚𝐿. The investigated range of PEG concentration varies according to the
precipitation behavior of every protein. For lysozyme, myoglobin, and BSA, PEG
concentrations up to 5.6·10−5𝑚𝑜𝑙/𝐿 are shown. The mAb precipitated at lower PEG
concentration, so that PEG concentrations up to 2·10−5𝑚𝑜𝑙/𝐿 are presented. Despite
Figure 3.2.: Protein precipitation data points from high-throughput experimentation used
for model calibration (circles) and resulting precipitation model (solid lines). Plot (a) - (e)
shows lysozyme, myoglobin, BSA, and mAb at pH7.5 and pH8.5, respectively.
of very different protein characteristics such as size, hydrophobicity, and surface
charge distribution, the calibration data sets are described by the precipitation model
accurately in all cases. Regardless of the differences in experimental conditions such
as PEG concentration and pH value, a good identifiability of precipitation model
parameters is observed. As the smallest protein investigated, lysozyme (14.6 𝑘𝐷𝑎)
shows the highest number of proteins affected by one PEG molecule with 𝑛 = 5.32.
The slightly larger protein myoglobin (17 𝑘𝐷𝑎) shows the next highest 𝑛 with 3.73.
For all other proteins the 𝑛 values were similar, compared to those of myoglobin.
The hydration number constants 𝛽0, 𝛽1, and 𝛽2 of each protein, influence the 𝛽
function in the same order of magnitude, compared to each other. 𝛽1 accounts for the
dependency of hydration of PEG. Consequently, the behavior can be reconciled to
the theory of excluded volume. By adding PEG, the accessible water for the protein
is reduced. As this exclusion is caused by a steric phenomena, the influence can be
attributed to protein size. A linear correlation between 𝛽1 and the molecular weight
is observed, in accordance with the linear correlation of precipitation behavior and
the hydrodynamic radius of the protein for PEG as precipitant reported by Sim et
al.. Furthermore, Hämmerling et al. confirmed this assumption, but pointed out the
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influence of additional factors, like protein shape and other surface characteristics.
The similarity of the 𝛽1 values determined for the mAb at pH 7.5 and pH8.5, supports
this assumption.
In case of mAb, a pH shift toward its pI (pH8.3-8.5) to pH8.5 from pH7.5 leads
to increased 𝑛, 𝑘𝑒𝑞, and 𝛽0, resulting in earlier precipitation of mAb. At the same
time a decrease of 𝛽2 was observed. While 𝛽1 could be assigned to the protein size,
the nature of 𝛽0 and 𝛽2 appears to be more complex. The pH dependence of these
parameters suggests a correlation to the surface characteristics of protein. The pH
dependency of the hydration number 𝛽0 is consistent with the results delivered by
Xia and coworkers [153] that the water release increases as the buffer pH approaches
the protein’s pI in HIC. The hydration number parameter 𝛽2 is referred to the
influence of the protein concentration. Closer to the pI, this influence appears to be
less important. In the absence of electrostatic interactions the well-ordered water
conformation is reported to be less stable and therefore it is favored to set free
well-ordered water molecules [154].
3.4.2. Model Validation
To assess the predictive power of the calibrated precipitation models, the validation
data sets were used. Fig. 3.3 shows the model prediction as solid curves and the
experimental data excluded from model calibration as triangles for lysozyme (Fig. 3.3
a), myoglobin (Fig. 3.3 b), BSA (Fig. 3.3 c), mAb at pH7.5 (Fig. 3.3 d) and pH8.5
(Fig. 3.3 e). A very good prediction can be found especially for myoglobin, BSA, mAb
at both pH values, and lysozyme at higher PEG concentration. For PEG concentrati-
ons below 2.5·10−5𝑚𝑜𝑙/𝐿 however, the model prediction tends to underestimate the
precipitated amount of lysozyme. Although simplifications and assumptions were
made during the precipitation model derivation to balance accuracy with ease of
use, predictability and validity are backed up by high-throughput experimental data
of very different proteins under diverse operating conditions. The main difference
between the widely used models, such as Cohn equation and models related to it, and
the proposed precipitation model is its mechanistic nature and capability to describe
the protein precipitation process dependent on both PEG and protein concentration.
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Figure 3.3.: Comparison of model prediction (solid lines) and high-throughput experimental
data (triangles). (a) represents lysozyme, (b) myoglobin, (c) BSA, (d) mAb at pH7.5, and (e)
mAb at pH8.5. The solid lines are identical with Fig. 3.2 and shown here for comparability.
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3.5. Conclusion
In the presented work, a mechanistic model for protein precipitation behavior with
PEG was introduced by considering the insights into the water structure on a
hydrophobic surface. The present approach proposes the equilibrium between well-
ordered and bulk-like ordered water molecules on the hydrophobic surfaces of protein
as the driving force for the precipitation process. This equilibrium is described for a
constant buffer composition, in particular without change of pH and PEG type.
In further studies, the dependency of model parameters on changes of pH and
PEG type should be investigated to enhance the mechanistic understanding of
protein precipitation with PEG. The applicability of the suggested model to protein
precipitation with salt should be tested in a systematic manner. Multi-component
systems such as harvested cell culture fluid should be described to enable model-based
optimization of selective precipitation processes.
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Abstract
Mechanistic modeling has been repeatedly successfully applied in process development
and control of protein chromatography. For each combination of adsorbate and
adsorbent, the mechanistic models have to be calibrated. Some of the model
parameters, such as system characteristics, can be determined reliably by applying
well-established experimental methods, whereas others cannot be measured directly.
In common practice of protein chromatography modeling, these parameters are
identified by applying time-consuming methods such as frontal analysis combined
with gradient experiments, curve-fitting, or combined Yamamoto approach. For new
components in the chromatographic system, these traditional calibration approaches
require to be conducted repeatedly.
In the presented work, a novel method for the calibration of mechanistic models based
on artificial neural network (ANN) modeling was applied. An in silico screening of
possible model parameter combinations was performed to generate learning material
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for the ANN model. Once the ANN model was trained to recognize chromatograms
and to respond with the corresponding model parameter set, it was used to calibrate
the mechanistic model from measured chromatograms. The ANN model’s capability
of parameter estimation was tested by predicting gradient elution chromatograms.
The time-consuming model parameter estimation process itself could be reduced
down to milliseconds. The functionality of the method was successfully demonstrated
in a study with the calibration of the transport-dispersive model (TDM) and the
stoichiometric displacement model (SDM) for a protein mixture.
4.1. Introduction
Preparative liquid chromatography is the workhorse for the purification purposes of
today’s pharmaceutical and biopharmaceutical industry [14, 15]. Several methods
for chromatography process development are proposed in the literature, including
purely experimental approaches which are time-consuming and labor-intensive. High-
throughput approaches have improved such experimental development setups, but
still these methods are often highly ineffective [16].
Especially in the light of the Quality by Design (QbD) initiative [17], mechanistic
modeling is currently the most promising method in protein chromatography process
development as it allows to gain a high degree of process understanding [18, 19].
Successful studies have been conducted for conventional single-column batch chro-
matography [20, 21], and continuous multi-column chromatography processes [22].
Furthermore, model-based process control strategies are enabled [23–25].
The chromatographic models consist of mathematical equations describing the mass
transfer phenomena within the column on macroscopic level and the thermodynamics
on the adsorber surfaces. For the mass transfer part, the transport-dispersive
model (TDM) is often chosen because of its simplicity and wide acceptance in the
literature [21, 41]. The thermodynamic binding term can be described by different
isotherm models. Among them, the stoichiometric displacement model (SDM) is
known to be well suited for ion-exchange chromatography (IEX) [56]. It describes
the multi-point protein binding in IEX based on the electrostatic equilibrium theory
and displacement effect, such that the salt-dependent protein-ligand interaction is
included. Brooks and Cramer introduced the popular steric mass-action (SMA)
model as an extension to cover the steric effects on the adsorber surface [90].
While modeling has several advantages over the experimental approach, it also pos-
sesses several limitations. This includes mainly the need for profound mathematical
and thermodynamic understanding. Already in the early stage of model calibration,
the hurdle becomes noticeable: Some parameters, such as system characteristics,
can be determined reliably by applying well-established experimental methods. Ot-
hers, like the mass transfer and isotherm parameters, cannot be measured directly
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but are estimated by applying time-consuming methods such as frontal analysis
combined with gradient experiments [90, 155], curve-fitting [116, 150], or combined
Yamamoto approach [156]. For the linear region of adsorption isotherm, Parente and
Wetlaufer proposed a correlation between retention parameters and gradient elution
retention data [157]. These traditional calibration approaches, however, require to
be conducted repeatedly if new components are introduced in the chromatographic
setup.
In other research fields, the artificial neural network (ANN) modeling has been applied
to obtain an initial guess for inverse problems in heat and radiative transfer [158, 159],
and in gas-liquid adsorption [160]. In all cases, a combination with stochastic methods
was reported to be necessary to achieve satisfactory estimates. To our best knowledge,
ANN modeling approach has not been applied to the protein chromatography model
calibration.
Inspired by the aforementioned contributions, the presented work introduces a
novel approach for the estimation of the mass transfer parameter and the isotherm
parameters for a chromatography model consisting of the TDM and the SDM
isotherm. Here, the ANN modeling is not used for initial guess, but directly for
the final estimation. The fundamental idea is to consider all possible parameter
combinations as the superset of the true parameter set. The information contained
in an uncalibrated model is approximated with in silico experiments by varying the
model parameters of interest. An ANN model is trained by mapping the results of the
in silico experiments to the corresponding model parameters. This ANN model was
used to recognize particular chromatograms generated experimentally in the lab, and
deliver the model parameters in demand. The ANN model’s capability of estimating
the film transfer coefficient, the equilibrium coefficient, and the characteristic charge
is tested with a spiked protein mixture consisting of an industrial monoclonal
antibody (mAb), cytochrome c, and lysozyme. The accuracy and the reliability of the
parameter estimates is proven by predicting further gradient elution chromatograms
and calculating the confidence intervals at 95% level.
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4.2. Theory
4.2.1. Artificial Neural Networks
ANN modeling offers numerous advantages over first principles modeling such as
the ability to detect unconsidered nonlinear relationships and possible interactions
between variables, and the requirement for less formal statistical training [161].
Hence, it is not surprising that extensive utilization has been found in many complex
real-world problems [162]. Silva Neto et al. carried out ANN as a solution for inverse
problems [158–160]. In the field of chromatography, the most popular ANN type
is the back-propagation ANN (BP-ANN). It is considered a useful tool to model
retention times in different chromatographic modes and formats [26–30]. As shown
in Fig. 4.1, a BP-ANN of simple architecture typically consists of an input layer
with nodes representing input data, a hidden layer, and an output layer returning
the output data. Each neuron is connected to every neuron in the next layer. In
the nodes of the hidden layer, the sum of products of inputs and weights, and the
products of biases and weights 𝑛 is transferred with a hyperbolic tangent sigmoid
activation function to an output signal between −1 and +1 as shown in Eq. (4.1).
Here, the nonlinearity in the data is captured.
𝑓(?˜?) = 21 + 𝑒−2?˜? (4.1)
Figure 4.1.: The topological structure of a simple multi-layer BP-ANN.
In the nodes of the output layer, a linear activation function transfers the sum of
weighted outputs from the former layer and the weighted biases to the final outputs.
By mapping the input data to the correct output data using supervised learning with
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the delta rule, the difference between the model response and the desired output is
iteratively minimized by updating the weights in the network [163].
4.2.2. Transport-dispersive Model
To model the macroscopic mass transport inside a chromatography column with
length 𝐿 and adsorber beads with radius 𝑟𝑝, the transport-dispersive model is
employed [41]:
𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑡
= −𝑢(𝑡)𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑥
+𝐷𝑎𝑥
𝜕2𝑐𝑖(𝑥,𝑡)
𝜕𝑥2
−1− 𝜖𝑏
𝜖𝑏
𝑘𝑒𝑓𝑓,𝑖
3
𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑡)) (4.2)
𝜕𝑐𝑝,𝑖(𝑥,𝑡)
𝜕𝑡
= −1− 𝜖𝑝
𝜖𝑝
𝜕𝑞𝑖(𝑥,𝑡)
𝜕𝑡
+ 𝑘𝑒𝑓𝑓,𝑖
3
𝜖𝑝𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑡)) (4.3)
𝜕𝑐𝑖(0,𝑡)
𝜕𝑥
= 𝑢(𝑡)
𝐷𝑎𝑥
(𝑐𝑖(0,𝑡)− 𝑐𝑖𝑛,𝑖(𝑡)) (4.4)
𝜕𝑐𝑖(𝐿,𝑡)
𝜕𝑥
= 0 (4.5)
Eq. (4.2) describes the convectional flow, the axial dispersion, and the mass transfer
between the concentration in interstitial volume of the mobile phase 𝑐𝑖(𝑥,𝑡) and the
pore volume 𝑐𝑝,𝑖(𝑥,𝑡) of component 𝑖. It depends on the peak-broadening effects
in the interstitial volume that are lumped in the component-specific film transfer
coefficient 𝑘𝑒𝑓𝑓,𝑖, the axial dispersive coefficient 𝐷𝑎𝑥, and the voidage of the bed 𝜖𝑏.
Eq. (4.3) models the exchange between stationary phase concentration 𝑞𝑖 and the
pore volume concentration 𝑐𝑝,𝑖(𝑥,𝑡) depending on the particle voidage 𝜖𝑝 and the
overall mass transport coefficient 𝑘𝑒𝑓𝑓,𝑖. Eqs. (4.4) and (4.5) are the Danckwerts
boundary conditions.
4.2.3. Stoichiometric Displacement Isotherm Model
To describe the adsorption and desorption mechanisms on the IEX adsorber surface,
the kinetic formulation of the stoichiometric displacement isotherm model (SDM) is
employed [56, 164]:
𝑘𝑘𝑖𝑛,𝑖
𝜕𝑞𝑖(𝑥,𝑡)
𝜕𝑡
= 𝑘𝑒𝑞,𝑖𝑞𝑠𝑎𝑙𝑡(𝑥,𝑡)𝜈𝑖𝑐𝑝,𝑖(𝑥,𝑡)− 𝑐𝜈𝑖𝑠𝑎𝑙𝑡𝑞𝑖(𝑥,𝑡) (4.6)
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As proposed in [116], the equilibrium coefficient 𝑘𝑒𝑞,𝑖 = 𝑘𝑎𝑑𝑠,𝑖/𝑘𝑑𝑒𝑠,𝑖 and the kinetic
coefficient 𝑘𝑘𝑖𝑛,𝑖 = 1/𝑘𝑑𝑒𝑠,𝑖 are used instead of the adsorption coefficient 𝑘𝑎𝑑𝑠,𝑖 and the
desorption coefficient 𝑘𝑑𝑒𝑠,𝑖. The advantage of this formulation is that 𝑘𝑒𝑞,𝑖 strongly
affects the retention time, whereas 𝑘𝑘𝑖𝑛,𝑖 has a slight influence on the peak height
in most cases. 𝜈𝑖 is the characteristic charge of the component 𝑖. The counter-ion
concentration in the pore phase is depicted as 𝑐𝑠𝑎𝑙𝑡, and the salt concentration in the
stationary phase 𝑞𝑠𝑎𝑙𝑡 is given as:
𝑞𝑠𝑎𝑙𝑡(𝑥,𝑡) = 𝛬−
𝑚∑︁
𝑖=1
𝜈𝑖𝑞𝑖(𝑥,𝑡) (4.7)
with the ionic capacity of the stationary phase being 𝛬. Since the derivation of
the SDM isotherm does not consider the adsorber binding sites which are sterically
hindered by adsorbed molecules, the shielding effect is neglected.
4.2.4. Numerical Solution
For mechanistic modeling, the discretization in space is performed using the finite
element method on a grid with equidistant nodes. The discretization in time is carried
out with the fractional step 𝜃-scheme [111]. The nonlinear equation system is treated
with Picard iteration [112]. For parameter estimation, the Levenberg-Marquardt
algorithm [114] is employed.
4.3. Materials and Methods
4.3.1. Instruments
Gradient elution experiments were carried out using an Ettan liquid chromatography
(LC) system equipped with pump unit P-905, dynamic single chamber mixer M-925
(90 𝜇𝑙 mixer volumne), UV monitor UV-900 (3 mm optical path length), conducti-
vity cell pH/C-900, and autosampler A-905 (all GE Healthcare, Little Chalfont,
Buckinghamshire, UK).
4.3.2. Software
The control software UNICORN 5.31 (GE Healthcare, Little Chalfont, Buckinghams-
hire, UK) was used in combination with the LC system. The model was simulated
using the chromatography simulation software ChromX (GoSilico, Karlsruhe, Ger-
many). ChromX was employed for numerical simulation of the system of partial
differential equations, as well as optimization and statistical analysis [115]. The ANN
modeling was carried out in Matlabő R2016a (MathWorks, USA).
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4.3.3. Adsorber, Proteins, and Chemicals
The strong cation-exchange chromatography (CEX) adsorber medium, TOYOPEARL®
GigaCap S-650M supplied by Tosoh Bioscience (Griesheim, Germany) was used as
pre-packed 0.965mL Toyoscreen® column with dimension 30mm × 6.4mm. Between
the runs, the adsorber media were stored in 20% ethanol. Before experimentation,
the storage solution was removed by prolonged equilibration with water, low-salt
and high-salt buffer.
Three proteins of different sizes and different isoelectric points were used as model
proteins to investigate the ANN’s capability of model parameter identification. A
monoclonal antibody (mAb, 144-147 kDa, pI 8.3-8.5) of the IgG isotype was kindly
provided by Lek (Ljubljana, Slovenia). Cytochrome c (bovine heart, no.A4612,
12.3 kDa, pI 10.4-10.8) was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Lysozyme (hen egg, no.HR7-110, 14.6 kDa, pI 11.0) was purchased from Hampton
Research (Aliso Viejo, CA, USA).
To perform experiments below the isoelectric points of all three proteins, 50mM
sodium phosphate buffer was used at pH 6.5 with additional 0 and 1M NaCl.
For cleaning-in-place, 0.5M NaOH was used. All solutions were prepared with
ultra pure water (arium pro UV, Sartorius, Göttingen, Germany). All buffers and
storage solutions were filtrated with a membrane cutoff of 0.22𝜇m and degassed by
sonication. All proteins were prepared in accordance with the loading conditions and
were filtrated with a membrane cutoff of 0.22𝜇m prior to usage.
4.3.4. System Characterization
The ÄKTA system and chromatography column were characterized via tracer pulse
injection at a constant flow rate of 0.2ml/min. For determination of the system and
total voidage of the column, 25𝜇L 1%(v/v) acetone (Merck, Darmstadt, Germany)
was used as a pore-penetrating, non-interacting tracer. Filtrated 10 g/L blue dextran
2000 kDa (Sigma-Aldrich, St. Louis, MO, USA) solution was used as non-pore-
penetrating, non-interacting tracer to determine the interstitial volume of the column.
The UV signal at 260 nm was recorded to determine these parameters and correct
all measurements regarding dead volumes. The ionic capacity 𝛬 of GigaCap S-
650M was determined by acid-base titration following Huuk et al. [165]. The UV
signal at 280 nm was recorded during pulse injection of pure protein samples. The
measurement factors of each protein were calculated from the protein concentration
and adsorption units according to the Lambert-Beer law [116].
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4.3.5. In Silico Screening
Since the model parameter 𝑘𝑘𝑖𝑛,𝑖 has just a minor impact on the peak height, it was
eliminated from the screening process and set to 1·10−9 with the aim of reducing
the design space. 780 model parameter combinations of 𝑘𝑒𝑓𝑓,𝑖, 𝑘𝑒𝑞,𝑖 and 𝜈𝑖 within
boundaries as shown in Tab. 4.1 were used to carry out in silico experimentation
using ChromX. Wide ranges were chosen to cover very different protein adsorption
behaviors on CEX. 𝑘𝑒𝑞,𝑖 was logarithmized to be within reasonable range. Finally,
all model parameters and the resulting 780 chromatograms were normalized to the
minimum and maximum values.
Figure 4.2.: Design space of the in silico screening:𝑘𝑒𝑓𝑓 ∈ [0.002,0.02]𝑚𝑚/𝑠, 𝑘𝑒𝑞 ∈ [1 ·
10−9,0.1], and 𝜈 ∈ [3,8].
Table 4.1.: Design space of model parameters for in silico screening.
Lower boundary Upper boundary
𝑘𝑒𝑓𝑓 [mm·𝑠−1] 0.002 0.02
𝑘𝑒𝑞 [-] 1.0·10−10 0.1
𝜈 [-] 3 8
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4.3.6. ANN Model Calibration and Validation
A BP-ANN model with a hidden layer with 18 neurons and an output layer with
three neurons was created in MATLAB®. In the nodes of the hidden layer, the
hyperbolic tangent sigmoid activation function tansig was implemented. In the ones
of the output layer, the linear activation function purelin was chosen. The function
divideint was applied to divide the in silico data into training, validation, and test
data sets by a ratio of 7:2:1 using interleaved indices. The network training function
traingdx was used to update weight values for inputs and biases according to gradient
descent momentum and an adaptive learning rate. The momentum constant and the
learning rate were set to 0.9 and 0.05. A root-mean-square error (RMSE) of 1·10−5
and a maximal iteration number of 1·103 were set as stopping criteria.
4.3.7. Bind-and-elute Experiments
1mg/ml of each protein were dissolved in corresponding binding buffer and loaded
via a 100𝜇L loop. Different gradients and steps were mixed within the LC system
from low-salt and high-salt buffer. A subset of the chromatograms was used as input
to perform the parameter estimation with the previously calibrated ANN model.
The remaining runs were used for model validation.
The linear gradient experiments were conducted by applying the varying gradient
lengths 5CV, 15CV, 20CV, and 25CV. After a post-loading wash step over 1CV
equilibration buffer, elution was started with 50mM sodium phosphate and an
increasing salt gradient ranging from 0mM to 350mM sodium chloride. After protein
elution, the column was stripped over 3CV at a sodium chloride concentration of
1M and re-equilibrated with 1CV equilibration buffer.
The step elution comprised of three elution steps. First, the column was equilibrated
with 2CV equilibration buffer. After a wash step over 2CV equilibration buffer, the
salt concentration was raised to 50mM sodium chloride. After 8CV the concentration
was further increased to 140mM sodium chloride and was kept constant over 8CV.
The column was finally stripped over 3CV at a sodium chloride concentration of 1M
and re-equilibrated with equilibration buffer.
All experiments were conducted at a flow rate of 0.2ml/min to ensure a constant
residence time.
4.3.8. Mechanistic Model Calibration and Validation
Two bind-and-elute chromatograms using linear gradient elution of 15CV and 25CV
were fitted with exponentially modified Gaussian distribution [166] with the aim of
signal smoothing and peak separation. After normalization, the separated peaks were
62 Model Calibration Based on Mechanistic Models and ANN
fed into the calibrated BP-ANN model which returned the estimates of 𝑘𝑒𝑓𝑓,𝑖, 𝑘𝑒𝑞,𝑖
and 𝜈𝑖 for each protein. As fine adjustment of the peak height, Levenberg-Marquardt
algorithm [114] was employed. Three uninvolved bind-and-elute chromatograms were
predicted and compared to wet-lab experiments. To prove the estimation reliability,
confidence intervals at 95% level were calculated subsequently.
4.4. Results and Discussion
4.4.1. System Characterization
The system dead volume of 280𝜇𝑙 of the LC was determined by tracer injection
without a column attached. This volume was subtracted from all other data obtained
from the LC. Bed and particle voidage, and axial dispersion were calculated based
on the results of the tracer injections. The ionic capacity was calculated based
on the acid-basic titration. The results are listed in Tab. 4.2. The transformation
from protein concentration to adsorption units was performed with the measurement
factors 6.651·107 𝑚𝐴𝑈 · 𝐿/𝑚𝑜𝑙 for IgG, 6.762·106𝑚𝐴𝑈 · 𝐿/𝑚𝑜𝑙 for cytochrome c,
and 1.054·107 𝑚𝐴𝑈 · 𝐿/𝑚𝑜𝑙 for lysozyme, according to the Lambert-Beer law.
4.4.2. ANN Model Calibration and Validation
For ANN model calibration, the results of in silico screening were correlated with
the corresponding model parameter sets using back-propagation. 546 training data
sets were used for the ANN’s adjustment according to the respective errors. 156
validation data sets were used to measure the capability of generalization, and to
stop training when generalization stopped improving. Test data consisting of 78
chromatograms and parameter sets were excluded during model calibration for cross
validation. The best correlations achieved for the mass transfer coefficient 𝑘𝑒𝑓𝑓 are
Table 4.2.: The voidages and axial dispersion are calculated from retention volume and peak
broadening of tracer injections.
GigaCap S-650M
Bed voidage 𝜖𝑏 0.404
Particle voidage 𝜖𝑝 0.765
Total voidage 𝜖𝑡 0.860
Axial dispersion [𝑚𝑚2 · 𝑠−1] 𝐷𝑎𝑥 0.048
Ionic Capacity [M] 𝛬 1.284
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given in Figs. 4.3 (a) - (c) which represent the training data set, validation data
set, and test data set, respectively. Figs. 4.3 (d) - (f) show the correlation for the
equilibrium coefficient 𝑘𝑒𝑞 and Figs. 4.3 (g) - (i) the characteristic charge 𝜈.
Figure 4.3.: Plots of screened parameters versus simulated parameters using ANN model.
(a) - (c) present the training data set, validation data set, and test data set of the parameter
𝑘𝑒𝑓𝑓 , respectively. (d) - (e) present 𝑘𝑒𝑞. (f) - (h) present 𝜈.
A good agreement between the predictions by the ANN model and the parameters set
for the in silico screening was observed. The deviations found were in a statistically
acceptable range (𝑅2 = 0.98971 for the validation data set of 𝑘𝑒𝑓𝑓 , 𝑅2 = 0.98488 for
the validation data set of 𝑘𝑒𝑞, and 𝑅2 = 0.98729 for the validation data set of 𝜈).
According to correlation results of test data sets (𝑅2 = 0.99526 for 𝑘𝑒𝑓𝑓 , 𝑅2 = 0.98729
for 𝑘𝑒𝑞, and 𝑅2 = 0.9972 for 𝜈), the generalization capability of the ANN model was
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verified, making it suitable for the estimation of model parameters.
4.4.3. Mechanistic Model Calibration and Validation
To estimate the model parameters 𝑘𝑒𝑓𝑓 , 𝑘𝑒𝑞, and 𝜈, two linear gradient chromato-
graphy experiments were performed with gradient lengths of 15 CV and 25 CV. After
data preparation, these chromatograms were presented to the beforehand calibrated
and verified ANN model. The returned parameters are given in Tab. 4.3. The
confidence intervals at 95% level confirm the reliability of the parameter estimates.
For a slight adjustment of the peak height, the kinetic coefficients 𝑘𝑘𝑖𝑛 were estimated
subsequently by applying the Levenberg-Marquardt algorithm. Figs. 4.4 (a)-(b) show
the simulated and experimental chromatograms used for the parameter estimation.
The weakly binding component mAb, moderately binding component cytochrome c,
and the strongly binding component lysozyme are eluted due to the salt gradient in
successive order. To assess the predictive power of the calibrated mechanistic model,
three additional experiments have been conducted as validation data. Figs. 4.5 (a)-(c)
show good agreement of model prediction and experimental data. Thus, the establis-
hed method for model calibration can reliably identify SDM parameters in the linear
or weakly nonlinear isotherm region based on chromatograms presented to ANN.
Figure 4.4.: Plots of UV signals over process run time for bind-and-elute experiments. Dashed
lines display the UV signal measured at column outlet and the adjusted salt gradients. Solid
lines represent the simulated chromatograms. The elution peaks of the first eluting component
mAb, the intermediate eluting component cytochrome c, and the last eluting component
lysozyme by applying linear salt gradients from 0.05M to 1.05M over 25CV and 15CV are
shown in (a) and (b), respectively.
4.5. Conclusion 65
Table 4.3.: Parameters of the mass transfer model and kinetic isotherm formulation estimated
from two bind-and-elute experiments. 𝑘𝑒𝑓𝑓 , 𝑘𝑒𝑞, and 𝜈 were determined using the ANN model.
𝑘𝑘𝑖𝑛 was estimated using the inverse method.
Parameter mAb Cytochrome c Lysozyme
𝑘𝑒𝑓𝑓 [mm/s] 6.593·10−3± 3.685·10−3 6.300·10−3± 1.447·10−3 6.644·10−3± 3.333·10−4
𝑘𝑒𝑞 [-] 8.363 ·10−6± 2.594·10−7 6.062 ·10−6± 8.707·10−6 1.445·10−2± 1.489 ·10−5
𝜈 [-] 5.220± 0.015 5.167± 9.900·10−3 5.195± 8.079·10−3
𝑘𝑘𝑖𝑛 [𝑠−1] 2.239 ·10−4± 3.973·10−5 3.440·10−9± 7.133·10−4 1.225·10−8± 2.540·10−3
Figure 4.5.: Plots of UV signals over process run time for bind-and-elute experiments. Dashed
lines display the UV signal measured at column outlet and the adjusted salt gradients. Solid
lines represent the simulated chromatograms. The elution peaks of the first eluting component
mAb, the intermediate eluting component cytochrome c, and the last eluting component
lysozyme by applying linear salt gradients from 0.05M to 1.05M over 5CV, 20CV, and a
step-wise salt gradient from 0.05M to 0.20M and up to 1.05M are shown in (a), (b), and (c).
4.5. Conclusion
In the presented work, artificial neural network modeling was applied for the si-
multaneous estimation of TDM and SDM parameters mass transfer coefficient 𝑘𝑒𝑓𝑓 ,
equilibrium coefficient 𝑘𝑒𝑞, and characteristic charge 𝜈 for a tertiary protein mixture
in CEX. After data generation by conducting in silico experiments, data preparation,
and calibration of the ANN model by mapping the resulting simulated chromato-
grams to the corresponding model parameter sets, parallel estimations of nine model
parameters were carried out in milliseconds using the ANN model. The ANN model’s
capability of generalization was verified by coefficients of determination of the cross
validation set between 0.98729 and 0.99526. The correctness of the estimated model
parameters was proved by good agreement between simulation and measurement of
two linear gradient chromatography experiments. The reliability of the parameter
estimates was underlined by small confidence intervals at 95% level. Furthermore,
three uninvolved bind-and-elute gradient chromatography experiments were predicted
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with high accuracy using the estimated parameters. Because of the ability of ANN
to cover nonlinearities, there is no necessity to carry out the calibration experiments
in the linear region of the adsorption isotherm.
The presented novel method has several unique characteristics compared to establis-
hed methods. Once the ANN model is calibrated, it possesses the ability to process
new chromatograms and determine the underlying model parameter sets without
overhead. Also, it can assign suitable model parameters to new components in the
chromatographic system, where traditional model calibration approaches require to
be conducted again and are therefore computationally more expensive. Potentially,
this method can be implemented for automated real-time model parameter estimation
during the chromatographic experiments, since the parameter estimation process
itself only takes milliseconds. As a next step, the presented method will be applied
to different modes of chromatography and isotherm equations in order to check
universal applicability to mechanistic model calibration.
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Abstract
Recent studies highlighted the potential of PEGylated proteins to improve stabilities
and pharmacokinetics of protein drugs. Ion-exchange chromatography (IEX) is among
the most frequently used purification methods for PEGylated proteins. However,
the underlying physical mechanisms allowing for a separation of different PEGamers
(proteins with a varying number of attached PEG molecules) are not yet fully
understood.
In this work, mechanistic chromatography modeling was applied to gain a deeper
understanding of the mass transfer and adsorption/desorption mechanisms of mono-
PEGylated proteins in IEX. Using a combination of the general rate model (GRM)
and the steric mass action (SMA) isotherm, simulation results in good agreement
with the experimental data were achieved. During linear gradient elution of proteins
attached with PEG of different molecular weight, similar peak heights and peak
shapes at constant gradient length were observed. A superimposed effect of increased
desorption rate and reduced diffusion rate as a function of the hydrodynamic radius
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of PEGylated proteins was identified to be the reason of this anomaly. That is why
the concept of the diffusion-desorption-compensation effect is proposed. In addition
to the altered elution orders, PEGylation resulted in a considerable decrease of
maximum binding capacity. By using the SMA model in a kinetic formulation, the
adsorption behavior of PEGylated proteins in the highly concentrated state was
described mechanistically. An exponential increase in the steric hindrance effect
with increasing PEG molecular weight was observed. This suggests the formation
of multiple PEG layers in the interstitial space between bound proteins and an
associated shielding of ligands on the adsorber surface to be the cause of the reduced
maximum binding capacity. The presented in silico approach thus complements the
hitherto proposed theories on the binding mechanisms of PEGylated proteins in IEX.
5.1. Introduction
It is estimated that in 2020 about 46% of the sales volume of the 100 highest-
selling pharmaceutical products will be achieved by biopharmaceutical products [167].
Biopharmaceuticals contain active substances based on biological molecules, such as
recombinant proteins. Compared to conventional small molecular pharmaceuticals,
proteins have a complex three-dimensional structure allowing for a more efficient
and specific intervention in cellular metabolic pathways. The efficacy of systemically
administered protein drugs however, may be hampered by a low bioavailability due to
a poor solubility under physiological conditions, a short in vivo half-life due to a rapid
elimination by the body and proteolysis. A promising approach to overcoming these
drawbacks is the covalent attachment of polyethylene glycol (PEG) to protein drugs
[168]. As early as in 1977, the group of Abuchowski and Davis found an increased
blood circulation half-life and a reduced immunogenicity of PEGylated proteins
compared to the native form [169, 170]. Additional positive effects of PEGylation
are an increased thermal stability as well as a higher solubility allowing for higher
concentrated protein formulations [171]. Two successfully approved PEGylated
protein drugs are interferon 𝛼-2a (Pegasys®, Hoffman-LaRoche) for the treatment of
hepatitis C and granulocyte-colony stimulating factor (Neulasta®, Amgen) for the
treatment of leukemia.
The emergence of conjugates with varying number (PEGamers) and site of attachment
(positional isoforms) upon PEGylation reactions creates a need for a thorough purifi-
cation in order to gain regulatory approval [172, 173]. Ion-exchange chromatography
(IEX) is among the most frequently used purification methods for PEGylated pro-
teins [172, 174]. Understanding the underlying physical mechanisms is an important
prerequisite to optimize, control, predict, and scale-up the separation of PEGamers
to pilot and production level. In this context, mechanistic modeling provides an
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excellent opportunity to generate various information about mass transport and
adsorption isotherm parameters in silico.
The physico-chemical properties and thus the behavior of a protein in chromato-
graphic separation processes are significantly influenced by its PEGylation [172,
173]. Due to the high hydration of the hydrophilic PEG, PEGylated proteins have
a distinctly higher hydrodynamic radius than unmodified proteins with the same
molecular weight. A non-linear correlation introduced by Fee and Van Alstine allows
a reliably mathematical prediction of the hydrodynamic radius ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 based
on the molecular weight of the protein and the attached PEG [172, 175]. In case
of chromatographic separation, the PEG ‘cloud’ around the protein results in an
increased distance between protein binding site and adsorber surface [173]. Seely
and Richey [176] observed that the elution order of different PEGamers was the
same in both cation-exchange and anion-exchange chromatography. They proposed
the ‘charge-shielding effect’ which links the weakened electrostatic interactions to
the increased distance between protein binding site and adsorber surface. A deeper
process understanding was achieved by Yamamoto et al. [177] using mechanistic
chromatography modeling. They applied the stoichiometric displacement model
(SDM) to verify the ‘charge-shielding effect’ quantitatively and associated it with
the decreased elution volume of PEGamers. Moreover, it was shown that mono-
PEGylated proteins are bound to the ion-exchange adsorber with binding sites similar
to the unmodified protein. In following studies, this model was applied to PEGylated
lysozyme and BSA [178, 179]. The aforementioned contributions demonstrated the
successful application of mechanistic modeling to understand the adsorption behavior
of PEGylated proteins in the linear region of the adsorption isotherm.
This work presents a full investigation of the behavior of mono-PEGylated proteins
in IEX based on mechanistic chromatography modeling. In contrast to previous
studies, information on the adsorption and desorption behavior in the non-linear
region of the isotherm, i.e. the overloaded state, is included by using the steric
mass action (SMA) model [57] in kinetic formulation. Compared to the equilibrium
isotherm used hitherto, the kinetic formulation is suitable for the description of
protein behavior in higher concentrated state on adsorber surface. To further account
for mass transfer effects within the chromatography column the general rate model
(GRM) [180] is employed. To best of our knowledge, mechanistic modeling of polymer
grafted proteins in IEX using a combination of GRM and SMA isotherm has not
been studied. By connecting these two approaches, this study delivers supplements
by the quantitative investigation on the film diffusion, pore diffusion, charge and
shielding parameters, as well as the adsorption and desorption rate coefficients.
The model protein lysozyme from chicken egg was chosen as PEGylation target and
conjugated to activated PEG of three different molecular weights (2 kDa, 5 kDa and
10 kDa). The preparative isolation of the mono-PEGylated species was carried out
using a single cation-exchange (CEX) chromatography step. For each purified protein
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species, three linear gradient elution (LGE) experiments with different gradient slopes
were conducted to confirm the constancy of the characteristic charge. Breakthrough
experiments were carried out to gain insight into the binding behavior of PEGylated
proteins in the highly non-linear region and to investigate whether the perceivable
behavior of PEGylated proteins originates from adsorption/desorption or mass
transfer. Confidence intervals at 95% level were calculated for parameter estimates.
5.2. Materials and Methods
5.2.1. Adsorber, Proteins, and Chemicals
All stock solutions and buffers were prepared with ultra-pure water (PURELAB Ultra
water purification system, ELGA Labwater, Germany), filtrated using a cellulose-
acetate filter with a membrane cut-off of 0.22𝜇m (Satorius, Germany) and degassed
by sonication. The used buffer substances were sodium acetate trihydrate (Sigma-
Aldrich, USA) for pH 5 and sodium phosphate monobasic dihydrate (Sigma-Aldrich,
USA) as well as di-sodium hydrogen phosphate dihydrate (Merck, Germany) for
pH 7.0 and pH7.2, respectively. Hydrochloric acid and sodium hydroxide (NaOH) for
pH adjustment were obtained from Merck (Germany). Lysozyme from chicken egg-
white (no. HR7-110) was purchased from Hampton Research (USA). Methoxy-PEG-
propionaldehyde (mPEG-aldehyde) with an average molecular weight (MW) of 2 kDa
(Sunbright®ME-020 AL), 5 kDa (Sunbright®ME-050 AL) and 10 kDa (Sunbright®ME-
100 AL) was obtained from NOF Corporation (Japan). Sodium cyanoborohydride
(NaCNBH3) and L-lysine were purchased from Sigma-Aldrich (USA). For preparative
isolation of PEGamers as well as for modeling purposes, the strong cation-exchange
(CEX) chromatography adsorber medium TOYOPEARL® GigaCap S-650M (Tosoh
Bioscience, Germany) was used. It is a high capacity polymer grated cation exchange
resin based on hydroxylated methacrylic polymer with a 100 nm pore size and a
75𝜇m particle size. For preparative isolation of PEGamer species, 5mL pre-packed
MiniChrom columns (dimension: 100mm × 8mm) and for modeling purposes, a
pre-packed 0.965mL Toyoscreen®column (dimension: 30mm × 6.4mm) were used.
Between the runs, the resin media were stored in 20% ethanol. The storage solution
was removed by prolonged equilibration with ultra-pure water and flushed with
binding and elution buffer before experimentation. Sodium chloride (NaCl) used
for protein elution was purchased from Merck (Germany). 0.5M NaOH (Merck,
Germany) was used for cleaning-in-place.
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5.2.2. Instrumentation and Software
pH adjustment of all buffers was performed using a five-point calibrated pH-meter HI-
3220 (Hanna Instruments, USA) equipped with a SenTix®62 pH electrode (Xylem Inc.,
USA). Protein concentration measurements were conducted using a NanoDrop2000c
UV–vis spectrophotometer (Thermo Fisher Scientific, USA). Purity of isolated mono-
PEGylated lysozyme was determined by high-throughput capillary gel electrophoresis
(HT-CGE) using the Caliper LabChip®GX II device (PerkinElmer, USA). For data
processing and purity determination, the LabChip®GX 3.1 software (PerkinElmer,
USA) was used.
Preparative isolation of mono-PEGylated lysozyme species was performed on an
ÄKTA™ purifier system equipped with a Fraction Collector Frac-950 (GE Healthcare,
Sweden). All experiments for chromatography model calibration were carried out
using an Ettan liquid chromatography (LC) system with the UV monitor UV-900 (3
mm optical path length), pump unit P-905, dynamic single chamber mixer M-925
(90 𝜇𝑙 mixer volumne), and conductivity cell pH/C-900 (all GE Healthcare, Little
Chalfont, Buckinghamshire, UK). The UNICORN 5.31 software (GE Healthcare,
UK) was used to control both chromatographic systems and to record the signals.
The protein chromatography simulation software ChromX (GoSilico, Germany) was
used for the numerical simulations of the system of partial differential equations,
estimation of model parameters, as well as for statistical analysis [115]. Other data
evaluations were conducted in Matlab® R2016a (MathWorks, USA).
5.2.3. PEGylation Reaction
As reaction buffer 25mM sodium phosphate (pH7.2) containing 20mM sodium
cyanoborohydride (NaCNBH3) as reducing agent was used. PEGylation experiments
were performed batch-wise in 50mL Falcon Tubes (BD Biosciences, USA). Lysozyme
(5mg/mL) and mPEG-aldehyde were dissolved in the reaction buffer with a molar
polymer to protein ratio of 6.67:1 [181, 182]. The tube was continuously shaken in
an overhead shaker LabincoLD79 (Labinco BV, Netherlands) for 3.5 h at 25∘C. The
PEGylation reaction was stopped by adding 200mM of L-lysine according to [183].
5.2.4. Preparative Purification of Mono-PEGylated Lysozyme
For preparative isolation of mono-PEGylated lysozyme, the stopped PEGylation
batch was diluted to a ratio of 1:12 in 10mM sodium acetate buffer (pH5) [181].
For column loading, the system was equilibrated in 10mM sodium acetate buffer
(pH 5). Sample application was performed using a 50mL super loop (GE Healthcare,
Sweden). Elution was initiated by applying an NaCl step gradient with 10mM
sodium acetate buffer (pH 5) containing 1.0M sodium chloride. The NaCl molarities
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used for the step elution of the different PEGamers are displayed in Tab. 5.1 as
a function of the molecular weight of the attached PEG molecules. The flow rate
for binding and elution was set to 1mL/min. Fractions of 2mL were collected
into a 96-well deep well plate (VWR, USA). To obtain sufficient sample volume for
the linear gradient and the breakthrough experiments, fractions containing mono-
PEGylated lysozyme of multiple chromatography runs were pooled. To ensure similar
binding conditions for all PEG molecular weights during the calibration runs, the
mono-PEGylated samples were concentrated to approximately 3.76·10−4M. This was
accomplished by evaporation using a vacuum concentration unit RVC 2-33CDplus
(Martin Christ Gefriertrocknungsanlagen GmbH, Germany) operated at 24mbar.
After concentrating, the protein samples were transferred to 25mM sodium phosphate
buffer (pH7) using Slide-A-Lyzer™ Dialysis Cassettes (Thermo Fisher Scientific,
USA) with a molecular weight cut-off of 2 kDa. All chromatography experiments
were carried out at 25∘C.
5.2.5. Offline Identification and Quantification of PEGamer Species
Purity of isolated mono-PEGylated lysozyme was determined by high-throughput
capillary gel electrophoresis (HT-CGE) as described in [181]. The experiments were
performed with an HT Protein Express LabChip® and an HT Protein Express Reagent
Kit (Perkin Elmer, Hopkinton, MA, USA). The LabChip® installation, sample
preparation and analysis were performed according to the manufacturer’s standard
protocol [184]. Sample preparation was performed in skirted 96-well polypropylene
twin.tec® PCR plates from Eppendorf (Hamburg, Germany). Molecular weight
determination was performed according to protein standards from the HT Protein
Express Reagent Kit.
For protein quantification, absorption measurements at 280 nm were performed.
Since the bound PEG molecules do not absorb at 280 nm, the extinction coefficient
of 𝜀1%280𝑛𝑚,𝑙𝑦𝑠𝑜𝑧𝑦𝑚𝑒 = 22.00 was used for native as well as for mono-PEGylated lyso-
zyme [181, 185]. Appropriate blanks were subtracted. Molar concentrations were
Table 5.1.: NaCl steps in mM used for the elution of different PEGamer species from Toyopearl
GigaCap S-650M at pH5 as a function of the PEG molecular weight
Native lysozyme mono-PEGylated
lysozyme
di-PEGylated lyso-
zyme
M𝑤=2 kDa 1000 460 290
M𝑤=5 kDa 1000 350 160
M𝑤=10 kDa 1000 250 75
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calculated using a lysozyme molecular mass of 14.6 kDa [186]. The final concentra-
tions of native lysozyme and mono-PEGylated species attached with 2 kDa, 5 kDa,
and 10 kDa PEG used for the linear gradient and breakthrough experiments were
3.87·10−4± 7.19·10−7M, 3.63·10−4± 1.41·10−7M,
3.60·10−4 ±1.61 ·10−7M, and 3.81·10−4± 1.57·10−5M, respectively. The slight devia-
tions in PEGamer concentrations are due to concentrating and buffer exchange. For
subsequent modeling the exact concentrations were employed.
5.2.6. Chromatography System Characterization
Tracer pulse injections at constant flow rate of 0.33mL/min were carried out to
characterize the ÄKTA™ system and chromatography column. For determination
of the interstitial volume of the column, 25𝜇L of 10 g/L non-interacting, non-pore-
penetrating tracer blue dextran 2000 kDa (Sigma-Aldrich, St. Louis, MO, USA) in
ultra-pure water was used. 25𝜇L of 1%(v/v) pore-penetrating, non-interacting tracer
acetone (Merck, Darmstadt, Germany) in ultra-pure water was used to determine
system and total voidage of the column. The UV signals at 260 nm were recorded
for that purpose. All measurements were corrected with respect to system dead
volumes. The ionic capacity 𝛬 of GigaCap S-650M was determined via acid-base
titration following Huuk and coworkers [165].
5.2.7. Linear Gradient Experiments for Model Calibration
Protein solutions with lysozyme and its PEGylated species were prepared in binding
buffer (25mM sodium phosphate buffer, pH7.0). Before injection, the protein
solutions were filtrated with a membrane cut-off of 0.22𝜇m.
Linear gradient elution (LGE) experiments were used for determining model parame-
ters for native lysozyme, lysozyme attached with PEG 2kDa, PEG 5 kDa, and PEG
10 kDa. Protein solutions were injected via a 100𝜇L loop. After a post-loading wash
step of 1CV binding buffer, elution was carried out by increasing the salt gradient
from 0M to 1.0M NaCl. From low-salt and high-salt buffer, linear gradients with
a gradient length of 15CV, 20CV, and 25CV were mixed within the LC system.
After that, the column was stripped over 3CV at an NaCl concentration of 1.0M
and re-equilibrated for 5CV binding buffer. To ensure a constant residence time, all
experiments were carried out at a flow rate of 0.33mL/min.
5.2.8. Breakthrough Experiments for Model Calibration
Breakthrough experiments were used for modeling of the SMA isotherm model in
the non-linear region. Protein solutions with native lysozyme, lysozyme attached
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with PEG 2kDa, PEG 5 kDa, and PEG 10 kDa were prepared in binding buffer and
injected via a 50mL superloop (GE Healthcare, UK). The loading was carried out
under strong binding condition at 0M NaCl until 100% breakthrough was observed.
To ensure a constant residence time, all experiments were carried out at a flow rate
of 0.33mL/min.
5.2.9. General Rate Model
In the presented study, the general rate model (GRM) was employed to cover
convection and diffusion within a one-dimensional chromatography column of length
𝐿. Here, the concentrations of all components 𝑖 in the bulk phase 𝑐, in the pore
phase 𝑐𝑝, and adsorbed to the stationary phase 𝑞 depend on time 𝑡 and axial position
𝑥. Eq. 7.1 describes the mass transfer between the bulk phase and the pore phase
depending on the flow velocity 𝑢, axial dispersion 𝐷𝑎𝑥, bed porosity 𝜖𝑏, film diffusion
coefficient 𝑘𝑓𝑖𝑙𝑚, particle radius 𝑟𝑝, and the concentrations 𝑐 and 𝑐𝑝. The chosen
Danckwerts boundary conditions are shown in Eqs. 7.2 and 7.3. In Eq. 7.4 the
mass transfer between the pore phase and the stationary phase is described to be
dependent on the radial position in the pore 𝑟, pore diffusion coefficient 𝐷𝑝, particle
porosity 𝜖𝑝, film diffusion coefficient 𝑘𝑓𝑖𝑙𝑚, and concentrations in the bulk phase 𝑐,
pore phase 𝑐𝑝, and stationary phase 𝑞.
𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑡
= −𝑢(𝑡)𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑥
+𝐷𝑎𝑥
𝜕2𝑐(𝑥,𝑡)
𝜕𝑥2
(5.1)
−1− 𝜖𝑏
𝜖𝑏
𝑘𝑓𝑖𝑙𝑚,𝑖
3
𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑡))
𝜕𝑐𝑖(0,𝑡)
𝜕𝑥
= 𝑢(𝑡)
𝐷𝑎𝑥
(𝑐𝑖(0,𝑡)− 𝑐𝑖𝑛,𝑖(𝑡)) (5.2)
𝜕𝑐𝑖(𝐿,𝑡)
𝜕𝑥
= 0 (5.3)
𝜕𝑐𝑝,𝑖(𝑥,𝑡)
𝜕𝑡
=
⎧⎪⎨⎪⎩
1
𝑟2
𝜕
𝜕𝑟
(𝑟2𝐷𝑝,𝑖 𝜕𝑐𝑝,𝑖(𝑥,𝑡)𝜕𝑟 )− 1−𝜖𝑝𝜖𝑝
𝜕𝑞𝑖(𝑥,𝑡)
𝜕𝑡
for 𝑟 ∈ (0, 𝑟𝑝),
𝑘𝑓𝑖𝑙𝑚,𝑖
𝜖𝑝𝐷𝑝,𝑖
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑡)) for 𝑟 = 𝑟𝑝,
0 for 𝑟 = 0.
(5.4)
5.2.10. Adsorption Isotherm Model
Based on the stoichiometric displacement model (SDM) [187], Brooks and Cramer
derived the steric mass action (SMA) isotherm model by introducing the shielding
factor 𝜎, which accounts for the sterically hindered binding sites on the adsorber
surface due to protein binding [57]. In Eq. 5.5, the kinetic formulation according
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to Nilsson and coworkers is shown [188]. It describes the protein concentration
in the stationary phase 𝑞 as a function of 𝑞 itself, in the pore phase 𝑐𝑝, and salt
concentration 𝑐𝑝,𝑠𝑎𝑙𝑡 in the pore phase.
𝑘𝑘𝑖𝑛,𝑖
𝜕𝑞𝑖(𝑥,𝑡)
𝜕𝑡
= 𝑘𝑒𝑞,𝑖(𝛬−
𝑘∑︁
𝑗=1
(𝜈𝑖 + 𝜎𝑖)𝑞𝑗(𝑥,𝑡))𝜈𝑖𝑐𝑝,𝑖(𝑥,𝑡) (5.5)
−𝑐𝑝,𝑠𝑎𝑙𝑡(𝑥,𝑡)𝜈𝑖𝑞𝑖(𝑥,𝑡), ∀𝑖 ̸= 𝑠𝑎𝑙𝑡
Eq. 5.6 describes the salt concentration in the stationary phase as a function of
proteins bound to the adsorber surface.
𝑞𝑠𝑎𝑙𝑡(𝑥,𝑡) = 𝛬−
𝑘∑︁
𝑗=1
𝜈𝑗𝑞𝑗(𝑥,𝑡) (5.6)
Instead of the adsorption rate coefficient 𝑘𝑎𝑑𝑠 and the desorption rate coefficient 𝑘𝑑𝑒𝑠,
the equilibrium coefficient 𝑘𝑒𝑞=𝑘𝑎𝑑𝑠/𝑘𝑑𝑒𝑠 and the kinetic coefficient 𝑘𝑘𝑖𝑛 = 1/𝑘𝑑𝑒𝑠
were used. In this way, parameter estimation was simplified, since 𝑘𝑒𝑞 and 𝑘𝑘𝑖𝑛
correlate mainly with the retention time and peak height, respectively [115]. 𝜈 is the
characteristic charge, also known as the number of binding sites directly involved
in binding. 𝛬 is the column-specific ionic binding capacity equal to the number
of potential binding sites. Here, the SMA isotherm has been chosen to cover the
overloading state in investigated breakthrough experiments. For the description of
low protein loading as usually applied in the step gradient experiments for preparative
separation, the SDM isotherm would be sufficient. The kinetic formulation has been
chosen out of several reasons. According to Carta and Jungbauer, protein adsorption
is often slower than small molecules because of limitations in the binding kinetics.
In addtion, a true adsorption equilibrium may not be established since the protein
may undergo molecular changes due to unfolding, aggregation, or degradation before
reaching equilibrium with the surface [189]. Furthermore, Toyopearl GigaCap S-650M
is a hydroxylated methacrylic polymer grafted adsorber providing high ligand density.
As result, fast adsorption rates may be favored initially, but with increasing protein
binding, steric crowding and electrostatic repulsion may limit the access to binding
sites [190, 191].
5.2.11. Numerical Methods
The chromatograms resulting from LGE and breakthrough experiments were used to
estimate the parameters with the inverse method [116].The adaptive simulated anne-
aling (ASA) [113] yielding the first guess was followed by the Levenberg-Marquardt
(LM) algorithm [114] for the fine adjustment of the parameter estimates. Subse-
quently, the confidence intervals at 95% level were calculated to verify estimation
76 Model-based Investigation on PEGylated Proteins in Chromatography
reliability. Discretization in space on a grid with equidistant nodes and 𝜃-scheme
discretization in time were carried out by employing the finite element method and
the fractional step [111], respectively. Picard iteration was employed to approximate
the solution of the non-linear equation system [112].
5.3. Results
5.3.1. PEGylation and Purification
In case of lysozyme, six lysine residues and the N-terminal amino group are available
as binding sites for the PEG aldehyde reaction [192]. The large number of binding
sites allows for the formation of different PEGamers. Preparative isolation of
the mono-PEGylated species was performed by a single cation-exchange step. In
Fig. 5.1 the resulting chromatograms are shown for 1:12 diluted PEGylation batches
with 2 kDa (a), 5 kDa (b) and 10 kDa (c) PEG. After peak fractionation, HT-CGE
analysis was performed according to [181] to verify purity and PEGylation degree.
As observed and discussed by [174, 176, 193], a decrease in elution volume with
increasing PEGylation degree was observed for all PEG molecular weights. The red
areas in Figs. 5.1a-c indicate the respective pooling limits for the mono-PEGylated
species based on purity requirements greater than 97%. Purity was determined by
HT-CGE analysis according to the analytical protocol established by [181]. The
resulting fluorescence signals of HT-CGE for the native lysozyme and the purified
mono-PEGylated species with a concentration of 6.99·10−5 M showed a distinct peak
broadening of PEGylated proteins compared to the native species (Supplementary
Fig. 5.5). By using the calibration established by [181], this peak broadening was
taken into account in the calculation of purities.
Figure 5.1.: Chromatograms of preparative CEX for 1:12 diluted PEGylation batches (r=6.67,
pH 7.2, 3.5 h) loaded with a 50 mL loop for 2 kDa PEG (a), 5 kDa PEG (b) and 10 kDa PEG
(c). The red area indicates the respective pooling limits for the mono-PEGylated species.
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5.3.2. System Characteristics
Tracer experiments were carried out to determine the system parameters bed voidage,
particle voidage, and axial dispersion. The ionic capacity was determined by applying
acid-base titration. The results are shown in Tab. 5.2. The axial dispersion was
found to be similar to literature data [194].
5.3.3. Linear Gradient Elution and Breakthrough Experiments
Linear gradient experiments were carried out to generate information about proteins
in the linear region of the adsorption isotherm. The retention time of every protein
species over three different salt gradient lengths yielded information about the
isotherm parameters characteristic charge 𝜈 and equilibrium coefficient 𝑘𝑒𝑞. The
height, width, and shape of the elution peaks provided partial information about the
mass transfer parameters film diffusion coefficient 𝑘𝑓𝑖𝑙𝑚 and pore diffusion coefficient
𝐷𝑝. Thus, by employing ASA and LM, 𝜈 and 𝑘𝑒𝑞 were estimated with high reliability,
for 𝑘𝑓𝑖𝑙𝑚 and 𝐷𝑝 an initial guess was delivered. As can be seen by comparing the
dashed lines in Figs. 5.2a, d, g, and j, lysozyme in its native form was the strongest
binding species for all investigated gradient lengths. Comparison of the elution peaks
of native and PEGylated species at a constant gradient length in Fig. 5.2 reveals
that the elution times decreased with increasing PEG chain length. Except for the
different elution times of all protein species, their peak heights and widths are highly
similar at each salt gradient conditions. A small shoulder peak behind the main peak
can be seen in Fig. 5.2d-f, indicating a small amount of a stronger binding protein
species. Presumably this species is by unmodified lysozyme, since for the 2 kDa
PEGylation no peak baseline sepearation between the different PEGamer species
could be achieved in in preparative chromatography (compare Fig. 5.1a).
Table 5.2.: For the Toyoscreen column,the voidages and axial dispersion are calculated from
the retention volume and peak broadening of tracer injections. The ionic capacity is determined
by acid-base titration.
GigaCap S-650M
Particle diameter 𝑑𝑝 75𝜇𝑚
Bed voidage 𝜖𝑏 0.414
Particle voidage 𝜖𝑝 0.779
Total voidage 𝜖𝑡 0.871
Axial dispersion [𝑚𝑚2/𝑠] 𝐷𝑎𝑥 6.691·10−2
Ionic capacity [M] 𝛬 1.389
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Additionally, breakthrough experiments were carried out under strong binding condi-
tion. The 280 nm signals were highly non-linear above 2000mAU and reached the
detector saturation at approximately 2500mAU. As shown by the dashed lines in
Fig. 5.3, lysozymes with 10 kDa, 5 kDa and 2 kDa PEG attached, and the native
lysozyme exhibited their breakthrough in successive order. Based on this information,
the shielding parameter 𝜎 was estimated and the correlation between 𝑘𝑘𝑖𝑛 and 𝑘𝑓𝑖𝑙𝑚
that both affect the peak height in the linear part of the adsorption isotherm was
dissolved.
The final parameter estimates and the related confidence intervals at 95% level are
summarized in Tab. 5.3. The simulated LGE for the four protein species are displayed
in measurements was found for the retention time, peak width, and peak shape.
Overall, the conformity was highest for the native lysozyme. The peak heights of
PEGylated species were slightly overestimated. The simulated breakthrough curves
for all protein species are displayed in Fig. 5.3. Here, the model accurately accounted
for the overall slopes and reflected the process relevant times at 10% and 50%
breakthrough. The relative offsets for the process times at 10% breakthrough were
1.83% for lysozyme in the native condition, 3.53% for lysozyme attached with 2 kDa
PEG, 1.93% for lysozyme attached with 5 kDa, and 4.17% for lysozyme attached
with 10 kDa.
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Figure 5.2.: Plots of UV signals over process run-time for bind-and-elute experiments. Dashed
lines display the UV signals measured at the column outlet and the adjusted linear salt gradients.
Solid lines represent the simulated chromatograms. The elution peaks of native lysozyme,
lysozyme attached with 2 kDa PEG, 5 kDa PEG, and 10 kDa PEG by applying linear salt
gradients from 0.05M to 1.0M over 10CV, 15CV, and 20CV are shown in (a) - (c), (d) - (f),
(g) - (i), and (j) - (l). Similar peak heights and widths, but different retention times can be
seen for different protein species. Here, the Toyoscreen column was employed.
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Figure 5.3.: Plots of normalized protein concentration over process run-time for breakthrough
experiments. Dashed lines display the normalized protein concentrations calculated from UV
Fig. 5.2 as solid lines. In all cases, a good agreement between simulations and signals measured
at the column outlet and the constant salt concentration at 0.05M. Solid lines represent the
normalized protein concentrations calculated from the simulated chromatograms. The native
lysozyme and lysozyme attached with 2 kDa PEG, 5 kDa PEG, and 10 kDa PEG are shown in
purple, yellow, green, and red, respectively. Here, the Toyoscreen column was employed.
5.3.4. Mass Transfer and Kinetic Phenomena
The GRM assumes that the adsorbent particles have a spherical shape and a uniform
diameter. The shape of PEGylated proteins is influenced by the surrounding PEG
layer which is higlhly dynamic. Due to the high hydration of PEG, PEGylated
proteins have a significantly greater hydrodynamic radius than unmodified proteins
with a comparable molecular weight. Fee and Van Alstine introduced a nonlinear
relationship between the degree of PEGylation in terms of total molecular weight of
PEG attached and the hydrodynamic radius of the PEGylated protein [172, 175].
This non-linearity is the reason why the behavior of conjugated proteins in IEX must
necessarily be described as a function of the hydrodynamic radius and not in terms
of the total molecular weight of attached polymer. According to the correlation
introduced by Fee and Van Alstine [172], the hydrodynamic radii ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 were
calculated to be 2.00 nm, 2.37 nm, 3.08 nm, and 3.84 nm for the four lysozyme species
with increasing PEG MW.
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Table 5.3.: Parameters of the mass transfer model and kinetic isotherm formulation estimated
from bind-and-elute experiments with linear salt gradient and breakthrough curves using
the inverse method are shown for native and mono-PEGylated lysozyme species. Confidence
intervals at 95% level reflect the reliability of the parameter estimates.
Parameter Native 2 kDa
PEGylated
5 kDa
PEGylated
10 kDa
PEGylated
𝑘𝑓𝑖𝑙𝑚 [𝑚𝑚/𝑠] 9.95·10−2
± 5.20·10−2
8.92·10−2
± 5.49·10−2
6.62·10−2
± 3.12·10−2
4.07·10−2
± 2.53·10−2
𝐷𝑝 [𝑚𝑚2/𝑠] 2.85·10−4
± 2.38·10−5
1.33·10−4
± 7.56·10−6
8.42·10−5
± 2.08·10−6
5.75·10−5
± 2.28·10−6
𝑘𝑒𝑞 [-] 4.62 ·10−2
± 9.16·10−5
5.94 ·10−3
± 2.79·10−5
1.16·10−3
± 5.13·10−6
1.92·10−5
± 1.48·10−6
𝑘𝑘𝑖𝑛 [𝑠𝑀−𝜈 ] 3.94 ·10−2
± 7.56·10−4
4.58 ·10−3
± 2.10·10−4
2.31·10−4
± 6.74·10−5
6.34·10−6
± 2.82·10−5
𝜈 [-] 4.21
± 1.82 ·10−3
4.21
± 2.65·10−3
4.20
± 1.10·10−3
4.22
± 1.56·10−3
𝜎 [-] 5.61
± 1.27·10−2
6.81
± 1.35·10−2
9.79
± 1.67·10−2
25.90
± 1.08·10−1
For lysozyme, the mass transfer coefficient 𝑘𝑒𝑓𝑓 calculated according to 1/𝑘𝑒𝑓𝑓 =
1/𝑘𝑝𝑜𝑟𝑒+1/𝑘𝑓𝑖𝑙𝑚 with the internal mass transfer resistance 𝑘𝑝𝑜𝑟𝑒 = 10𝐷𝑝𝜖𝑝/𝑑𝑝 [41] was
found to be consistent with literature data [194]. An approximately linear decrease
of the film diffusion coefficient 𝑘𝑓𝑖𝑙𝑚 with increasing ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 was determined as
displayed in Fig. 5.4 a. A comparable dependency was reported by Mejía-Manzano
et al. [195] for affinity chromatography. As shown in Fig. 5.4 b, the pore diffusion
coefficient 𝐷𝑝 decreased reciprocally with increasing ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 according to the
Stokes-Einstein equation qualitatively. The adsorption and desorption rate coefficients
𝑘𝑎𝑑𝑠 = 𝑘𝑒𝑞/𝑘𝑘𝑖𝑛 and 𝑘𝑑𝑒𝑠 = 1/𝑘𝑘𝑖𝑛 were calculated and are displayed in Figs. 5.4 c
and d. With increasing PEG MW, both 𝑘𝑎𝑑𝑠 and 𝑘𝑑𝑒𝑠 showed an exponential
increase. A similar trend has been observed by Mejía-Manzano et al. [195] for affinity
chromatography. The increase of 𝑘𝑑𝑒𝑠 exceeded the increase of 𝑘𝑎𝑑𝑠 by more than
two orders of magnitude. For native and 5 kDa mono-PEGylated lysozyme, 𝑘𝑒𝑞 was
found to be of the same magnitude as reported in the literature [178].
5.3.5. Characteristic Charge and Shielding
The characteristic charges 𝜈 of PEGylated lysozyme (4.20-4.22) were found to be
equal to the value determined for native lysozyme (4.21) as shown in Fig. 5.4 e.
𝜈 was unaffected by PEGylation degree and PEG chain length. This finding was
consistent with data delivered by Abe and coworker [178]. A small shielding factor
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Figure 5.4.: (a) - (f) the show film diffusion coefficient, pore diffusion coefficient, adsorp-
tion coefficient, desorption coefficient, characteristic charge, and shielding factor versus the
hydrodynamic radius ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 of PEGamers. ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 takes into account the non-linear
relationship between conjugate size and total molecular weight of attached PEG [172, 175].
Blue dots from left to right represent the native lysozyme and lysozyme attached with 2 kDa
PEG, 5 kDa PEG, and 10 kDa PEG.
𝜎 of 5.61 was found for the native lysozyme. With increasing PEG chain length, 𝜎
increased from 6.81 for 2 kDa to 9.79 for 5 kDa, and up to 25.90 for 10 kDa PEG
as displayed in Fig. 5.4 f. The dependency of 𝜎 on the hydrodynamic radius was
highly non-linear. Based on the definition of 𝑞𝑚𝑎𝑥 being 𝛬/(𝜎 + 𝜈), the maximal
binding capacity 𝑞𝑚𝑎𝑥 for the four protein species was calculated to be 1.41·10−1M
for native species, 1.26·10−1M for 2 kDa PEGylated species, 9.93·10−2M for 5 kDa
PEGylated species and 4.61·10−2M for 10 kDa PEGylated species. 𝑞𝑚𝑎𝑥 was found
to be reduced by 10.6% when attached with 2 kDa PEG by 29.6% when attached
with 5 kDa PEG, and by 67.3% when attached with 10 kDa PEG compared to the
native lysozyme species.
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5.4. Discussion
PEGylation is commonly used in biopharmaceutical industry to improve protein sta-
bilities and pharmacokinetics of protein drugs. However, the currently used reaction
mechanisms and conditions usually result in a heterogeneous product mixture of unre-
acted protein and conjugates with varying number and modification site of attached
polymers [172, 173]. For this reason, purification processes of PEGylated proteins
are imperative. Chromatographic processes based on electrostatic interactions e.g.
ion-exchange chromatography, are among the most effective purification processes
for this application [179]. So far, the development of ion-exchange steps for the
purification of the individual PEGamers has been driven mainly by expert-based or
experimental approaches (high-throughput process development and statistical design
of experiments). These approaches are time-consuming and cost-intensive due to the
wide variety of proteins and polymers (linear vs. branched, molecular weight etc.).
Mechanistic modeling and simulations can help to reduce the number of experiments
during process optimization by in silico predictions [85]. From the perspective of
process development, the parameters estimated by mechanistic modeling can be
used for process up scaling, process optimization, and process control, meeting the
demands of the Quality by Design approach (QbD) proposed by the US food and
drug administration (FDA) [17].
In our work, the SMA isotherm in kinetic formulation coupled with the GRM
produced a comprehensive description of the adsorption and desorption behavior on
the adsorber surface, steric hindrance, and the mass transfer for native lysozyme
and its PEGylated species. The model parameters 𝑘𝑓𝑖𝑙𝑚, 𝐷𝑝, 𝑘𝑒𝑞, 𝑘𝑘𝑖𝑛, 𝜈, and 𝜎
were determined and 𝑘𝑎𝑑𝑠, 𝑘𝑑𝑒𝑠, ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡, and 𝑞𝑚𝑎𝑥 were calculated to improve the
mechanistic understanding of PEGylated proteins in CEX. It should be mentioned,
that the PEGylation reaction usually delivers various PEGamer isoforms. In the
presented case, the isoforms behaved highly similar and could not be separated with
the used CEX setup. Hence all isoforms of each lysozyme species had to be modeled
as lumped components, resulting in slight overestimation of the peak heights.
As reported by many researchers, PEGylated proteins elute earlier than their native
analogs [176, 178, 179]. Based on the observation of the elution order of different
PEGylated species beeing the same in both cation-exchange and anion-exchange
chromatography, Seely and Richey suggested the ‘charge-shielding effect’ to explain
this phenomenon [176]. Later, Abe and coworkers applied the equilibrium stoichiome-
tric displacement isotherm model (SDM) to describe the retention time of PEGylated
proteins in linear gradient experiments and determined similar numbers of binding
sites for lysozyme and BSA attached with PEG of different lengths. Furthermore,
they reported the decrease of a lumped parameter consisting of the equilibrium
coefficient, the binding site, and the ionic binding capacity with increasing PEG
chain length [178]. In this way, the ‘charge-shielding effect’ hypothesis was verified
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and the equilibrium coefficient was identified to be responsible for the weaker binding
of PEGylated proteins [178].
𝑘𝑓𝑖𝑙𝑚 showed a linear dependency on ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡 as expected according to the corre-
lation suggested by Jungbauer and Carta [189]. Its decrease with increasing PEG
chain length was to be reflected by broader and lower elution peaks. However, the
LGE under same operating conditions showed similar peak heights and widths for all
PEGylated and native species. Considering the fact that there is a strongly exponen-
tial correlation of 𝑘𝑑𝑒𝑠 with ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡, a diffusion-desorption-compensation effect is
suggested to be responsible for the uniformity in peak heights and width. The faster
desorption of proteins attached with longer PEG chain may be neutralized by the
slower film diffusion. This hypothesis is highly consistent with the widely accepted
view of the ‘charge-shielding effect’, since weaker charged proteins increasingly tend
to undergo desorption. 𝐷𝑝 showed a reciprocal correlation with ℎ𝑅,𝑃𝐸𝐺𝑝𝑟𝑜𝑡, as had
been expected according to the Stokes-Einstein equation [196], which is reflected by
slight tailing of elution peaks in LGE. 𝐷𝑝 was found to exceed the molecular diffusion
coefficient for native lysozyme. As intensively studies in literature, there are two
opinions to explain this effect. Carta et al. and Rodrigues et al. [197–199] introduced
the convection-enhanced effective intra-particle diffusivity. Many more experimental
examples of intra-particle convection in protein chromatography could be found in
the literature [200–204]. However, convective mass transfer into the bead interior
was observed for large pores (> 5000𝐴)[204, 205]. For small pores up to 700Å, Nash
et al. assumed diffusional mass transport only. For the TOYOPEARL® GigaCap
S-650M resin having an average pore size of 1000Å, the observed molecular diffusion
coefficient cannot be explained completely by convective mass transport in the pores.
An additional effect observed by Dziennik et al. [206] for porous resins with high
charge density applies to TOYOPEARL® GigaCap S-650M. They found indications
that non-diffusive mechanisms of electrostatic origin could enhance protein uptake
rates in ion exchange particles, resulting in enhanced effective pore diffusivities.
The shielding factor 𝜎 showed an exponential increase with increasing PEG chain
length. In comparison to native lysozyme, approximately 12%, 43%, and 207% more
free binding sites are sterically hindered by the species with 2 kDa, 5 kDa, and 10 kDa
PEG attached, respectively. In contrast to this, 𝜈 was found to be independent of
PEGylation and PEG chain length, indicating the same binding orientation for all
species. Thus, the steric hindrance of free binding sites was identified to be the main
contributor to the observed exponential decrease of molar binding capacity 𝑞𝑚𝑎𝑥
upon PEGylation. It is indicated that the longer PEG chains of an adsorbed protein
make many more free binding sites inaccessible than the shorter ones or equally sized
unmodified proteins. Fee and Van Alstine proposed a correlation for the average
shape of the PEG-layers around a protein over timescale [172, 173]. These layers
are expected to have increasing degree of dynamics with increasing PEG molecular
weight [207]. This concept could also explain the non-linearity in 𝑘𝑎𝑑𝑠, 𝑘𝑑𝑒𝑠, and 𝜎
shown in Fig. 5.4c, d, f.
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Especially in the overloading state under strong binding condition, a high density
of proteins bound could result in formation of multiple PEG chain layers covering
adjacent free binding sites. The multiple PEG chain layers would not shield the
electrostatic interactions, but keep the proteins in the mobile phase distant from the
adsorber surface, so that the electrostatic attraction would become weak and binding
impossible. This hypothesis is schematically represented by Fig. 5.5. Along the
increasing binding density, several transitional states are supposed to exist. First, in
the linear part of the adsorption isotherm, the proteins could distribute uniformly on
the adsorber surface; secondly, unfavorable binding sites between the proteins covered
by thin PEG chain layers could be occupied, though the electrostatic attraction could
already be reduced; finally, the multiple PEG chain layers could become dominant,
so that the electrostatic attraction could disappear and binding could be suppressed.
This concept is consistent with the observation made by Blaschke and coworkers
[208]. They found that adsorption was less enthalpy-driven at higher loading states
for proteins attached with longer PEG chains. Of course, the PEG-layers around
PEGylated proteins are not static, rather of dynamic nature. Thus, the mechanistic
chromatography model describes the average behavior of lysozyme species in CEX.
As suggested by Fee et al., the dynamicism of PEG-layers tend to increase with
increasing PEG chain length. This concept could be an alternative explanation for
the nontrivial behavior of PEGylated lysozymes observed in the presented work.
Using mechanistic chromatography modeling and considering insights provided
by former pioneer work, the hydrodynamics and thermodynamics of PEGylated
lysozymes in CEX were investigated. The diffusion-desorption-compensation effect
was introduced to explain the anomaly of peak heights and widths remaining constant
in spite of an increasing hydrodynamic radius. Additionally, it reflects the exponential
dependency of the shielding factor on the MW of PEGylated proteins and suggests
that multiple PEG chain layers formed in the overloading state are responsible for
this non-trivial phenomenon. Thus, the model view of PEGylated proteins’ behavior
in CEX was supplemented by the overloading state.
This study clearly demonstrates that mechanistic chromatography modeling can be
applied to describe PEGylated proteins with high accuracy and reliability. Thus it has
great potential for the optimization, prediction, and scale-up of purification processes
for PEGylated proteins. A future challenge is to show whether the separation of
positional isoforms can be predicted by this kind of simulation. In this respect, a
combination of mechanistic chromatography modelling combined with molecular
modeling could be profitable.
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Figure 5.5.: Molecular picture of the adsorption of lysozymes on an adsorber surface.
Increasing PEG chain length results in the formation of multiple PEG chain layers hindering
the binding of further lysozymes. The reduction of accessible binding sites explains the observed
decrease in binding capacity upon protein PEGylation. (Molecular graphic of lysozyme (PDB:
1LYZ) was created with YASARA (www.yasara.org)).
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Abstract
In the past decades, research was carried out to find cost-efficient alternatives
to Protein A chromatography as a capture step in monoclonal antibody (mAb)
purification processes. In this work, polyethylene glycol (PEG) precipitation has
shown promising results in the case of mAb yield and purity. Especially with respect
to continuous processing, PEG precipitation has many advantages, like low cost of
goods, simple setup, easy scalability, and the option to handle perfusion reactors.
Nevertheless, replacing Protein A has the disadvantage of renouncing a platform
unit operation as well. Furthermore, PEG precipitation is not capable of reducing
high molecular weight impurities (HMW) like aggregates or DNA. To overcome
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these challenges, an integrated process strategy combining PEG precipitation with
cation-exchange chromatography (CEX) for purification of a mAb is presented.
This work discusses the process strategy as well as the associated fast, easy, and
material-saving process development platform. These were implemented through the
combination of high-throughput methods with empirical and mechanistic modeling.
The strategy allows the development of a common batch process. Additionally, it is
feasible to develop a continuous process.
In the presented case study, a mAb provided from cell culture fluid (HCCF) was puri-
fied. The precipitation and resolubilisation conditions as well as the chromatography
method were optimized, and the mutual influence of all steps was investigated. A
mAb yield of over 95.0% and a host cell protein (HCP) reduction of over 99.0%
could be shown. At the same time, the aggregate level was reduced from 3.12% to
1.20% and the DNA level was reduced by five orders of magnitude. Furthermore,
the mAb was concentrated three times to a final concentration of 11.9𝑚𝑔/𝑚𝐿.
6.1. Introduction
From 1992 to 2015, 47 monoclonal antibodies (mAbs) have been approved either by
the US Food and Drug Administration (FDA), or the European Medicines Agency
(EMA) [4]; until January 11, 2017, the number of approved therapeutic mAbs by
FDA has increased to 68 [5]. Currently, 230 and 52 mAbs have been reported to
undergo the phase 2 and phase 3 clinical studies, respectively. Compared to early
2010 (26 mAbs in late-stage studies), a 100% increase has been achieved, delivering
the evidence for a continuing strong growth of the mAb market [209]. The global
mAb market was currently expected to reach almost $ 125 billion by 2020 [6].
Based on recent advances in upstream processing, a titer increase at commercial
scale up to approximately 20% from 2014 to 2019 has been predicted, whereas
improvements in downstream processing have been adopted more slowly [13]. In
2016, FDA has approved the first mAb biosimilar infliximab-dyyb for the US market,
which will be sold with an estimated discount at 20-30% to its originator. The game-
changing biosimilars, along with the increasing demand for mAbs, and achievements
in upstream processing have placed downward pressure on downstream processing.
As Protein A chromatography provides highly specific binding to the Fc-region of a
variety of mAb types, resulting in high product yield and purity in a single step, it
has become the golden standard for the capture step in the platform process [210–
212]. However, its disadvantages such as slow volumetric throughput and high resin
costs have become even more pronounced under the circumstances mentioned above.
As a result, a growing interest in the development of non-chromatographic mAb
purification processes could be observed [131, 213–218]. Especially precipitation
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methods based on polyethylene glycol (PEG) showed promising results as alternative
capture step [219, 220]. Hammerschmidt et al. [221] investigated the economics of
precipitation in comparison to the actual platform process. The results showed cost
reduction for the precipitation process during clinical as well as in the commercial
phase. Especially in the clinical phases and in small scale production replacing
Protein A resins showed economical benefit.
Additionally, a trend from conventional single column batch chromatography towards
multi-column chromatography has been reported [222–228]. While operating in
semi-continuous fashion, the overall operating time can be reduced. Furthermore,
higher resin utilization per cycle leads to columns with reduced volume. Thus, an
increased productivity may be achieved.
On the process side, Protein A chromatography has been established as an expensive
but easy-to-use technique for mAb capturing, which does not require high development
effort. In comparison, the process development for both precipitation and multi-
column chromatography, however, is much more complicated, which contradicts the
desire for shorter development timelines in the biopharmaceutical industry. Thus,
the necessity of simplification of process development while maintaining product
quality is a major challenge.
Figure 6.1.: Flowchart of the development toolbox and the integrated process which combines
precipitation, resolubilisation and cation-exchange chromatography.
In this work, a case study on industrial mAb purification from a harvested cell culture
fluid (HCCF) by integrating PEG precipitation and cation-exchange chromatography
(CEX) is presented. The occurring difficulties by renouncing Protein A chromato-
graphy are addressed. A combined process development strategy minimizing the
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amount of feedstock needed and experimental effort is suggested. In particular,
high-throughput experimentation, design of experiments (DoE), and mechanistic
chromatography modeling were employed to develop the precipitation, resolubili-
sation, and CEX chromatography step. The developed toolbox and the process
scheme of the case study are illustrated in Fig 6.1. Additionally, based on mechanistic
modeling, the optimized single-column batch chromatography process was transferred
to a three-column CEX periodic counter-current chromatography (3C-PCCC) mode
to investigate the advantages and potential of multi-column chromatography in the
considered case.
6.2. Theory
6.2.1. Fundamentals of Precipitation
Protein precipitation has been known for a long time as a separation method for the
purification of complex protein solutions [229]. Phase separation is carried out by
adding precipitation agents, like inorganic salts, organic solvents, or nonionic polymers
to the protein solution [124–127]. For the precipitation of a complex mAb solution,
in particular the use of polyethylene glycol (PEG) with an average molecular weight
of 6000DA as precipitation agent has shown promising results [64]. Although this
phenomenon is well investigated and there are several models describing the behavior
of proteins in PEG solution, the mechanism is not completely understood [65, 66,
230]. The two theories which describe the mechanism of PEG-induced precipitation
are, on the one hand, the theory of excluded volume [138–140] and on the other
hand the theory of attractive depletion [231, 232]. The theory of excluded volume
is based on the assumption that PEG traps the solvent in the coiled structure and
the folded filament of the solved molecules. This results in the steric exclusion of
proteins from the solvent regions occupied by the polymers. Molecules with a larger
hydrodynamic radius are more strongly excluded compared to molecules with a
smaller one. According to this view, the sterically excluded proteins are concentrated
until their solubility is exceeded and precipitation occurs [68]. In contrast to this
assumption, the theory of attractive depletion describes a force of the order of osmotic
pressure which leads to protein precipitation. This force is caused by mainly steric
exclusion of the PEG molecules from the ambience of the proteins, described as
depletion zone. If two depletion zones are overlapping, a PEG-free area is created
and, therefore, a concentration gradient is formed. This gradient leads to an osmotic
pressure which further leads to precipitation of the proteins. Both theories describe
the mechanism of PEG-induced precipitation but additionally other factors which
influence the colloidal stability of protein solutions like protein concentration, pH or
ionic strength, have to be considered [219].
6.2. Theory 93
6.2.2. Ion-exchange Chromatography Modeling
The following theoretical background was used to carry out mechanistic chroma-
tography modeling for the subsequent CEX step. The general rate model (GRM)
is employedf to cover the convection and diffusion in a chromatography column of
length 𝐿 and adsorber beads of radius 𝑟𝑝 [41]:
𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑡
= −𝑢(𝑡)𝜕𝑐(𝑥,𝑡)
𝜕𝑥
+𝐷𝑎𝑥
𝜕2𝑐(𝑥,𝑡)
𝜕𝑥2
−1− 𝜖𝑏
𝜖𝑏
𝑘𝑓𝑖𝑙𝑚,𝑖
3
𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑟𝑝,𝑡)) (6.1)
𝜕𝑐𝑝,𝑖(𝑥,𝑟,𝑡)
𝜕𝑡
=
⎧⎪⎪⎨⎪⎪⎩
1
𝑟2
𝜕
𝜕𝑟
(︁
𝑟2𝐷𝑝,𝑖
𝜕𝑐𝑝,𝑖(𝑥,𝑟,𝑡)
𝜕𝑟
)︁
− 1−𝜖𝑝
𝜖𝑝
𝜕𝑞𝑖(𝑥,𝑟,𝑡)
𝜕𝑡
for 𝑟 ∈ (0, 𝑟𝑝),
𝑘𝑓𝑖𝑙𝑚,𝑖
𝜖𝑝𝐷𝑝,𝑖
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑟𝑝,𝑡)) for 𝑟 = 𝑟𝑝,
0 for 𝑟 = 0.
(6.2)
𝜕𝑐𝑖(0,𝑡)
𝜕𝑥
= −𝑢(𝑡)
𝐷𝑎𝑥
(𝑐𝑖(0,𝑡)− 𝑐𝑖𝑛,𝑖(𝑡)) (6.3)
𝜕𝑐𝑖(𝐿,𝑡)
𝜕𝑥
= 0 (6.4)
Within the mobile phase 𝑐𝑖(𝑥,𝑡), the mass transfer between the pore volume 𝑐𝑝,𝑖(𝑥,𝑟,𝑡)
and the interstitial volume is described by Eq. (6.1). The voidage of the adsorber
bed 𝜖𝑏, the axial dipersive coefficient 𝐷𝑎𝑥, and the film transfer coefficient 𝑘𝑓𝑖𝑙𝑚,𝑖
describe the peak-broadening effects in the interstitial volume. The mass transfer is
from the pore volume concentration 𝑐𝑝,𝑖 to the stationary phase 𝑞𝑖 and vise versa.
𝜖𝑝 is the adsorber particle voidage and 𝐷𝑝,𝑖 the component-specific pore diffusion
coefficient. Eqs. (6.3) and (6.4) are the Danckwerts boundary conditions.
The widely accepted steric mass action (SMA) isotherm model introduced by Brooks
and Cramer describes adsorption and desorption processes on adsorber surfaces [90].
The kinetic formulation suggested by Nilsson et al. is shown in Eq. 6.5 [188]. Here,
the stationary phase protein concentration 𝑞 depends on 𝑞 itself, pore phase protein
concentration 𝑐𝑝, and pore phase salt concentration 𝑐𝑝,𝑠𝑎𝑙𝑡. 𝜈 is the characteristic
charge representing the binding sites number involved in binding directly. 𝜎 is the
number of binding sites on the adsorber surface sterically hindered by protein binding.
𝛬 is the ionic binding capacity of the column related to adsorber skeleton.
𝑘𝑘𝑖𝑛,𝑖
𝜕𝑞𝑖(𝑥,𝑡)
𝜕𝑡
= 𝑘𝑒𝑞,𝑖(𝛬−
𝑘∑︁
𝑗=1
(𝜈𝑖 + 𝜎𝑖)𝑞𝑗(𝑥,𝑡))𝜈𝑖𝑐𝑝,𝑖(𝑥,𝑡) (6.5)
−𝑐𝑝,𝑠𝑎𝑙𝑡(𝑥,𝑡)𝜈𝑖𝑞𝑖(𝑥,𝑡) ∀𝑖 ̸= 𝑠𝑎𝑙𝑡
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The salt concentration in the stationary phase is described in Eq. 6.6.
𝑞𝑠𝑎𝑙𝑡(𝑥,𝑡) = 𝛬−
𝑘∑︁
𝑗=1
𝜈𝑗𝑞𝑗(𝑥,𝑡) (6.6)
The adsorption rate coefficient 𝑘𝑎𝑑𝑠 and the desorption rate coefficient 𝑘𝑑𝑒𝑠 were
replaced by the equilibrium coefficient 𝑘𝑒𝑞=𝑘𝑎𝑑𝑠/𝑘𝑑𝑒𝑠 and the kinetic coefficient
𝑘𝑘𝑖𝑛 = 1/𝑘𝑑𝑒𝑠 to simplify parameter estimation, as 𝑘𝑒𝑞 and 𝑘𝑘𝑖𝑛 correlate mainly with
the retention time and peak height, respectively [115]. Out of several reasons, the
kinetic formulation has been chosen. Because of limitations in the binding kinetics,
protein adsorption is often slow as reported by Carta and Jungbauer. Additionally,
true adsorption equilibrium may not be established in column chromatography. The
hydroxylated methacrylic polymer-based and polymer-grafted adsorber (Toyopearl
GigaCap S-650M) provides high ligand density, resulting in limited access to bin-
ding sites with increasing protein binding due to steric crowding and electrostatic
repulsion [190, 191].
Combining both GRM and SMA, the presented CEX chromatography process can
be modeled using numerical methods.
6.2.3. 3C-PCCC
Periodic counter-current chromatography is a simulated moving-bed process patented
by GE Healthcare as a semi-continuous purification process [233]. Usually, it is
operated in three- or four-column configurations.
Since PCCC allows the loading of columns much closer to their static binding
capacity, it has the potential to reduce resin volume, buffer consumption, and
process time in comparison to conventional batch chromatography [222–224, 234].
Economical simulation of a Protein A capture step in 3C-PCCC and 4C-PCCC mode
has demonstrated that PCCC can reduce manufacturing costs particularly in early
clinical phases [234]. Compared to traditional batch single-column chromatography,
where the process steps of a chromatography cycle are conducted consecutively, in
PCCC, multiple steps are performed simultaneously but distributed along several
columns. In 3C-PCCC, the process consists of two interconnected columns and one
short-circuited column. The columns are shifted only periodically after two out of
four process steps. In the first stage, column 3 is interconnected with column 2. In
steady-state, column 3 was fed with feed material in the previous steps and is now
fully saturated. Wash buffer is passed through this column to remove unbound and
weakly bound proteins. The wash effluent is directed to the equilibrated column 2 to
recover leached product. In the meantime, feed material is loaded onto column 1.
The flow-through is discarded until the first product breaks through. As soon as the
first product breaks through, column 1 is switched into the interconnected lane and
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the outflow is loaded directly onto column 2. Since the load step is now performed
with two columns in series, resin capacity utilization can be increased by loading
column 1 beyond 1% product breakthrough [233].
While column loading is continued in the interconnected lane, column 3 is short-
circuited and the product is eluted. The short circuit allows the application of
arbitrary elution gradients and center-cut separation. After product elution, column 3
is regenerated and equilibrated. Column 1 and column 2 remain in the interconnected
lane and continue to receive feed material without product breaking through column 2.
The procedure is repeated several times, so that each column is loaded, washed, eluted,
and regenerated several times in the process. In addition to column regeneration, it
might also be necessary to integrate a CIP step. This step can be carried out after
a certain number of process cycles, or, alternatively, as a part of each regeneration
step [233].
6.3. Materials and Methods
6.3.1. Feed Stock
The mAb used in this work was provided as HCCF from LEK d.d. (Ljubljana,
Slovenia). The HCCF was stored at -80∘𝐶 for long-term and at -30∘𝐶 for short-term
storage. All samples were filtered through 0.2𝜇m syringe filters (Satorius, Göttingen,
Germany) directly before use.
6.3.2. Disposables
All precipitation experiments were carried out in 350𝜇l polypropylene flat bottom 96-
well micro plates (Grainer Bio-One, Kremsmünster Austria). For all resolubilisation
studies, 350𝜇l AcroPrep filter plates with a 0.2𝜇m GH polypro membrane (Pall
Corporation, Port Washington, NY, USA) were used. For DNA quantification, black
96-well polystyrene microplates (Thermo Fisher Scientific, Waltham, MA, USA) were
used. Before loading onto the CEX column, pH of the mAb samples was adjusted
using pD 10 desalting columns (GE Healthcare, Little Chalfont, UK).
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6.3.3. Chemicals and Stock Solutions
As buffer substance, acetic acid, sodium acetate trihydrate, sodium chloride, sodium
hydrogen carbonate, and tris(hydroxymethyl)-aminomethane (all Merck KGaA,
Darmstadt, Germany) were used. Tris hydrodochloride was obtained from PanReac
AppliChem (Darmstadt, Germany). Sodium carbonate was obtained from Sigma
Aldrich (St. Louis, MO, USA). The PEG with an average molecular mass of 6000
was obtained from Merck KGaA (Darmstadt, Germany). All buffers were prepared
with a concentration of 100𝑚𝑀 . For this, the appropriate amounts of associated
buffer components were weighted and dissolved in 𝑑𝑑𝐻2𝑂. The desired pH was
reached by varying the amount of acid and basic component for each buffer. For the
40% (w/w)PEG 6000 stock solution, the buffer components were first dissolved in
𝑑𝑑𝐻2𝑂 followed by adding the appropriate amount of PEG 6000.
6.3.4. Liquid Handling Station
All precipitation experiments were carried out on a Tecan Freedom Evo 200 System
liquid handling station (Tecan, Männedorf, Switzerland). The liquid handling station
was equipped with an 8-tips liquid handling arm, a Te-VacS vacuum separation
module, a Te-Shake orbital shaker (all Männedorf, Switzerland), and a Rotanta
46RSC centrifuge (Hettlich GmbH & Co. KG, Tuttlingen, Germany). The system was
controlled by Evoware 2.5 (Tecan, Männedorf, Switzerland). Excel 2013 (Microsoft,
Redmond, WA, USA) was used as data import format and for data storage. All
calculations were done using Matlab R2015a (The Mathworks, Natick, MA, USA).
For reproducible HTS, the 8-tips liquid handling arm was calibrated. A separate
liquid class for each buffer, precipitant, and protein solution was created. The
calibration procedure was described earlier by Oelmeier et al. [235] in detail. By
variation of air gaps and the adjustment of the aspiration, dispensing and beakeoff
speed accuracy pipetting, even for viscous solutions, could be ensured.
6.3.5. Liquid Chromatography System
The chromatographic experiments for mechanistic model calibration were performed
using an Ettan liquid chromatography (LC) system equipped with a pump module
P-905, a dynamic single chamber mixer M-925 (90𝜇𝐿 mixer volume), an autosampler
A-905, and a fraction collector Frac-950. The LC system was additionally equipped
with an UV monitor UV-900 (3𝑚𝑚 optical path length) and a pH and conductivity
monitor pH/C-900 (all GE Healthcare, Little Chalfont, Buckinghamshire, UK). The
LC system was controlled with UNICORN™ 5.31.
As chromatography resin, the strong cation exchanger TOYOPEARL™ GigaCap
S-650M (TOSOH, Stuttgart, Germany) was applied. The resin beads are comprised
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of a polymethacrylate backbone with a mean particle size of 75 𝜇𝑚. The resin
was prepacked by TOSOH in three 1𝑚𝐿 ToyoScreen™ columns with dimensions of
6.4𝑚𝑚𝑥 3 𝑐𝑚.
6.3.6. Analytical Methods
To determine mAb concentration and aggregate content, the UltraHPLC system
Ultimate 3000RSLC, controlled with Chromeleon 6.8 (both Thermo Fisher Scientific,
Waltham, MA, USA) was used. For mAb concentration, a POROS analytical Protein
A column (Thermo Fisher Scientific, Waltham, MA, USA) was connected to a
UHPLC system. Analytical size exclusion chromatography (SEC) was performed
using a TSKgel SuperSW mAb HTP column (TOSOH, Stuttgart, Germany). Host
cell protein (HCP) concentrations of all samples were determined using a microfluidic
CD-based ELISA-like assay on the Gyrolab XPlore station controlled by Gyrolab
(Gyros AB, Uppsala, Sweden). DNA was quantified using a Quant-iT dsDNA assay
kit (Thermo Fisher Scientific, Waltham, MA, USA). The fluorescence intensity
was measured using a Tecan Infinity 200 UV-Vis spectrometer (Tecan, Männedorf,
Switzerland).
6.3.7. High-throughput Method for Precipitation Screening
The precipitation procedure on the automated liquid handling station was described
in detail by Oelmeier et al. [32]. All experiments were carried out at 20∘𝐶, controlled
by air conditioning. Systems with a total volume of 250𝜇l containing an mAb concen-
tration of 1.5𝑚𝑔/𝑚𝐿 were prepared. For finding the optimal precipitation conditions,
the PEG concentration was varied in 24 steps from 0% (w/w) to 13.8% (w/w)PEG
6000. Additionally, the pH was varied in four steps from pH7.5 to pH10.5. After
adding the complex protein stock solution, the system was incubated for 15𝑚𝑖𝑛 on
the orbital shaker at 1000 𝑟𝑝𝑚, and afterwards 15𝑚𝑖𝑛 without shaking. To analyze
the amount of precipitated protein, the microplate was centrifuged for 30𝑚𝑖𝑛 at
4000 𝑟𝑝𝑚. Then, 100𝜇l of the supernatant was sampled and diluted at a ratio of 1:2.
Subsequently, mAb and HCP concentration of the samples were analyzed.
6.3.8. Optimization of the Resolubilisation Using Empirical Modeling
To find optimal resolubilisation process parameters, a DoE was established using the
software Modde 10.1.1 (Umetrics, Umeå, Sweden). As design space, a full factorial
design with three factors was chosen. In preliminary experiments, the mAb showed
instabilities below pH4.0 during resolublisation (data not shown). Therefore, the
pH value of the resolubilisation buffer was varied between pH4.0 and pH6.0. The
filtration time after precipitation and resolubilisation was varied between 150 𝑠 and
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600 𝑠, and the incubation time of the resolubilisation was varied between 75𝑚𝑖𝑛
and 150𝑚𝑖𝑛. As response, mAb yield and the mAb purity were investigated. The
experiments for resolubilisation were carried out on the liquid-handling station with
a method similar to the one described before. Instead of mixing the systems in
96-well microplates, 96-well filterplates were used. After incubation, phase separation
was carried out applying three times 700𝑚𝑏𝑎𝑟 pressure difference for various times.
Subsequently, 240𝜇l of resolubilisation buffer were added to each system. Afterwards,
the filterplates were incubated on the orbital shaker for various times. After the
incubation, a second filtration step was carried out using the vacuum separation
module three times at 700𝑚𝑏𝑎𝑟 pressure difference for various times.
6.3.9. Chromatography System Characterization
The ÄKTA™ system and chromatography column were characterized using tra-
cer pulse injections at constant flow rates of 0.33𝑚𝐿/𝑚𝑖𝑛. 25𝜇L of 10 g/L non-
interacting, non-pore-penetrating tracer blue dextran 2000 𝑘𝐷𝑎 (Sigma-Aldrich, St.
Louis, MO, USA) and 25𝜇L of 1%(v/v) pore-penetrating, non-interacting tracer
acetone (Merck, Darmstadt, Germany) in ultra-pure water were used to determine
the system voidage, interstitial volume and total voidage of the column. Here, the
UV signals at 260 nm were used and corrected due to system dead volumes. The
ionic capacity 𝛬 of GigaCap S-650M was determined by applying acid-base titration
suggested by Huuk et al. [165].
6.3.10. Bind-and-elute Experiments
After the precipitation and resolubilisation steps, linear gradient elution (LGE)
experiments were carried out by means of model calibration. To determine the model
parameters in the linear region of the adsorption isotherm, a 0.5𝑚𝐿 loop was used.
Post-loading wash steps of 1𝐶𝑉 binding buffer were carried out, followed by an
elution step by increasing the salt gradient from 0𝑀to 1.0𝑀 NaCl with gradient
lengths of 10𝐶𝑉 , 15𝐶𝑉 , and 20𝐶𝑉 . For the nonlinear region, 23.16𝑚𝐿 protein
solution was injected via 50𝑚𝐿 superloop before a wash step of 5𝐶𝑉 binding buffer.
Subsequently, the elution was carried out by increasing the salt gradient from 0𝑀 to
1.0𝑀 NaCl with a gradient length of 25𝐶𝑉 . After elution, the column was stripped
over 3𝐶𝑉 at an NaCl concentration of 1.0𝑀 and re-equilibrated for 5𝐶𝑉 binding
buffer. All experiments were conducted at 0.33𝑚𝐿/𝑚𝑖𝑛.
6.3.11. Model Calibration
The chromatograms from LGE in both linear and nonlinear region of the adsorption
isotherm were used to carry out the parameter estimation via the inverse method [116].
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The first guess was delivered using adaptive simulated annealing (ASA) [113]. For fine
adjustment, the Levenberg-Marquardt (LM) algorithm [114] was used. Discretization
in space on a grid with equidistant nodes was carried out using the finite element
method. The 𝜃-scheme discretization in time was conducted using the fractional
step [111]. The solution of the non-linear equation system was approximated via the
Picard iteration [112].
6.3.12. In Silico Optimization and Model Validation
Pareto optimization of the batch single-column chromatography was performed using
ChromX. As objective functions, monomer yield, purity, and production rate were
chosen. Optimization parameters are the injection volume and sodium chloride
concentration in elution step. The salt concentrations of the binding buffer and strip
buffer were kept constant to ensure maximal binding and a complete regeneration
of the columns. The OpenBeagleMultiObjective algorithm was employed for the
in silico optimization. One of the Pareto optima that provided monomer yield and
purity above 90% and 99%, respectively, and the maximal production rate were
chosen to be validated in the laboratory. In silico screening was carried out to
approximate the Pareto optima of the 3C-PCCC process. Here, 1000 simulations
of the 3C-PCCC process were generated by varying the protein injection volume
and the optimal salt elution concentration. Here, 1000 simulations of the 3C-PCCC
process were generated by varying the protein injection volume and the optimal salt
elution concentration. The fractionation was chosen to start and end at 300𝑚𝐴𝑈 .
6.4. Results
6.4.1. Investigation of Precipitation Conditions
In this work, PEG precipitation of the mAb was performed as alternative capture
step for an mAb purification process. In specific, the goal was to find optimal process
conditions for selective precipitation of the mAb. On the one hand, the precipitant
concentration and, on the other hand, the pH value of the buffer used was varied.
As target parameters, mAb yield and HCP reduction were considered.
The mAb as well as the HCP concentration in the supernatant, after phase separation
through centrifugation, are shown in Fig 6.2. All values shown are mean values of
at least triple determinations and refer to conditions at 0% PEG. 98.5% yield was
chosen as target parameter for the precipitation, as this was the maximum reached
yield in this study.
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Figure 6.2.: Selected results of the precipitation screening. Data points represent the mean
values of at least triplicates. As feedstock HCCF was used. Precipitation was carried out using
PEG 6000, varied from 0% (w/w) to 13.8% (w/w)PEG, as precipitant. Additionally the pH of
the utilized buffer was varied. The relative amount refereed to conditions with 0% (w/w)PEG
of (a) mAb and (b) HCP in the supernatant after centrifugation are displayed.
With increasing PEG concentration, a decrease in the mAb concentration in the
supernatant could be observed (Fig. 6.2 (a)). This correlates to an increase in mAb
precipitation. For all pH values, the mAb stayed stable in solution for PEG concen-
trations below 4.2% (w/w)PEG. With the exception of pH 10.5, all other conditions
led to yields above 98.5%. Therefor, no further investigations were carried out at
pH 10.5. The shape of all curves of the different pH values differed in the initial PEG
concentration where the precipitation of the mAb began. For conditions with pH7.5,
pH 8.5, and for pH 9.5, PEG concentrations of 12.6% (w/w)PEG, 13.2% (w/w)PEG,
respectively 13.8% (w/w)PEG were required to reach the predetermined yield.
All examined systems with pH values except for pH10.5 were investigated on HCP
concentration in the supernatant after phase separation (Fig. 6.2 (b)). For all con-
ditions, a decrease in HCP concentration in the supernatant could be observed
with increasing PEG concentration. This correlates to a decrease in the theoretical
purity of the precipitated mAb referred to HCP. Precipitation of HCP was not
detectable for conditions with PEG concentrations less than 7.2% (w/w)PEG. For
all conditions with pH8.5, a stronger reduction in the HCP concentration could
be observed compared to pH7.5 and pH9.5. Furthermore, for PEG concentrations
above 11.8% (w/w)PEG, less HCP reduction could be observed for systems with
pH9.5 compared to pH7.5. For conditions with the predetermined yield being greater
than 98.5% and pH8.5, HCP reduction over 60% could be reached. For systems
with pH7.5, 70%, and for systems with pH9.5, over 79% HCP reduction could be
detected.
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6.4.2. Investigation of Resolubilisation Conditions
For precipitation, with the exception of pH10.5, all other investigated pH values
achieved satisfying results in the case of mAb yield. One precipitation condition
for each investigated pH value with an mAb yield over 98.5% and with the least
amount of PEG was chosen for further process optimization. For these conditions,
the resolubilisation was investigated. In detail, for pH 7.5 at least 13.2% (w/w)PEG,
for pH 8.5 12.6% (w/w)PEG, and for pH 9.5 13.8% (w/w)PEG were needed to reach
the predetermined yield. To optimize the resolubilisation, three factors were taken
into account. The pH of the resolubilisation buffer, the filtration time of the phase
separation through vacuum filtration, and the incubation time of the resolubilisation.
The screenings were carried out as DoE. From the results, a multiple linear regression
model (MLR) was built.
For all three precipitation conditions, a similar behavior of the responses, mAb yield
and purity, could be observed. No significant influence of the filtration time could
be measured and, therefore, this factor was not considered for the model (Fig. 6.3).
This results allow the reduction of the parameter set for further investigations. By
Figure 6.3.: Factors of the MLR model of mAb yield and mAb purity after resolubilisation.
HCCF was precipitated at pH7.5 and 13.2% (w/w)PEG, pH8.5 and 12.6% (w/w)PEG
and pH9.5 and 13.8% (w/w)PEG. Afterward the precipitated mAb was resolubilisation for
incubation times varying from 75𝑚𝑖𝑛 to 150𝑚𝑖𝑛. Additionally the pH of the resolubilisation
buffer was varied from pH4.0 to pH 6.0. Furthermore the filtration time of the phase separation
by vacuum filtration was varied from 150 𝑠 to 600 𝑠. For further investigation only the
resolubilisation time in case of yield and the pH of the resolubilisation buffer in case of the
mAb purity were taken into account for the MLR.
reducing the filtration time an overall time saving for the HTS could be reached.
No influence of the pH of the resolubilisation could be observed in the case of mAb
yield. The only factor which had a significant influence on the mAb yield was the
resolubilisation time (Fig. 6.3 (a)). With longer resolubilisation times, higher yields
were detected. At 150𝑚𝑖𝑛 incubation, yields from up to 100% could be measured
(Fig. 6.4 (a)). For the mAb purity, the only factor which had a significant influence
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was the pH of the resolubilisation buffer (Fig. 6.3 (b)). With lower pH values, a
higher mAb purity could be observed for all precipitation conditions. Purity of mAb
up to 97% could be detected under conditions with pH4.0 (Fig. 6.4 (b)).
Figure 6.4.: MLR model of mAb yield (a) and mAb purity (b) after resolubilisation. HCCF
was precipitated at pH7.5 and 13.2% (w/w)PEG, pH8.5 and 12.6% (w/w)PEG, and pH9.5
and 13.8% (w/w)PEG. Afterwards the precipitated mAb was resolubilised. For the MLR
model of the mAb yield the influence of the incubation time was considered. For the MLR
model of the purity the pH influence of the resolubilisation buffer was considered.
6.4.3. CEX System Characterization
By conducting tracer experiments without a column attached, the LC system dead
volume of 280𝜇𝐿 was determined, which was subtracted from all other data from
the LC. Based on the results of the tracer injections with a column attached, bed
and particle voidage, and axial dispersion were calculated. The acid-basic titration
was conducted to determine the ionic capacity. The results are listed in Tab. 6.1.
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Table 6.1.: The voidages and axial dispersion are calculated based on tracer experiments.
The ionic capacity is determined via acid-base titration.
GigaCap S-650M
Bed voidage 𝜖𝑏 0.414
Particle voidage 𝜖𝑝 0.779
Total voidage 𝜖𝑡 0.870
Axial dispersion [𝑚𝑚2 · 𝑠−1] 𝐷𝑎𝑥 0.067
Ionic capacity [𝑀 ] 𝛬 1.383
6.4.4. In Silico CEX Process Development
Three linear gradient experiments with gradient lengths of 10𝐶𝑉 , 15𝐶𝑉 , 20𝐶𝑉 , and
25𝐶𝑉 in linear and one with 25𝐶𝑉 in nonlinear region of the adsorption isotherm
were used to estimate the chromatography model parameters 𝑘𝑓𝑖𝑙𝑚, 𝐷𝑝, 𝑘𝑒𝑞, 𝜈, and
𝜎 via inverse method by employing ASA and LM algorithm. Non-binding impurities
were lumped to one component. The estimated parameter for monomer, aggregate,
and lumped impurity are given in Tab. 6.2. 𝑘𝑘𝑖𝑛 was found to be not necessary for
the description of the system, since the equilibria of the components considered
were reached immediately. Figs. 6.5 (a) - (d) show the simulated and experimental
chromatograms used for the model calibration. The lumped impurity broke through
during the wash step. The mAb and aggregate show similar behavior and peak
overlapping during gradient elution, whereas the latter shows a slightly stronger
binding. Figs. 6.5 (e) shows the magnified simulated and measured signals of the
same process as in Figs. 6.5 (d).
Knowledge of mass transfer and SMA parameters eventually enabled identification
of the optimal step-wise gradient process for the considered separation problem. To
find the optimal protein loading volume and elution salt concentration with respect
to maximizing monomer yield, purity, and production rate, a multi-objective in silico
process optimizaton was performed. The resulting Pareto-optimal points can be
seen in Fig. 6.6. Constraints for monomer yield and purity were set to be above
90% and 99%, respectively, whilst the maximal production rate was chosen. The
optimal protein injection volume and elution NaCl concentration were predicted to
be 35.98𝑚𝐿 and 0.161M. The validation experiment conducted in the laboratory is
compared to the model prediction in Figs. 6.8 (a) - (c). It can be seen that the behavior
of lumped impurity, mAb monomer, and aggregate are predicted accurately. As
magnified details of Fig. 6.8 (a), Figs. 6.8 (b) and (c) show the simulated and measured
signal of lumped impurities and the aggregate, respectively. Small deviations, such
as the slight underestimation of the aggregate level in the main peak and the tailing
of mAb monomer, are shown. The in silico predicted and experimentally determined
monomer purity, yield, and concentration in the product fraction are compared in
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Table 6.2.: The mass transfer model and adsorption isotherm parameters are estimated using
the inverse method.
Parameter mAb Aggregate Lumped impurity
𝑘𝑓𝑖𝑙𝑚 [𝑚𝑚 · 𝑠−1] 0.086 0.049 0.100
𝐷𝑝 [𝑚𝑚2 · 𝑠−1] 3.508 ·10−5 2.788·10−5 1.648·10−5
𝑘𝑒𝑞 [-] 2.724 ·10−7 6.832 ·10−9 3.995·10−12
𝜈 [-] 8.899 11.340 -
𝜎 [-] 101.380 98.262 -
Tab. 6.3. The monomer purity has a deviation of 0.3%, yields a prediction error of
8.4%, and the monomer concentration in pooled fraction is underestimated by 8.5%.
To investigate the potential of a 3C-PCCC process in the considered case, an in silico
screening was carried out to approximate the Pareto optimal points with respect to
maximizing monomer purity and yield simultaneously. Overall, the optimal protein
injection volumes were found to be greater and the optimal salt elution concentrations
were lower than the ones in the batch single-column process. Improvements of both
monomer purity and yield were found as shown in Fig. 6.7.
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Figure 6.5.: Plots of UV signals over process run time for the bind-and-elute chromatography
experiments. Dashed lines display the UV signal measured at column outlet. Black solid lines
represent the adjusted salt gradients with elution gradient lengths of 10𝐶𝑉 (a), 15𝐶𝑉 (b),
20𝐶𝑉 (c), and 25𝐶𝑉 (d). Blue solid lines and bars represent the simulation of monomer and
offline analytical result, respectively. Red and green are the aggregate and lumped impurity.
(d) displays the breakthrough of lumped impurity and the elution of aggregate.
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Figure 6.6.: Pareto-optimal operating points for the batch single column chromatography
process represent the maximal monomer yield, purity, and production rate by varying protein
loading volume and elution salt concentration.
Figure 6.7.: Comparison of the Pareto-optimal operating proteins for the batch (blue triangles)
and 3C-PCCC process (orange circles).
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6.4.5. Batch Process Validation
After optimization of each process step, a validation run with the optimal process
parameters was performed. The precipitation was performed at pH 8.50 with a PEG
concentration of 12.6% (w/w)PEG. Afterwards, the samples were resolubilised at
pH4.00 for 150𝑚𝑖𝑛 with a filtration time of 150 𝑠. Before the CEX step, the pH of
the sample was adjusted to pH5.00. The subsequent CEX step was conducted at a
loading volume of 35.98𝑚𝐿, and elution NaCl concentration of 0.161M, as predicted
by the mechanistic chromatography model. At the beginning and after each step, the
mAb, HCP and DNA concentration as well as the aggregate content were measured.
In Tab. 6.4, these results are compared to a common purification run. The values
for Protein A are provided from Lek d.d. and were measured directly after Protein
A elution. During the integrated process, HCP and DNA reduction were mainly
reached during the precpitation and resolubilisation step. Aggregate reduction and
concentration of the product were reached during CEX. Compared to Protein A,
mAb yield, HCP reduction, and aggregate content reached similar values. The mAb
concentration of the integrated process was 63% lower in comparison to Protein A
chromatography, the DNA reduction was four magnitudes higher.
Table 6.3.: Comparison between the in silico predicted and experimentally determined
objectives.
Objective Model Experiment Deviation
Monomer purity [%] 99.00 98.70 0.30
Monomer yield [%] 91.10 98.75 8.40
c(monomer) pooled [𝑚𝑔/𝑚𝐿] 10.94 11.87 8.50
Table 6.4.: Case study validation run after optimisation of the integrated process. Monomer
concentration, yield, and purity were detected after each step and compared to a common
Protein A process.
Objectives HCCF Precipitation CEX Protein A
c(monomer) [𝑚𝑔/𝑚𝑙] 3.30 1.69 11.87 32.20
Monomer yield [%] - 96.47 95.41 > 95.00
HCP reduction [%] - 98.23 99.28 99.99
Aggregate content [%] 3.12 3.96 1.30 1.20
DNA [𝑛𝑔/𝑚𝑙] 8.09e+07 2.3 e+03 2.48e+02 1.90e+06
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Figure 6.8.: Plot of UV signal over process run time for the validation experiment. Dashed
lines display the UV signal measured at column outlet. Black solid lines represent the adjusted
step-wise salt gradient. Blue solid lines and bars represent the simulation of monomer and
offline analytical result, respectively. Red and green are the aggregate and lumped impurity.
(b) and (c) display the magnified details of the breakthrough of lumped impurity and the
elution of aggregate in the same process as shown in (a), respectively.
6.5. Discussion
A process strategy for mAb processes was successfully developed. The integration of
PEG precipitation and CEX showed the potential of replacing Protein A as capture
step in an mAb process.
Through the replacement of Protein A, the necessity of establishing an alternative
development platform was given. Furthermore, in comparison to protein A chro-
matography, PEG precipitation alone is not capable of reducing high molecular
weight impurities (HMW) like aggregates or DNA. The integrated process and the
development platform presented in this work can solve both problems. The PEG
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precipitation showed promising results based on mAb yield and HCP reduction.
Resolubilisation at low pH values led to high mAb yields and a high amount of HCP
reduction. The results were comparable to common Protein A steps [236]. Further-
more, it allowed a direct loading onto CEX column. Resolubilisation in combination
with concentration is reported as being time-consuming and might end up with low
yields though incomplete resolubilisation [220]. Using CEX in bind-and-elude mode
combined a reduction of HMW with a volume reduction at the same time.
For this integrated process, a process development platform was designed. It com-
bines high-throughput methods with empirical and mechanistic modeling. For the
precipitation, a high-throughput method on a liquid handling station was successfully
generated. The PEG concentration and the pH of the surrounding buffer showed
significant influence on the precipitation behavior. Although PEG is a cheap raw
material, recycling is currently not an issue. Therefore, the amount of PEG is one
of the driving costs of the process and consequently at least possible PEG should
be used. Studies by Hammerschmidt et al. have shown that precipitation results,
like yield or purity, are independent of the operation mode [237]. This indicates that
development strategy presented here could be used for batch and continuous process
development. After the precipitation, the resolubilisation was optimized using a DoE
and a MLR model, avoiding brute-force methodology. Afterwards, critical process pa-
rameters could be detected and optimized in a goal-driven manner. The mechanistic
chromatography modeling reduced the number of experiments needed to be carried
out in the laboratory. Thus, the material and time required for the development
of precipitation, resolubilisation, and chromatography processes could be reduced.
Furthermore, based on the mechanistic understanding gained, the potential of a
3C-PCCC process could be explored.
The development strategy was used to purify an mAb, provided as HCCF. The
highest observed mAb yield after precipitation was 98.5%. Comparing different pH
values, under conditions with pH 8.5, the least amount of PEG was needed to attend
this objective. Conditions with pH7.5 and pH9.5 reached this yield at slightly higher
PEG concentrations as well. Altogether, the lowest colloidal phase stability of the
mAb was observed near its isoelectric point (pI). This is equal to least electrostatic
repulsion. However, for these conditions, no more than 79.0% HCP reduction were
detected. Co-precipitation of HCP following the mAb could be a reason for this
partial reduction. Higher purities were detected under conditions with minor colloidal
phase stability of the mAb.
As the precipitation alone was not sufficient enough, the resolubilisation was optimized
as second purification step. The DoE showed the pH value to be a critical process
parameter for the reduction of HCP. The resolubilisation was carried out at pH
values near the pI of most of the HCP. This is reported to be around pH5.0 [238].
A selective resolubilisation was observed, and HCP reductions of over 98.0% were
detected. This suggests that most of the HCP were not resolubilised and remained on
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the filter. Simultaneously, the investigated pH values were at least 2.5 pH steps below
the pI of the mAb. This was probably the reason for a complete resolubilisation of
the mAb. Shifting the pH to even lower values could be a possibility to combine virus
inactivation with the resolublisation step. The resolubilisation time was detected
as the second significant process parameter. Higher yields were detected at longer
resolubilisation times. This implies a slow resolubilisation kinetics. The formation
of a filter cake is reported as reason for this phenomenon [237]. No reduction of
molecules with a hydrodynamic radius bigger than that of the mAb was expected.
The aggregate level stayed constant. However, a DNA reduction of over 5 magnitudes
could be seen. This might be due to the incubation conditions, as DNA is reported
to be sensitive towards low pH values [239].
Because the mAb showed instabilities at high salt concentrations (data not shown),
the pH was adjusted from pH4.0 to pH5.0 before the CEX step. For the CEX
step, the predicted Pareto-optimal process could be validated successfully. Here, the
chromatogram predicted showed good agreement with the validation experiment
carried out in the laboratory. The elution of aggregate in the first step was slightly
underestimated, leading to a monomer purity overestimated by 0.3%. The tailing of
monomer was predicted to be more pronounced by the model, resulting in a yield
deviation of 8.4%. The reason of these deviations might be the simplification of the
protein system by neglecting different binding orientations and charge variants. In
the case of the 3C-PCCC process, an in silico screening predicted higher monomer
purity and yield, whereas the optimal protein injection volumes were found to be
greater and the optimal salt elution concentrations were lower than the ones in
the batch single-column process. This observation can be explained by the nature
of the 3C-PCCC mode i.e., by the fact, that a column can be loaded with more
protein. For for the monomers, a more nonlinear region of the adsorption isotherm
could be reached. This resulted in a lower elution salt concentration required. The
aggregates, however, bind in the linear region of the adsorption isotherm due to their
low concentration and tend to retain in the column during the elution step. Hence,
3C-PCCC shows a great potential to be combined with a continuous precipitation
capture process.
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6.6. Conclusion
This work has shown a fast and material saving-process development method for an
mAb process. By integrating a PEG precipitation and CEX chromatography, a feasi-
ble alternative to Protein A chromatography as capture step was demonstrated. For
process development, a strategy combining high-throughput methods with empirical
and mechanistic modeling has shown promising results which might overcome the
drawback of replacing an affinity step.
Precipitating under conditions with pH8.5 and 12.6% (w/w) PEG and resolubilisation
at pH 4.0 led to a significant reduction in HCP level in combination with a yield of over
96.4%. Additionally, loading onto a CEX column with only minor pH adjustments
was enabled. Using a step gradient, an aggregate reduction in combination with
product concentration to 11.9𝑚𝑔/𝑚𝐿 was demonstrated. All in all, a flexible
time-and material-saving method was demonstrated which allows screening of even
more parameters than shown in this case study. Furthermore, the capability of a
continuous chromatography process was explored theoretically based on the calibrated
mechanistic chromatography model.
In further studies, the upscale of these results should be demonstrated. The execution
of a fully continuous process including continuous PEG precipitation in combination
with CEX-PCCC at a larger scale would be desirable.
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Abstract
In protein chromatography, process variations, such as aging of column or process
errors, can result in deviations of the product and impurity levels. Consequently,
the process performance described by purity, yield, or production rate may decrease.
Based on visual inspection of the UV signal, it is hard to identify the source of the error
and almost unfeasible to determine the quantity of deviation. The problem becomes
even more pronounced, if multiple root causes of the deviation are interconnected and
lead to an observable deviation. In the presented work, a novel method based on the
combination of mechanistic chromatography models and the artificial neural networks
is suggested to solve this problem. In a case study using a model protein mixture,
the determination of deviations in column capacity and elution gradient length was
shown. Maximal errors of 1.5% and 4.90% for the prediction of deviation in column
capacity and elution gradient length respectively demonstrated the capability of this
method for root cause investigation.
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7.1. Introduction
Mechanistic models have found extensive applications in protein chromatography as
reported [24, 240–242]. It requires little experimental effort and provides mechanistic
process understanding, which satisfies the demands of the Quality by Design (QbD)
approach promoted by the US Food and Drug Administration (FDA) [17–19].
Mechanistic models for chromatography consist of partial differential equations
describing the convection, diffusion, and adsorption mechanisms in the chromato-
graphic column. For ion-exchange chromatography, a proven approach is given by
the combination of the widely accepted general rate model (GRM) covering the mass
transfer [41], and the stoichiometric displacement isotherm model (SDM) [56, 164]
or its extension, the steric-mass action (SMA) isotherm model [90]. Although these
mechanistic models contain a huge amount of information, they has been almost
exclusively applied to model-based process development [240, 241, 243–245] and
robustness analysis [246–250].
Artificial intelligence and machine learning based on artificial neural networks (ANNs)
have been among the fastest growing research topics in the last decades. The
multilateral applicability of ANN has been demonstrated in numerous fields for
solving many complex real-world problems [162, 251]. In chromatography, ANNs
were thought to be an alternative to first-principle modeling. The back-propagation
ANN (BP-ANN) of simple architecture was employed to model retention times in
different chromatographic modes and formats [26–30]. In this context, however, it
lacks mechanistic understanding and requires a large amount of data for the learning
process that is often not available.
Combining both mechanistic and non-mechanistic modeling results in the so-called
hybrid models or metamodels which enable entirely new opportunities [242, 252–255].
ANNs can make accessible hidden unused information contained in mechanistic
models; whereas the mechanistic model supports the learning process of ANNs with
overwhelming data amounts generated by in silico experimentation. To demonstrate
the power of this combined method, root cause investigation is considered. Here,
an exact mechanistic model which can immediately identify the root causes of the
deviation does not exist. Also the conventional ANN approach would fail, because
it is unfeasible to artificially generate process variations of any magnitude in the
laboratory to gather enough information for its application.
In this work, the combination of mechanistic models and ANNs is carried out to
identify causes for deviation in chromatograms. The presented case study pays
special attention to the ionic capacity for two reasons. First, the ionic capacity of a
column can be influenced by day-to-day operations, column aging, or even a column
exchange - and its deviation can result in deviation of the elution behavior of product
and impurities, leading to reduced purity, yield, or production rate. Secondly, a
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real-time analytical tool for determination of the ionic capacity is not available,
and the current standard method is the time-consuming acid-base titration. The
additional parameter salt gradient length was chosen to complicate the case study,
since its deviation has a very similar effect on the chromatogram. Of course, the
actual values of the salt gradient length can be measured easily using a conductivity
sensor. However, the measurement itself does not allow a quantitative explanation
of deviating chromatograms.
After the mechanistic model has been calibrated, it is employed for in silico experi-
mentation to generate information about the interrelationships between the chroma-
tograms and the two parameters ionic capacity and salt gradient length. Based on
this information, the ANN learns to recognize chromatograms and to respond with
the corresponding parameter values. To verify the ANN’s generalization capability,
20% of the in silico data are used for cross-validation. To demonstrate the practical
applicability of this method, experimental errors are imitated by manipulating the
parameters in the laboratory.
7.2. Theory
7.2.1. Transport-dispersive Model
As a basis for generating large data sets for ANN calibration, mechanistic models
were employed using the following theoretical background. To model the convection
and diffusion inside the chromatography column of length 𝐿 and adsorber beads of
radius 𝑟𝑝, the general rate model (GRM) is used [41]:
𝜕𝑐𝑖(𝑥,𝑡)
𝜕𝑡
= −𝑢(𝑡)𝜕𝑐(𝑥,𝑡)
𝜕𝑥
+𝐷𝑎𝑥
𝜕2𝑐(𝑥,𝑡)
𝜕𝑥2
−1− 𝜖𝑏
𝜖𝑏
𝑘𝑓𝑖𝑙𝑚,𝑖
3
𝑟𝑝
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑟𝑝,𝑡)) (7.1)
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for 𝑟 ∈ (0, 𝑟𝑝),
𝑘𝑓𝑖𝑙𝑚,𝑖
𝜖𝑝𝐷𝑝,𝑖
(𝑐𝑖(𝑥,𝑡)− 𝑐𝑝,𝑖(𝑥,𝑟𝑝,𝑡)) for 𝑟 = 𝑟𝑝,
0 for 𝑟 = 0.
(7.4)
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The mass transfer between the pore volume 𝑐𝑝,𝑖(𝑥,𝑟,𝑡) and the interstitial volume of
the mobile phase 𝑐𝑖(𝑥,𝑡) is described by Eq. (7.1). The peak-broadening effects in
the interstitial volume are lumped in the voidage of the bed 𝜖𝑏, the axial dispersive
coefficient 𝐷𝑎𝑥, and the film transfer coefficient 𝑘𝑓𝑖𝑙𝑚,𝑖. Eqs. (7.2) and (7.3) are the
Danckwerts boundary conditions. Eq. (7.4) describes the exchange between the
stationary phase 𝑞𝑖 and the pore volume concentration 𝑐𝑝,𝑖 depending on the adsorber
particle voidage 𝜖𝑝 and the component-specific pore diffusion coefficient 𝐷𝑝,𝑖. Here,
the less complex linear driving force (LDF) model could also be chosen in spite of
large molecules, if the number of transfer units is high and the adsorption isotherm
is linear.
7.2.2. Stoichiometric Displacement Isotherm Model
In the linear region of the adsorption isotherm, the steric hindrance effect of proteins
can be neglected, resulting in equivalence of the steric mass action (SMA) [90] and
stoichiometric displacement isotherm model (SDM). Since the presented work only
investigates the linear region, for description of the interaction between protein and
ligand on the IEX adsorber surface, SDM in the kinetic formulation is employed [56,
164]:
𝑘𝑘𝑖𝑛,𝑖
𝜕𝑞𝑖(𝑥,𝑟,𝑡)
𝜕𝑡
= 𝑘𝑒𝑞,𝑖𝑞𝑠𝑎𝑙𝑡(𝑥,𝑟,𝑡)𝜈𝑖𝑐𝑝,𝑖(𝑥,𝑟,𝑡)− 𝑐𝑠𝑎𝑙𝑡(𝑥,𝑟,𝑡)𝜈𝑖𝑞𝑖(𝑥,𝑟,𝑡) (7.5)
The adsorption coefficient 𝑘𝑎𝑑𝑠,𝑖 and the desorption coefficient 𝑘𝑑𝑒𝑠,𝑖 are replaced by the
equilibrium coefficient 𝑘𝑒𝑞,𝑖 = 𝑘𝑎𝑑𝑠,𝑖/𝑘𝑑𝑒𝑠,𝑖 and the kinetic coefficient 𝑘𝑘𝑖𝑛,𝑖 = 1/𝑘𝑑𝑒𝑠,𝑖
as proposed in [116]. The advantage of this formulation is that 𝑘𝑒𝑞,𝑖 strongly affects
the retention time, whereas 𝑘𝑘𝑖𝑛,𝑖 has a slight influence on the peak height when the
equilibrium is not reached instantly. 𝜈𝑖 is the characteristic charge of the component
𝑖. 𝑐𝑠𝑎𝑙𝑡 is the counter-ion concentration in the pore phase. The salt concentration in
the stationary phase 𝑞𝑠𝑎𝑙𝑡 is given as:
𝑞𝑠𝑎𝑙𝑡(𝑥,𝑟,𝑡) = 𝛬−
𝑚∑︁
𝑖=1
𝜈𝑖𝑞𝑖(𝑥,𝑟,𝑡) (7.6)
with the ionic capacity of the stationary phase being 𝛬.
Combined with the GRM Eqs. (7.1)-(7.4), an IEX chromatography process can be
modeled using numerical methods.
7.2.3. Numerical Solution
The finite element method is employed for the discretization in space on a grid with
equidistant nodes. The fractional step 𝜃-scheme is chosen for the discretization in
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time [111]. The solution of the non-linear equation system is approximated by Picard
iteration [112]. Adaptive simulated annealing [113] and the Levenberg-Marquardt
algorithm [114] are employed for parameter estimation. The former is a heuristic
algorithm that searches a defined space with random jumps to find the global
minimum. Thereafter, the results are refined by applying the latter algorithm which
is deterministic.
7.2.4. Artificial Neural Networks
In comparison to first-principles modeling, ANN modeling offers numerous advantages
such as the ability to detect possible correlations and unconsidered nonlinear relati-
onships between variables [161]. Its topological structure is shown in Fig. 7.1.Each
Figure 7.1.: Topological structure of a simple multi-layer BP-ANN.
node is connected to every node in the next layer. The nodes in the input layer
represent the input data and the ones in the output layer return the output data.
In the nodes of the hidden layer, the sum of products of biases and weights 𝑛, and
the products of inputs and weights is transferred with a hyperbolic tangent sigmoid
activation function to an output signal between −1 and +1 as shown in Eq. (7.7).
𝑓(?˜?) = 21 + 𝑒−2?˜? (7.7)
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Here, the nonlinearity in the data can be covered. A linear activation function is
employed in the nodes of the output layer to transfer the sum of weighted outputs
from the former layer and the weighted biases to the final outputs. By mapping the
input data to the correct output data using backpropagation, the difference between
the targeted and the actual output values is iteratively minimized by updating the
weights in the network [163].
7.3. Materials and Methods
7.3.1. Instruments
All chromatographic experiments were carried out using an Ettan liquid chromato-
graphy (LC) system equipped with pump unit P-905, dynamic single chamber mixer
M-925 (90 𝜇𝑙 mixer volume), UV monitor UV-900 (3 mm optical path length), and
conductivity cell pH/C-900 (all GE Healthcare, Little Chalfont, Buckinghamshire,
UK).
7.3.2. Software
The control software UNICORN 5.31 (GE Healthcare, Little Chalfont, Bucking-
hamshire, UK) was used in combination with the LC system. The mechanistic
model was simulated using the protein chromatography simulation software ChromX
(GoSilico, Karlsruhe, Germany). ChromX was used for the numerical simulation of
the system of partial differential equations, estimation of model parameters, as well
as optimization and statistical analysis [115]. The ANN modeling was conducted in
Matlab® R2016a (MathWorks, USA).
7.3.3. Adsorber, Proteins, and Chemicals
The strong cation-exchange chromatography (CEX) adsorber medium, TOYOPEARL®
GigaCap S-650M supplied by Tosoh Bioscience (Griesheim, Germany) was used as
pre-packed 0.965mL Toyoscreen® column with dimension 30mm × 6.4mm. The
adsorber media were stored in 20% ethanol between the runs. The storage solution
was removed by prolonged equilibration with water, and flushed with low-salt and
high-salt buffer before experimentation.
Three proteins of different mass transfer and adsorption behavior according to their
different sizes and different isoelectric points were used. A monoclonal antibody
(mAb, pI 8.3-8.5, 144-147 kDa) of the IgG isotype was provided by Lek (Ljubljana,
Slovenia). Cytochrome c (bovine heart, no.A4612, pI 10.4-10.8, 12.3 kDa) was
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purchased from Sigma-Aldrich (St. Louis, MO, USA). Lysozyme (hen egg, no.HR7-
110, pI 11.0, 14.6 kDa) was purchased from Hampton Research (Aliso Viejo, CA,
USA).
The experiments were conducted below the isoelectric points of all three proteins.
50mM sodium phosphate buffer was used at pH 6.5 with additional 0 and 1M
NaCl. 0.5M NaOH was used for cleaning-in-place. All solutions were prepared with
ultra pure water (arium pro UV, Sartorius, Göttingen, Germany), filtrated with
a membrane cutoff of 0.22𝜇m and degassed by sonication. Protein solution with
1mg/ml of IgG, cytochrome c, and lysozyme each was prepared in corresponding
binding buffer and filtrated with a membrane cutoff of 0.22𝜇m prior to usage.
7.3.4. System Characterization
The ÄKTA system and chromatography column were characterized via tracer pulse
injection at a constant flow rate of 0.5ml/min just like all other chromatography
experiments in this work. For determination of the interstitial volume of the column,
filtrated 10 g/L blue dextran 2000 kDa (Sigma-Aldrich, St. Louis, MO, USA) solution
was used as non-interacting, non-pore-penetrating tracer. The system and total
voidage of the column were determined using 25𝜇L 1%(v/v) acetone (Merck, Darm-
stadt, Germany) as a pore-penetrating, non-interacting tracer. For determination of
these parameters, the UV signal at 260 nm was recorded. All measurements were
corrected with respect to dead volumes. Acid-base titration following Huuk et al. was
applied to determine the ionic capacity 𝛬 of GigaCap S-650M [165] in triplicate. The
column was first equilibrated for 15CV with 0.5M HCl to exchange the counter-ion
against protons. Subsequently, the columns were washed with ultra-pure water for
20CV to displace the HCl solution. Finally, the adsorber was titrated with a 0.01M
NaOH solution. The total ionic capacity per adsorber skeleton volume was calculated
according to
𝑛𝑁𝑎+ = 𝑉𝑁𝑎𝑂𝐻 · 𝑐𝑁𝑎𝑂𝐻 (7.8)
and
𝛬 = 𝑛𝑁𝑎+
𝑉𝑐 · (1− 𝜖𝑡) , (7.9)
with the amount of exchanged sodium ions 𝑛𝑁𝑎+ , column volume 𝑉𝑐, total porosity
𝜖𝑡, and concentration of NaOH solution used 𝑐𝑁𝑎𝑂𝐻 .
7.3.5. Bind-and-elute Experiments
Protein solution with 1mg/ml of IgG, cytochrome c, and lysozyme each was prepared
in corresponding binding buffer and injected via a 100𝜇L loop. From low-salt and
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high-salt buffers, different steps and gradients were mixed within the LC system. A
subset of the chromatograms was used to perform the parameter estimation with
the inverse method [116]. The remaining runs were used for model validation and
the ANN-based root cause investigation.
The linear gradient experiments were conducted by applying the varying gradient
lengths 15CV, 20CV, and 25CV. After a post-loading wash step of 1CV equilibration
buffer, elution was started with 50mM and an increasing salt gradient ranging from
50mM to 400mM NaCl. After protein elution, the column was stripped over 3CV
at a NaCl concentration of 1.05M and re-equilibrated for 1CV binding buffer.
The step elution consisted of three elution steps. After an equilibration step with
2CV equilibration buffer and a wash step of 2CV binding buffer, the salt concen-
tration was raised to 100mM NaCl and held for 8CV. Then, the concentration was
further increased to 190mM NaCl and kept constant for 8CV. Finally, the column
was stripped for 3CV at a concentration of 1.05M NaCl and re-equilibrated with
equilibration buffer.
All experiments were carried out at a flow rate of 0.5ml/min to ensure a constant
residence time.
7.3.6. Mechanistic Model Calibration and Validation
Two bind-and-elute chromatograms using linear gradient elution of 20CV and 25CV
were used for model calibration. Widely accepted correlations suggested in the
literature were employed to determine the upper and lower boundaries for subsequent
parameter estimation. The penetration theory [256] was chosen to calculate the upper
boundary and the correlation suggested by Kataoka and coworker [257] was employed
to calculate the lower boundary of the film diffusion coefficient. The correlation
based on Guiochon [40], Tyn and Gusek [258], and Mackie and Meares [259] was used
to estimate the lower boundary, and the correlation based on Guiochon [40], Tyn and
Gusek [258], and Wackao and Smith [260] to estimate the upper boundary of the pore
diffusion coefficient. In parameter estimation, the genetic algorithm was employed
at first. For fine tuning of the parameter estimates, the Levenberg-Marquardt
algorithm [114] was employed. It is important to note, that a small discrepancy
between simulated and experimental chromatograms does not necessarily indicate
an accurate parameter estimation. Thus, the application of parameter estimation
need to be subjected to rigorous validation. Here, an uninvolved step-wise gradient
bind-and-elute chromatogram was predicted and compared to wet-lab experiment for
validation. The confidence intervals at 95% level were calculated based on parameter
sensitivities subsequently to assess the reliability of parameter estimates.
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7.3.7. In Silico Screening
570 model parameter combinations of salt gradient length and ionic capacity were
used to perform in silico experimentation using ChromX. The ranges from 1.0M to
1.3M for the ionic capacity and from 12CV to 28CV for the salt gradient length
were chosen. The salt gradient length and ionic capacity both affect the elution
behavior in very similar ways. Visually inspected, a deviation of the ionic capacity or
salt gradient length influences the retention time and the peak height. A pronounced
problem is given, when multiple root causes are potentially responsible for one
observed deviation. The ranges were chosen to cover different scenarios of deviated
elution behavior on CEX in a process-relevant parameter window. All parameters
and the resulting 570 chromatograms were normalized to the minimum and maximum
values observed. Since the in silico experimentation generates ideal data, white
Gaussian noise was added by a signal-to-noise ratio of 60. After that, all normalized
UV signals smaller than 0.2 were cut off with the aim to reduce the data amount.
This resulted in cheaper computation and was proven to be time-saving for potential
real-time application of the ANN.
7.3.8. ANN Model Calibration and Validation
A simply constructed BP-ANN model with a hidden layer of nine neurons and
an output layer of two neurons was built in MATLAB®. The hyperbolic tangent
sigmoid activation function tansig and the linear activation function purelin were
implemented in the nodes of the hidden layer and in the ones of the output layer,
respectively. The function divideint using interleaved indices was employed to divide
the in silico data into training, validation, and test data sets by a ratio of 5:3:2. The
network training function trainlm was applied to update weight values for inputs
and biases according to an adaptive learning rate and a gradient descent momentum.
The learning rate and the momentum were set to 0.05 and 0.9. A root-mean-square
error (RMSE) of 1·10−5 and a maximal iteration number of 1000 were set as stopping
criteria.
7.3.9. ANN-based Root Cause Investigation
Besides the verification of the ANN’s generalization capability with cross-validation
using 20% of the total in silico data sets, a case study with three runs with differently
pronounced deviations in their chromatograms was designed to show the practical
applicability of the presented root cause investigation method. The calibration
experiment with a linear gradient elution of 25CV and ionic capacity of 1.172M
was chosen to be the set point. Three further bind-and-elute experiments using
parameter combinations of 15CV and 1.172M, 20CV and 1.130M, as well as 25CV
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and 1.130M were carried out in the laboratory. The first experiment represented
the deviation of the salt gradient length only, the second the simultaneous deviation
of the salt gradient length and ionic capacity, and the third the deviation of the
ionic capacity only. Furthermore, they represented the different degrees of deviations
in the chromatogram. The chromatograms were fitted with exponentially modified
Gaussian distribution [166] in the aim of signal smoothing and peak separation. After
normalization, all UV signals smaller than 0.2 were cut off according to the data
preparation for ANN model calibration and validation. The separated peaks were
entered into the calibrated BP-ANN model which returned the predictions of salt
gradient length and ionic capacity for each experiment. Subsequently, the predictions
were compared to the settings and the percentage errors were calculated to prove
the predictive accuracy.
7.4. Results and Discussion
7.4.1. System Characterization
Without a column attached, the dead volume of 280𝜇𝑙 of the LC system was
determined by tracer injection. This dead volume was subtracted from all other data
generated with the LC. Based on the results of the tracer injections, axial dispersion,
bed and particle voidage were calculated. The ionic capacities were calculated based
on the acid-base titration in triplicate. The ionic capacity was reduced irreversibly
from 1.172M± 0.003M to 1.130M± 0.004M by flushing the column with 2.0M HCl
at a flow rate of 0.2ml/min for 24 h. The results are listed in Table 7.1.
Table 7.1.: The voidages and axial dispersion are calculated from the retention volume and
peak broadening of tracer injections. The ionic capacity 1 is the initial state of the column,
whereas the ionic capacity 2 is determined after acid treatment of the same column.
GigaCap S-650M
Bed voidage 𝜖𝑏 0.418
Particle voidage 𝜖𝑝 0.758
Total voidage 𝜖𝑡 0.829
Axial dispersion [𝑚𝑚2 · 𝑠−1] 𝐷𝑎𝑥 0.120
Ionic Capacity 1 [M] 𝛬 1.172± 0.003
Ionic Capacity 2 [M] 𝛬 1.130± 0.004
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7.4.2. Mechanistic Model Calibration and Validation
To estimate the model parameters 𝑘𝑓𝑖𝑙𝑚, 𝐷𝑝𝑜𝑟𝑒, 𝑘𝑒𝑞, and 𝜈 with the inverse method,
two linear gradient chromatography experiments were carried out with gradient
lengths of 20 CV and 25 CV. First, the genetic algorithm was employed. Thereafter,
a Levenberg-Marquardt algorithm was used to find the final optimum. The estimated
parameters are given in Table 7.2. The confidence intervals at 95% level confirm
the reliability of the parameter estimates. Obviously, 𝑘𝑘𝑖𝑛 was not necessary for
the description of the system considered, because the equilibria of all components
were reached instantly. Figs. 7.2 (a) and (b) show the experimental and simulated
chromatograms used for the model calibration. The weakly binding component mAb,
moderately binding component cytochrome c, and the strongly binding component
lysozyme are eluted in the salt gradient in successive order. To prove the prediction
performance of the calibrated mechanistic model, an additional experiment beyond
the calibration space has been conducted as validation data. Fig. 7.2 (c) shows very
good agreement of experimental data and model prediction. Since the reliability of the
parameter estimates and the accuracy of the calibration are given, this mechanistic
model is assessed to be suitable for in silico data generation.
7.4.3. ANN Model Calibration and Validation
570 in silico experiments were conducted to screen the design space as shown in
Fig. 7.3 (b). The resulting chromatograms can be seen in Fig. 7.3 (a). The ranges
from 1M to 1.3M and from 12CV to 28CV were chosen to cover the designed
deviations of ionic capacity and salt gradient length in the case study.Thereafter, all
normalized UV signals smaller than 0.2 were cut off with the aim to reduce the data
containing less relevant case-specific information. The resulting chromatograms can
be seen in Fig. 7.4. This resulted in cheaper computation and proved to be time-
saving for potential real-time application of the ANN. For ANN model calibration,
backpropagation was used to correlate the results of in silico screening with the
corresponding parameter sets. 50% of the total data were used as training data
Table 7.2.: Parameters of the mass transfer model and kinetic isotherm formulation estimated
from two bind-and-elute experiments using the inverse method.
Parameter mAb Cytochrome c Lysozyme
𝑘𝑓𝑖𝑙𝑚 [𝑚𝑚𝑠 ]·10−2 7.516·10−1± 2.474·10−1 1.899± 2.320 2.098± 1.871
𝐷𝑝𝑜𝑟𝑒 [𝑚𝑚
2
𝑠 ]·10−5 2.325± 0.315 6.823± 1.482 6.304± 0.836
𝑘𝑒𝑞 [-] ·10−5 4.388 ·10−5± 0.522·10−5 4.860·10−3± 0.227·10−3 2.982± 0.138
𝜈 [-] 9.720± 0.038 10.353± 0.018 10.012± 0.033
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Figure 7.2.: Plots of UV signals over process run time for bind-and-elute experiments. Dashed
lines display the UV signal measured at column outlet and the adjusted salt gradients. Solid
lines represent the simulated chromatograms. The elution peaks of the early eluting component
mAb, the moderate eluting component cytochrome c, and the late eluting component lysozyme
by applying linear salt gradients from 0.05M to 1.05M over 20CV and 25CV are shown in
(a) and (b). (c) represent a step-wise gradient elution from 0.05M, over 0.1M and 0.19M, to
1.05M.
Figure 7.3.: The resulting chromatograms of the in silico screening are displayed in (a). The
corresponding design space of the in silico screening is shown in (b): ionic capacity∈ [1,1.3]M,
and salt gradient length ∈ [12,28]CV.
set for the ANN’s adjustment according to the respective errors. 30% were used as
validation data set to measure the generalization performance, and to stop training
when generalization stopped improving. The remaining 20% were excluded during
model calibration and used subsequently as test data for cross-validation. The final
correlation achieved for the salt gradient length is given in Figs. 7.5 (a) - (c) which
represent the training data set, validation data set, and test data set, respectively.
Figs. 7.5 (d) - (f) show the correlation for the ionic capacity.
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Figure 7.4.: The post-processed results of the in silico screening are shown.
A good agreement between the predictions by the ANN model and the parameter sets
given in the in silico screening was observed. The smallest deviations were found to
be in the correlation results of training data set (𝑅2 = 0.9997 for salt gradient length,
and 𝑅2 = 0.9992 for ionic capacity). The deviations found in the correlation results
of validation data set were in a statistically acceptable range (𝑅2 = 0.9926 for salt
gradient length, and 𝑅2 = 0.9822 for ionic capacity). According to the correlation
results of the test data set (𝑅2 = 0.9965 for salt gradient length, and 𝑅2 = 0.9904
for ionic capacity), the ANN’s generalization was confirmed, verifying its usability
for the root cause investigation.
7.4.4. ANN-based Root Cause Investigation
Although the ANN’s generalization capability was verified with the cross-validation
using 20% of the total in silico data sets, three runs with strong, moderate, and
slight deviations in their chromatograms were generated in the laboratory to prove
the practical applicability of the presented method for root cause investigation. The
salt gradient length and ionic capacity were adjusted separately and simultaneously
to challenge the calibrated ANN model with the pronounced problem, when multiple
root causes were potentially responsible for one observed deviation. As can be seen
in Table 7.3, the casual relations in all three deviated runs were determined properly.
Overall, the deviations were found in a statistically acceptable range. Errors of
approximately 0% and 4.90% were given for the prediction of the deviated run 1.
The deviated run 2 with both adjusted salt gradient length and ionic capacity was
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Figure 7.5.: Plots of screened parameters versus simulated parameters using ANN model.
(a) - (c) represent the training data set, validation data set, and test data set of the parameter
ionic capacity. (d) - (f) represent the salt gradient length.
predicted accurately with the small errors of 0.53% and 0.55%. Errors of 1.5% and
3.35% were given for the prediction of the deviated run 3. Compared to the inverse
modeling approach proposed by Brestrich and coworkers [261], the presented method
is advantageous with respect to the computational expense. Unlike the necessity
of performing parameter estimation repeatedly, the calibrated ANN model can be
carried out with very little computational expense.
A correlation has been derived by Parente and Wetlaufer originally for determination
of the adsorption isotherm model parameters in linear region [157]. Its modified
formulation delivered by Shukla and coworkers [155] was employed with retention
Table 7.3.: The ionic capacity and salt gradient length adjusted in the laboratory and
predicted with the ANN model, and the percentage error of prediction for three deviated runs.
Ionic capacity [M] Salt gradient length [CV]
Adjusted Predicted Error Adjusted Predicted Error
Deviated run 1 1.172 1.172 0% 15 15.735 4.90%
Deviated run 2 1.130 1.136 0.53% 20 20.109 0.55%
Deviated run 3 1.130 1.147 1.50% 25 24.128 3.35%
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Figure 7.6.: Plots of UV signals over process run time for bind-and-elute experiments. The set
point run displayed as solid blue line is identical with Fig. 1 and shown here for comparability.
The deviated run 1 as dashed purple line was generated by adjusting the salt gradient length
to 15CV. The deviated run 2 as dashed green line was generated by adjusting both the salt
gradient length to 20CV and the ionic capacity to 1.130M. The deviated run 3 as dashed
orange line was generated by adjusting the ionic capacity to 1.130M.
volumes of the solutes and solved for ionic capacity and gradient length. To compare
the performance of this method and the presented one, the calculated results are
shown in Tab. 7.4.
Table 7.4.: The ionic capacity and salt gradient length adjusted in the laboratory and
calculated with the correlation delivered by Parente and Wetlaufer [157], and the percentage
error of calculation for three deviated runs.
Ionic capacity [M] Salt gradient length [CV]
Adjusted Calculated Error Adjusted Calculated Error
Deviated run 1 1.172 1.093 6.76% 15 15.104 0.65%
Deviated run 2 1.130 1.309 15.81% 20 15.003 23.27%
Deviated run 3 1.130 1.175 3.99% 25 20.906 15.25%
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7.5. Conclusion
This study presents a novel method for the root cause investigation in protein
chromatography when an exact mathematical model which can immediately identify
the root causes of the deviation is not given and the amount of data available does
not allow the direct application of an ANN approach. The fundamental idea was to
combine a mechanistic model and an ANN model to benefit from their respective
advantages. The learning material for the ANN model was generated by conducting
570 in silico experiments using the calibrated mechanistic model. Based on these
data, the ANN model learned the correlations between the appearances of the
chromatograms and the parameters of interest. Since only few experiments were
required for the calibration of the mechanistic model, the high wet-lab experimental
effort needed for the training of the ANN model is circumvented. The generalization
performance of the artificial intelligence of a very simple construction was assessed by
correlation results of cross-validation. The practical applicability was verified by an
experimental case study. Thereby, three experiments were conducted in the laboratory
to generate the deviating chromatograms by deliberately causing errors in the
parameters salt gradient length, ionic capacity, and both of them. These experiments
represented the cases of strong, moderate, and slight deviations in the chromatogram,
respectively. This pronounced problem, that multiple root causes could be potentially
responsible for one observed deviation, was solved successfully. The ionic capacity
that had hitherto been a non-observable parameter during operation, was notably
accurate with percentage errors of 0%, 0.53%, and 1.50%.
With this method, one can identify the root causes of the deviation and determine
their magnitudes within milliseconds. Thus, it is well-suited for real-time process
monitoring and control. It allows an immediate correction of the chromatography
process operating condition as a short-term solution. In this way, the economic harm
can be reduced drastically, especially when innovative technologies providing high
productivity e.g., continuous chromatography, are involved in the manufacturing.
For future work, the method should be extended by a decision-making strategy to
be able to correct the deviated operating conditions to the closest Pareto optimum.
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8. Conclusion and Outlook
The presented thesis addresses issues inhibiting the know-how transfer of mechanistic
modeling from academia to industry in DSP. Compared to technologies already
transferred to the industrial work-flow such as HTE and DoE, mechanistic modeling
provides numerous self-evident advantages, but shows challenges in model building,
model calibration, and model application. In these three fields, problems of particular
interest were defined i.e., the lack of suitable mechanistic description for HIC and PEG
induced protein precipitation, the requirement for repeated model calibration using
traditional calibration techniques, the uniform utilization of mechanistic modeling to
develop processes and to analyze process robustness. In this context, new mechanistic
models were derived, novel model calibration method based on ANN was proposed,
and further encouraging applications of mechanistic modeling were demonstrated
and suggested in the thesis.
The first part of this thesis pointed out that modeling of protein behavior in HIC
columns was seldom used due to the lack of a suitable adsorption isotherm model.
Inspired by preceding works and recent insights into water structure on hydrophobic
surfaces, an adsorption isotherm describing protein behavior dependent on variation
of both salt and protein concentration was derived. Hereby, the hydration number of
ions was considered as a function of salt concentration which reciprocally affects the
equilibrium of water structure. Coupled with the GRM, convection, diffusion, and
adsorption processes in chromatography column could be covered. Model’s capability
of describing bind-and-elute chromatograms and predictive power beyond calibration
space were demonstrated successfully.
As protein precipitation did not only share a similar problem, but also highly
similar mechanistic foundation with HIC, the second part of this thesis presented
the derivation of a mechanistic model for protein precipitation using PEG. Here,
the equilibrium between well-ordered and bulk-like ordered water molecules on
hydrophobic surfaces was considered. Compared to the widely used models nowadays,
the here introduced model has advantages such as the capability of modeling the
entire precipitation curve in dependence of protein and PEG concentration. High-
throughput experimental data of different proteins and experimental conditions were
generated to prove the validity of the model.
In the general work-flow of mechanistic modeling, the model has to be calibrated
properly after successful model selection and prior to the use of it at its full potential.
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The third part of this thesis addressed the disadvantages of the commonly employed
model calibration methods in protein chromatography, such as the requirement for
repeated calibration upon new compounds entering the chromatographic system, the
related time consumption, and the resulting computational expense. Solutions were
offered with a newly developed model calibration method based on ANN. In the
presented case study the trained ANN determined the mechanistic model parameters
for uncalibrated compounds immediately and thereby shortened the model calibration
procedure itself to milliseconds from hours or an even longer time.
To meet the QbD demand suggested by the US FDA, advanced process under-
standing provided by mechanistic modeling can be essential in order to transfer
chromatographic processes from laboratory to production scale. In the fourth part
of this thesis, GRM and SMA adsorption isotherm were employed to investigate the
hitherto not completely understood behavior of protein conjugates in IEX. This study
demonstrated that an increase in molecular weight of PEG resulted in abnormal
behavior of the protein conjugates in IEX, such as unchanged elution peak shape and
exponentially decreased binding capacity. Based on the determined mass transfer
and adsorption parameters, the anomalies were explained mechanistically.
An other study on utilizing mechanistic chromatography modeling in IEX was
presented in the fifth part of this thesis. Here, mechanistic modeling was combined
with HTE and DoE resulting in a process development toolbox providing advantages
such as, flexibility, time- and material saving. Based on this toolbox, an integrated
precipitation and IEX process for the purification of an industrial antibody feed was
developed. Its potential for superseding the cost driving Protein A chromatography
in mAb manufacturing was demonstrated. Compared to the industrial Protein
A chromatography step, the developed integrated process showed highly similar
performance with respect to monomer yield, HCP reduction, and aggregate content.
It is, however, inferior in terms of monomer concentration after pooling by threefold,
but superior regarding DNA reduction by four orders of magnitude. Furthermore,
the capability of the single column and three column continuous IEX processes was
studied by calculating the Pareto frontiers based on the mechanistic models. The
result indicated improvements in both purity and yield of monomer when switched
to continuous processing.
In the sixth and last part, a new approach for the root cause investigation of deviations
in protein chromatography is introduced. The presented case study focused on the
ionic capacity of the chromatography column, which can be influenced by a variety
of factors such as, column exchange, column aging, or day-to-day operations. The
deviation of the ionic capacity is unavoidable in manufacturing processes and can have
severe effects on the elution behavior of product and impurities, resulting in reduced
product quality and patient safety. Deviations in salt elution gradient were introduced
additionally. To determine the root causes of deviation, simulations of potential
process deviations generated employing a mechanistic chromatography model were
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used to construct an ANN model. After the ANN learned to recognize deviations in
chromatograms and to respond with the corresponding operating parameter values,
its practical applicability was verified by predicting deviations in wet laboratory
experiments with deliberately introduced errors. The deviations in ionic capacity –
a hitherto non-observable parameter during operation, was determined accurately
with a maximum error of 1.5%.
In summary, this thesis not only contributes to the state-of-the-art in HIC modeling,
protein precipitation modeling, model calibration technique, understanding for ad-
sorption behavior of protein conjugates in IEX, but also explores further application
scenarios of mechanistic modeling in DSP. With the proposed HIC and protein preci-
pitation models, a mechanistic framework is provided for possible model extensions
accounting for specific phenomena such as, irreversible binding, spreading, as well
as multi-layer adsorption of proteins. Furthermore, the possibility for model-based
process development in HIC and selective protein precipitation is given, which would
offer deeper process understanding in accordance with the QbD principle, time-
and material-saving, and the capability of process development in early stages of
product development. The investigation on adsorption and mass transfer behavior
of protein conjugates in IEX delivers mechanistic explanation for the anomalies
observed, which are of great academic and practical interest. The knowledge gained
would simplify the IEX process design and scale up for protein conjugate purification.
The suggested tool box for process development combines the advantages of HTE,
DoE, and mechanistic modeling. Its potential is demonstrated with the developed
and optimized integrated process as a competitive alternative to the widely used
Protein A chromatography for purification of industrial mAb feed stock. In future
studies, the feasibility of the tool box and integrated process could be tested in larger
scale, and both single- and multi-column format.
Compared to the mechanistic approaches, ANN – despite of its extremely versatile
applications in other fields of science and engineering, has noticeably less successes
in the field of chromatography modeling yet. The general reason is the lack of data
in protein chromatography due to its high experimental effort and the limitation
of material, which is compensated with the proposed method i.e., to generate a
necessary amount of data by conducting mechanistic model simulation for ANN
training. On this way, two methods were suggested, which are proven to be efficient
to calibrate mechanistic models and to investigate root causes of deviations in protein
chromatography, respectively. The properly built and trained ANN models are not
only advantageous regarding speed and computational expense, but also easy to
use, even without the otherwise prerequisite deep mathematical understanding. In
future work, the combined mechanistic and ANN-based approach could be used to
realize automated real-time mechanistic model calibration during chromatography
experiments, and implemented for real-time process monitoring and control. It could
be extended by a process development tool and a decision-making strategy that
enables immediate correction of operating parameters upon deviations. In long term,
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these mechanistic and ANN-based methods could be very fundamental building
blocks for an omniscient AI process expert in DSP.
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A. Abbreviations and Symbols
Abbreviations
AC Affinity Chromatography
AI Artificial Intelligence
ANN Artificial Neural Network
ASA Adaptive Simulated Annealing
BP-ANN Back-Propagation Artificial Neural Network
BSA Bovine Serum Albumin
CEX Cation-Exchange Chromatography
CIP Cleaning-in-Place
CV Column Volume
Cyt c Cytochrome c
DoE Design-of-Experiments
DSP Downstream Processing
EMA European Medicines Agency
EMG Exponentially-Modified-Gaussian
FDA Food and Drug Administration
FPLC Fast Protein Liquid Chromatography
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HCCF Harvested Cell Culture Fluid
HCP Host Cell Protein
HETP Height of an Equivalent Theoretical Plate
HIC Hydrophobic Interaction Chromatography
HMW High Molecular Weight Impurities
HT-CGE High-Throughput Capillary Gel Electrophoresis
HTE High-Throughput Experimentation
HTS High-Throughput Screening
IEX Ion-Exchange Chromatography
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IgG Immunoglobulin G
LC Liquid Chromatography
LDF Linear Driving Force
LGE Linear Gradient Elution
LHS Liquid Handling Station
LM Levenberg-Marquardt
LRM Lumped Rate Models
Lys Lysozyme
mAb Monoclonal Antibody
MCSGP Multicolumn Counter-Current Solvent Gradient Purification
MLR Multiple Linear Regression
MSE Mean Square Error
NRMSE Normalised Root Mean Square Error
NRMSEP Normalised Root Mean Square Error of Prediction
PAT Process Analytical Technologies
PCCC Periodic Counter-Current Chromatography
PEG Polyethylene Glycol
pI Isoelectric Point
RMSE Root Mean Square Error
RMSEP Root Mean Square Error of Prediction
QbD Quality by Design
QSAR Quantitative Structure Activity Relationship
SEC Size Exclusion Chromatography
SDM Stoichiometric Displacement Model
SMA Steric Mass Action
TDM Transport-Dispersive Model
UHPLC Ultra High Performance Liquid Chromatography
USP Upstream Processing
VLP Virus-like Particle
3C-PCCC Three-Column Periodic Counter-Current Chromatography
4C-PCCC Four-Column Periodic Counter-Current Chromatography
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Symbols
𝑎 Constant in activation function -
𝑎𝑖 Activity 𝑀
𝑏 Constant in activation function -
𝑐𝑖 Bulk phase concentration of species 𝑖 𝑀
𝑐𝐿 Concentration of free ligands 𝑀
𝑐𝑝,𝑖 Pore phase concentration of species 𝑖 𝑀
𝑐𝑠,𝑖 Stationary phase concentration of species 𝑖 𝑀
𝑐𝑠𝑎𝑙𝑡 Salt concentration in mobile phase 𝑀
𝐶 Output of cost function -
𝑑𝑐 Column diameter 𝑐𝑚
𝐷𝑎𝑝𝑝 Apparent dispersion coefficient 𝑚𝑚
2
𝑠
?˜?𝑎𝑝𝑝 Apparent dispersion coefficent 𝑚𝑚
2
𝑠
𝐷𝑎𝑥 Axial dispersion coefficient 𝑚𝑚
2
𝑠
𝐷𝑝 Pore diffusion coefficient 𝑚𝑚
2
𝑠
𝐺 Gibbs free energy -
𝐺0 Standard Gibbs free energy -
ℎ Ionic hydration number -
𝐾 Equilibrium constant -
𝑘𝑎𝑑𝑠 Adsorption coefficient -
𝑘𝑑𝑒𝑠 Desorption coefficient -
𝑘𝑒𝑓𝑓 Mass transfer coefficient 𝑚𝑚𝑠
𝐾𝑒𝑞 Equilibrium constant of isotherm -
𝑘𝑒𝑞 Equilibrium coefficient -
𝑘𝑓𝑖𝑙𝑚 Film diffusion coefficient 𝑚𝑚𝑠
𝑘𝑘𝑖𝑛 Kinetic coefficient -
𝑘𝑝 Protein specific isotherm constant 1𝑀
𝑘𝑠 Salt specific isotherm constant 1𝑀
𝐿𝑐 Column length 𝑐𝑚
?˜? Salt concentration during precipitation %𝑤/𝑤
𝑛 Number of ligands involved in hydrophobic binding -
?^? Total number of training data sets -
𝑁 Plate number -
𝑁𝑖 Molar flux of species 𝑖 𝑚𝑜𝑙𝑠
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?˜?𝑖 Mole fraction of species 𝑖 -
𝑞𝑖 Stationary phase concentration of species 𝑖 𝑀
𝑞𝑚𝑎𝑥 Saturation capacity of protein binding in chroma-
tography
𝑀
𝑟 Radius 𝑚𝑚
𝑟𝑝 Particle radius of adsorbent 𝑚𝑚
𝑅 Ideal gas constant 𝐽
𝑘𝑔·𝐾
𝑠 Shielding factor in HIC -
𝑠 Solubility of a protein 𝑚𝑔
𝐿
𝑆 Area dimension 𝑚𝑚2
𝑡 Time dimension 𝑠
𝑇 Temperature K
𝑢𝑖𝑛𝑡 Interstitial velocity 𝑚𝑚𝑠
𝑢𝑚 Effective velocity 𝑚𝑚𝑠
?˜? Input signal of activation function -
𝑥 Space dimension 𝑚𝑚
?¯? Mean of 𝑥 𝑚𝑚
𝑦 Output signal of activation function -
𝑦 Desired output of artificial neural network -
𝑦′ Response of artificial neural network -
?⃗?𝑗 Bias vector in the layer 𝑗 -
?˜? Precipitation constant depending on protein -
𝛽 Number of bulk-like water molecules involved in
adsorption/desorption
-
𝛽 Precipitation constant depending on salt -
𝛾 Activity coefficient -
𝛿 Error in an artificial neuron -
?⃗?𝑗 Error vector in the layer 𝑗 -
𝜀 Column porosity -
𝜀𝑡 Total porosity -
𝜀𝑝 Pariticle porosity -
𝛬 Total ligand density 𝑀
𝜈 Stoichiometric coefficient -
𝜇 Chemical potential -
𝜇0 Standard chemical potential -
𝜔 Output signal of an artificial neuron -
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𝜑 Activation function -
𝜑′ Changing rate of activation function 𝜑 -
𝜉 Weight -
𝜉𝑗 Weight vector in the layer 𝑗 -
𝜁 Bias -
𝜎 Shielding factor in IEX -
